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Abbreviations
a1m  alpha-1 microglobulin
ABC ATP-binding cassette
ACE angiotensin converting enzyme
AP alkaline phosphatase
AQP1 aquaporin
ASP 4-(4-(dimethylamino)styryl)-N-methylpyridinium iodide
ATP adenosine tri-phosphate
ß2m beta-2 microglobulin
BBM brush border membrane
BSA bovine serum albumin
CARKL carbohydrate kinase-like
CD13 cluster of differentiation 13
CDME cystine dimethyl ester
ciPTEC conditionally immortalized proximal tubular epithelial cell
CLCN5 chloride proton exchanger 5
CM-H2DCFDA 5-(and-6)-chloromethyl-2 7 -dichlorodihydrofluorescein 
diacetate acetyl ester
COX cytochrome C oxidase
CS citrate synthase
CTNS cystinosin
DAPI 4',6-diamidino-2-phenylindole
DBP vitamin D binding protein
DIG digitonin
DNA deoxyribonucleic acid
DOG 2-deoxyglucose
dppIV; CD26 dipeptidyl peptidase IV
ECA Erythrina cristagalli agglutinin
ECL enhanced chemiluminescence
EDTA ethylenediaminetetraacetic acid
ESRD end stage renal disease
FITC fluorescein isothiocyanate
G418 geneticin
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GSH glutathione
GSSG oxidized glutathione
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HEt hydroethidine
HK-2 human kidney cell line 2
HMW high molecular weight
HPLC high performance liquid chromatography
HPV human papilloma virus
HRP horse radish peroxidase
hTERT human telomerase reverse transcriptase
IgG immunoglobulin G
IMW intermediate molecular weight
iPF2a-VI 8-iso-prostaglandin F2a VI
kb kilobase
kDa kilo Dalton
LAT-2 L-type amino acid transporters
LAMP-2 lysosomal-associated membrane protein 2
LC-MS/MS liquid chromatography-tandem mass spectrometry
LMW low molecular weight
LLC-PK pork kidney cell line
LTA Lotus tetragonolobus agglutinin
MCNS minimal change nephrotic syndrome
MDCK Madin-Darby canine kidney cell line
MRP4; ABCC4 multi-drug resistant protein 4
MRP2; ABCC2 multi-drug resistant protein 2
NaPiIIa/c; SLC34A1/3 sodium dependent phosphate transporter
NMDG N-methyl-D-glucamine
OAT1; SLC22A8 organic anion transporter 1
OAT3; SLC22A10 organic anion transporter 3
OCRL1 phosphatidylinositol 4,5-biphosphate-5-phosphatase
OCT2; SLC22A2 organic cation transporter 2
OK opossum kidney cell line
OXPHOS oxidative phosphorylation
PBS phosphate buffered saline
Pgp; MDR1; ABCB1 P-glycoprotein
PKC-S protein kinase C delta
PMN polymorphonuclear leukocyte
PMSF phenylmethanesulfonyl fluoride
PTEC proximal tubular epithelial cell
RAP receptor associated protein
RBP retinol-binding protein
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ROS reactive oxygen species
SAP shrimp alkaline phosphatase
SD standard deviation
SDCT2; SLC13A3 sodium di-carboxylate transporter
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel
electrophoresis
SEM standard error of means
SIA sodium iodoacetate
SJA Sophora japonica agglutinin
SV40T temperature sensitive mutant U19 ts A58 of SV40 large T
antigen
TESA testicular epididymal sperm aspiration
TNF -a  tumor necrosis factor alpha
TPA tetrapentyl ammonium
TPR tubular phosphate reabsorption
TRPV1 transient receptor potential cation channel, subfamily V1
XS-BSA excess BSA
ZO-1 zona occludens 1
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Introduction
In the last few decades, recycling of 
waste materials has become general 
practice in the Western world to save 
energy, save waste of useful materials 
and reduce pollution. Therefore, used 
materials are usually degraded and 
processed to be recycled into new 
products. The idea of recycling used 
materials could have been derived from 
the human body: complex biological 
molecules, such as proteins, are 
catabolized via complex pathways into 
their basic components, amino acids, 
which in turn are available for cellular 
metabolism including synthesis of new 
proteins. The degradation of biological 
molecules into their basic components 
takes place in cellular organelles, called 
lysosomes.
On a larger scale, the human body 
is also careful with its waste material. 
In the kidneys, blood is filtered to 
excrete waste material via urine. This 
ultra-filtrate contains useful biological 
compounds such as small proteins, 
small peptides, amino acids, sugars and 
salts. The proximal tubular epithelium 
in the kidney is designed to reabsorb 
these useful compounds from the ultra­
filtrate, and to make them available for 
further metabolism. The reabsorption 
is mediated via specific transporters 
located on the cell membrane and 
receptors that enter the cell via a 
process called endocytosis (figure 1.1).
When these recycling processes in 
either lysosomes or proximal tubular 
epithelium fail, the human body is an
easy target for pathological conditions. 
An intriguing example for impaired 
recycling in lysosomes as well as in 
the human kidney is the inherited 
metabolic disorder cystinosis.
1.1 Renal Fanconi syndrome
The excretion of metabolic waste 
material from the human body is mainly 
regulated in the kidney by sophisticated 
mechanisms. Approximately one 
million functional units in each kidney, 
called nephrons, are responsible 
for urine production. This process is 
initiated in the glomerulus, where 
blood is filtered based on size and 
charge selectivity. Together with 
metabolic waste products, recyclable 
and useful compounds are present in 
the glomerular ultra-filtrate, such as 
albumin, amino acids, LMW proteins 
(e.g. ß2m, DBP), sugars (e.g. glucose, 
sucrose) and inorganic compounds 
(e.g. phosphate, sodium, potassium, 
bicarbonate). The renal proximal 
tubular epithelium is responsible for the 
reabsorption of these useful compounds 
from the glomerular ultra-filtrate and 
plays additionally an important role 
in the active excretion of other waste 
products and xenobiotics. Active 
reabsorption at the apical membrane 
of epithelial cells is mainly facilitated 
by sodium-dependent transporters 
or via receptor mediated endocytosis 
[Madsen KM 2008]. Defects in these 
transport systems ultimately lead to
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Figure 1.1. Reabsorption mechanisms in the proximal tubular epithelium. At
the apical membrane, receptors bind specifically to substances in the luminal 
ultra-filtrate, such as LMW proteins. Via clathrin coated pits, these complexes 
are internalized via endocytosis to early endosomes, where decreased pH results 
in dissociation of the ligand-receptor complex. Receptors are transported back 
to the apical membrane for another uptake cycle, while ligands are further 
processed or degraded in lysosomes. Next to receptor mediated endocytosis, the 
proximal tubular epithelium is responsible for sodium-dependent reabsorption 
via specific transporters located at the brush-border. The driving force behind 
this transport is a sodium gradient established by Na,K-ATPase, responsible for a 
trans-epithelial electrochemical gradient. This gradient facilitates the uptake of 
solutes in the ultra-filtrate, such as phosphate, amino acids and glucose.
impaired reabsorption by the proximal 
tubular epithelium and result in the 
excessive excretion of vital metabolites 
via the urine. This generalized proximal 
tubulopathy is called renal DeToni- 
Debré-Fanconi syndrome, often named 
(renal) Fanconi syndrome, clinically 
characterized by polyuria, failure to 
thrive, rickets and dehydration. Both
acquired and inherited causes can 
underlie the development of renal 
Fanconi syndrome. Several genes 
have been reported to be involved in 
the development of inherited renal 
Fanconi syndrome, including OCRL1 
(Lowe syndrome), CLCN5 (Dent's 
disease) and CTNS (cystinosis) [Charnas 
1991; Piwon 2000; Town 1998]. An
16
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overview of inherited causes for renal 
Fanconi syndrome is given in table 1.1 
[Monnens 2008].
Reabsorption via endocytosis 
is mainly mediated by multi-ligand 
receptors megalin, cubilin and 
amnionless, expressed at the BBM of 
the proximal tubular epithelium. These 
cooperative receptors are responsible 
for the reabsorption of a broad scale 
of substrates, including LMW proteins 
and albumin from the glomerular ultra­
filtrate [Christensen 2002; Kozyraki
1999]. Expression of megalin and 
cubilin is decreased in proximal tubular 
epithelium of patients with Dent's 
disease and in clcn5'/' mice [Christensen 
2003; Santo 2004]. It is suggested that 
mutations in the CLCN5 gene, encoding 
a lysosomal chloride-proton exchanger, 
affect endocytic recycling of megalin 
and cubilin resulting in deficient 
reabsorption of LMW proteins. Patients 
with mutations in the OCRL1 gene 
present with renal Fanconi syndrome, 
which is also thought to be caused 
by impaired recycling of megalin and 
cubilin receptors [Norden 2002].
Although cystinosis is the most 
common form of inherited renal 
Fanconi syndrome in children, the 
pathogenesis underlying this disease 
is still elusive. Three clinical forms of 
cystinosis are recognized, of which the 
infantile form of cystinosis is the most 
common, presenting with renal Fanconi 
syndrome in the first year of life. The 
second form of cystinosis usually
starts at childhood or adolescence, 
accordingly called juvenile or 
intermediate cystinosis with similar, 
but less severe, renal symptoms. A 
third form is reported in adults with 
exclusively ocular impairments and 
termed ocular or non-nephropathic 
cystinosis [Gahl 2001]. Despite this 
commonly used distinction of cystinotic 
phenotypes, a co-occurrence of juvenile 
and ocular cystinosis was recently 
reported in one family with cystinosis 
[Servais 2008]. The scope of this thesis 
mainly focuses on the pathogenesis of 
infantile cystinosis.
1.2 The fundaments of cystine 
accumulation in nephropathic 
cystinosis
For more than a century, clinical 
and fundamental research has been 
performed to improve life of patients 
suffering from nephropathic cystinosis. 
Although the pathogenesis is not 
completely elucidated, knowledge has 
been gained especially concerning the 
fundamental mechanisms underlying 
this inherited disorder.
1.2.1 Pioneering studies
During an autopsy of a child that died 
at 21 months, the chemist Abderhalden 
found cystine crystals in the spleen 
and liver [Abderhalden 1903]. Two 
siblings of this child had died with 
similar symptoms. Since this report in
17
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1903, which is generally recognized 
as the first description of cystinosis, 
pediatric patients were reported with 
rickets, failure to thrive, glucosuria and 
phosphaturia in the 20's and 30's of the 
last century [Lignac 1924; De Toni 1933; 
Fanconi 1931; Debre 1934]. These 
symptoms were later called DeToni- 
Debré-Fanconi syndrome and confusion 
arose whether renal Fanconi syndrome 
and cystinosis were two separate 
clinical disorders [Fanconi 1949]. In the 
60's, Schneider et al. showed increased 
intracellular cystine levels located in 
granular fractions of leukocytes from 
patients, identifying cystinosis as a 
cystine storage disease resulting in 
Fanconi syndrome [Schneider 1967a]. 
Nowadays, more causes leading to 
Fanconi syndrome are recognized, 
although cystinosis is the most common 
in children and should be suspected in 
infants presenting with polyuria, failure 
to thrive and dehydration [Monnens
2008].
1.2.2 Impaired lysosomal cystine 
transport
Following the pioneering studies by 
Schneider et al. in the 60's, electron 
microscopy of lymph nodes from 
patients with cystinosis suggested that 
accumulated cystine was located within 
the lysosomes [Patrick 1968]. The
lysosomal localization of cystine was 
confirmed in cystinotic leucocytes by 
Schulman et al. using sucrose density 
gradient centrifugation [Schulman 
1969]. Using dimethyl esters of cystine, 
Goldman and Reeves developed a 
method to artificially load isolated 
lysosomes with cystine [Goldman 1973; 
Reeves 1979]. In the following years, 
this technique appeared to be a giant 
leap forward to a better understanding 
of the mechanism underlying the 
pathogenesis of cystinosis. Using 
CDME, isolated lysosomes from 
cystinotic and normal leucocytes and 
fibroblasts could be loaded with radio­
labeled cystine [Steinherz 1982; Jonas 
1982]. This resulted in the recognition 
of defective lysosomal exodus of 
cystine as the basic defect responsible 
for cystine accumulation [Gahl 1982b; 
Gahl 1982a].
Following these observations, 
depletion of intracellular cystine 
levels became the main goal in order 
to treat cystinotic patients. Although 
moderate success was gained using 
DTT or ascorbic acid [Goldman 1970; 
Kroll 1974], a breakthrough in the 
treatment of cystinosis was found in the 
aminothiol cysteamine [Thoene 1976]. 
The use of cysteamine is discussed in 
more detail in section 1.3.3.
Noteworthy, a second lysosomal 
cystine storage disease is identified,
Table 1.1. Inherited causes of renal Fanconi syndrome. Adapted from Monnens 
and Levtchenko; Nephrol Dial Transplant 2008 [Monnens 2008].
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Disorder (OM IM ) Gene Inheritance Protein Key clin ical/biochem ical features
Cystinosis CTNS autosomal recessive Cystinosin Failure to thrive, rickets, metabolic, acidosis, renal 
failure, photophobia
Dent's d isease3 CLCN5
OCRL1
X-linked recessive 
X-linked recessive
Chloride channel 5
Phosphatidyl-inositol 4,5- 
biphosphate-5-phosphatase
LMW proteinuria, hypercalciuria, nephrocalcinosis, 
nephrolithiasis, renal failure
Fanconi-Bickel syndrom e SLC2A2 autosomal recessive Facilitative glucose transporter 2 
(GLUT2)
Hepatorenal glycogen accumulation, hepatomegaly, 
rachitic and osteomalacia, mental retardation
Galactosaem ia GALT autosomal recessive Galactose-l-phosphate-uridyl-
transferase
Hepatomegaly, liver disease, cataract, mental 
retardation
Glycogen Storage Disease Type 1 G6PC autosomal recessive Glucose-6-phosphatase hypoglycemia, lactic acidosis and hyperlipidemia, 
hepatomegaly
Hereditary fructose intolerance ALDOB autosomal recessive Aldose B Fructose intolerance, growth retardation
Lowe syndrom e3 OCRL1 X-linked recessive Phosphatidyl-inositol 4,5- 
biphosphate-5-phosphatase
Short stature, congenital cataract, mental retardation, 
seizures, cryptorchidism, elevated transaminases
M etachrom atic leukodystrophy ARSA; PSAP autosomal recessive Arylsulfatase A; Prosaposin muscle wasting and weakness, spasticity, 
developmental regression
Tyrosinaem ia FAHD2A autosomal recessive Fumaryl-acetoacetate hydrolase Glomerulosclerosis, nephrocalcinosis, hepatomegaly, 
cirrhosis, rickets, growth retardation
W ilson disease ATP7B autosomal recessive Copper-transporting ATPase (ß 
subunit)
Kayser-Fleischer rings (cornea) hepatitis, cirrhosis CNS 
abnormalities
l-cell disease (m ucolip idosis II) GNPTAB autosomal recessive N-acetylglucosamine-1-
phosphotransferase
Dwarfism, contractures of large joints, coarse facial 
features, thickend skin and mucosae, mental 
retardation
M itochondrial d iseaseb diverse diverse diverse diverse
Idiopathic Fanconi syndrom e unknown autosomal dominant 
autosomal recessive
unknown isolated Fanconi syndrome
a) glucosuria can be absent
b) Patients with mitochondrial diseases can present with Fanconi syndrome. Among other reported genes, affected proteins involve cytochrome C oxidase, 
phosphoenolpyruvate carboxykinase or Acyl-CoA dehydrogenase.
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called mucolipidosis type II or 
I-cell disease [Tietze 1979]. Clinical 
symptoms are very heterogeneous, 
but characteristics usually include 
dwarfism, coarse facial features and 
mental retardation [Beck 1995]. 
Additionally, proximal tubular 
dysfunction was reported with 
LMW proteinuria, aminoaciduria, 
hyperphosphaturia, and high urinary 
calcium excretion [Bocca 2003]. This 
autosomal recessive disorder is caused 
by a deficiency of N-acetylglucosamine-
1-phosphotransferase, resulting in 
defects of mannose-6-phosphorylation 
[Kornfeld 1995]. As a consequence, 
lysosomal enzymes are not transported 
to the lysosomes after post-translational 
modification in the Golgi-apparatus. 
Compared to cystinosis, lysosomal 
cystine levels were similar in fibroblasts 
from patients with I-cell disease, but 
hepatic or white blood cell cystine levels 
were within the normal range [Greene 
1985]. Both I-cell disease and cystinotic 
fibroblasts can be depleted from cystine 
accumulation by cysteamine treatment. 
Cystine efflux was significantly reduced 
in I-cell disease but not completely 
abolished as in cystinotic fibroblasts. 
No explanations are yet available for 
these observations in I-cell disease.
Several studies were conducted to 
investigate the source for lysosomally 
trapped cystine in cystinosis. Cystine 
can be produced by the oxidation of 
two cysteine molecules. Additionally, 
it was demonstrated that radio-labeled
extracellular cystine can enter the cell 
causing increased lysosomal cystine 
accumulation in cystinotic fibroblasts 
[Danpure 1986]. Most of this cystine 
transport in proximal tubular cells 
is mediated by a heterodimeric 
exchanger b0,+AT-rBAT, encoded by 
b0+AT1/SLC7A9 and rBAT/SLC3A1 
genes [Feliubadalo 1999]. Mutations 
in these genes can lead to cystinuria, 
due to defective proximal tubular 
reabsorption of cystine and dibasic 
amino acids. Although extracellular 
cystine can result in elevated lysosomal 
cystine levels in cystinotic fibroblasts, 
this effect was not observed with 
cysteine [Thoene 1982]. Additionally, 
proteolysis of cystine-containing 
proteins within the lysosomes account 
for lysosomal cystine. An interesting 
example is bovine serum albumin 
(containing 17 mol cystine / mol 
protein), which has been shown to 
stimulate cystine accumulation in 
cystinotic fibroblasts when present in 
culture medium [Thoene 1980]. To proof 
this, cystinotic fibroblasts were pre­
incubated with cysteamine to deplete 
cystine, followed by incubation with 
bovine serum albumin. This resulted 
in cystine accumulation, which could 
be inhibited by the lysosomotropic 
drug chloroquine, indicating lysosomal 
proteolysis of albumin caused cystine 
accumulation within the lysosomes.
Jonas et al. demonstrated lysosomal 
cystine efflux was dependent of a 
proton-pump ATPase [Jonas 1982].
20
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They showed that cystine efflux of 
CDME loaded lysosomes was increased 
by exogenous ATP and this effect was 
absent in isolated lysosomes obtained 
from cystinotic patients. The proton­
pump ATPase caused in both normal as 
well as in cystinotic isolated lysosomes 
acidification and the proton-pump 
activity correlated with cystine efflux 
in normal lysosomes, indicating two 
distinct but cooperative transporters 
[Jonas 1983].
Due to cellular reducing systems, 
most cystine is reduced to free 
cysteine. Next to de novo synthesis of 
cysteine from methionine, intracellular 
cysteine pool is regulated via peptide 
transporters (PEPT2) located at the 
apical membrane [Frey 2007] and LAT-2 
atthebasolateralmembrane[Fernandez 
2003]. A large part of the intracellular 
cysteine pool is incorporated in the anti­
oxidant GSH, a tripeptide consisting of 
cysteine, glutamate and glycine. The 
production of GSH is facilitated by the 
y-glutamyl cycle. Interestingly, one 
of its intermediates, 5-oxoproline, is 
increased in urine of cystinotic patients 
[Rizzo 1999]. Elevated urinary levels of 
5-oxoproline together with lysosomally 
trapped cystine resulted in the idea that 
perturbations in GSH metabolism might 
be associated with the development of 
renal disease in cystinosis. Decreased 
availability of the GSH precursors 
5-oxoproline and cysteine, which is the 
limiting precursor for GSH, might lead 
to decreased capacity of the cellular
defense against oxidative stress. Figure
1.2 illustrates the pathways involved 
in lysosomal cystine transport and 
sources for intracellular cysteine and 
cystine pool.
The effect of temperature on 
cystine accumulation was also studied 
in cystinotic fibroblasts [Lemons 
1986; Forster 1989]. These studies 
showed that cystine accumulation 
in cystinotic fibroblasts decreased at 
higher temperatures (up to 43°C) and 
increased at lower temperatures (28°C). 
This suggested either the expression 
of an alternative transport system 
with different affinities for cystine, or 
residual transporter activity of a cystine 
transporter is stimulated by increasing 
temperature. In respect of our 
current knowledge, this temperature 
dependent accumulation of cystine 
can be explained by the existence 
of severe and mild mutations in the 
CTNS gene [Kalatzis 2004]. Several 
mutations causing cystinosis have 
currently been reported with residual 
cystine transport. Possibly, Lemons and 
Forster used cystinotic fibroblasts with 
mild mutations in CTNS with residual 
cystinosin activity, stimulated by 
increasing temperature and resulting in 
decreased cystine levels. This modern 
era of our understanding of the 
pathogenesis of cystinosis was initiated 
by the discovery of the cystinosin gene, 
CTNS [Town 1998].
21
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Figure 1.2. Cystine metabolism and transport. Cystine can enter the lysosomes 
via cystine containing proteins (protein-cys) or enters the cell via b0,+AT/rBAT 
transporters at the apical membrane. After protein degradation, cystine efflux 
from the lysosomes via CTNS is mediated by a proton gradient. One mole 
cytosolic cystine is reduced to two moles cysteine, which is the limiting factor 
for the y-glutamyl cycle. This pathway is responsible for the production of GSH, 
a major antioxidant of the cell. GSH levels are also maintained via SDCT2 and 
OAT1/OAT3 located at the basal membrane or via reabsorption of filtered GSH 
at the apical membrane. Additionally, cysteine can be produced de novo from 
methionine or transported via LAT-2.
22
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1.2.3 The molecular basis of 
cystinosis
The Mendelian inheritance of 
cystinosis was already recognized in the 
first studies reported, but it lasted until 
the end of the 20th century to identify 
the gene responsible for nephropathic 
cystinosis [Town 1998]. Linkage analysis 
was used to map the gene between 
markers D17S1583 and D17S796 on 
chromosome 17p [The Cystinosis 
Collaborative Research Group 1995]. 
Finally, the cystinosin gene, encoding 
for the lysosomal cystine transporter, 
was mapped on 17p13.2 [Town 1998].
Molecular diagnosis in the following 
years reported over 90 mutations 
within the CTNS gene [Forestier 1999; 
Touchman 2000; Anikster 1999b; 
Fernandez-Valero 2005; Alcantara- 
Ortigoza 2008]. The gene contains 
12 exons, of which the first two are 
non-coding [Forestier 1999]. The
CTNS gene spans 23 kb and encodes 
a 367 amino acid protein, containing 
7 transmembrane domains with two 
lysosomal targeting motifs (figure 1.3). 
The functional relevant part of the 
CTNS promoter has been restricted to 
the region encompassing nucleotides 
-316 to +1 with respect to the start 
codon [Phornphutkul 2001]. The most 
common mutation, accounting for 
approximately 75% of the affected 
alleles in Northern Europe, is a 57 kb 
deletion [Anikster 1999a; Touchman
2000] that removes the first 10 exons 
of the CTNS gene, the upstream 5' 
region encoding for the CARKL gene 
and the first two non-coding exons of 
the transient receptor potential cation 
channel, subfamily V1 (TRPVlgene; 
figure 1.4a). The function of the 
CARKL gene has been identified in the 
phosphorylation of sedoheptulose, 
an intermediate metabolite of
Figure 1.3. Cystinosin protein. Cystinosin is located at the lysosomal membrane, 
consisting of 367 amino acids and 7 transmembrane domains. At the C terminus 
two lysosomal targeting motifs are described; YFPQA and GYDQL.
23
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Figure 1.4. CTNS gene is mapped at chromosome 17p13.2 (A) The CTNS gene is 
adjacent to CARKL and TRPV1 gene, which are mutually affected in the common 
57kb deletion detected in cystinosis patients. (B) The CTNS gene exon 1 and 
2 are non-coding and alternative splicing of exon 12 results in two isoforms, 
previously reported as CTNS and CTNS-LKG. The CTNS-LKG isoform is lacking the 
lysosomal targeting motif GYDQL.
the pentose phosphate pathway 
[Wamelink 2008]. Consequently, 
patients with homozygous 57 kb 
deletion have elevated urinary levels 
of sedoheptulose, which can be used 
as a fast screening method in families 
carrying this mutation. Phosphorylation 
of sedoheptulose is connected to 
the pentose phosphate pathway 
and therefore might contribute to 
alterations in cellular redox status. 
Since the pentose phosphate pathway 
is responsible for the production of 
NADPH, which has similar antioxidant 
functions as GSH, defects in CARKL 
might influence the NAPDH levels,
hence intracellular redox status 
[Wamelink 2008]. TRPV1 encodes for an 
ion channel that is primarily expressed 
in sensory nerves and is activated by 
a wide range of stimuli [Peng 2010]. 
It has been suggested that TRPV1 
activation protects against salt-induced 
renal damage [Wang 2008]. Although 
the contribution of the CARKL or TRPV1 
genes in the pathogenesis of cystinosis 
has not yet been fully elucidated, it 
should be appreciated that none of the 
families with late-onset nephropathic 
cystinosis described in a study by 
Servais et al. carried the 57 kb deletion 
in a homozygous state [Servais 2008].
24
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In addition, homozygosity for the 57 
kb deletion is generally more severe 
and associated with higher mortality 
[Gahl 2007]. Next to the common 57 kb 
deletion, smaller deletions, insertions, 
nonsense and missense mutations 
and mutations in the promoter region 
or splice site mutations have been 
reported. Taranta et al. also identified 
intronic mutations in two separate 
families in one or both CTNS alleles 
that affect splicing of exon 5 or exon 
9. These results indicate that cystinosis 
is probably a monogenic disorder and 
that cDNA sequence analysis should 
be performed when gene sequencing 
does not allow to identify mutations 
[Taranta 2010]. Recently, uniparental 
heterodisomy of the maternal 57 
kb del has been described [Lebre
2009]. By correlating residual cystine 
transport activity with different CTNS 
mutations, it was demonstrated that 
infantile cystinosis generally results 
from severe mutations that lead to a 
total loss of cystine transport activity 
[Kalatzis 2004]. Although cystinosis is a 
recessive disorder caused by elevated 
cystine levels up to 100 fold compared 
to healthy controls, heterozygous 
carriers of CTNS mutations present only 
with slightly increased cystine levels 
without the development of (renal) 
implications.
A variation in the translation of the 
CTNS gene was reported by Taranta 
et al., who showed a second CTNS 
isoform, CTNS-LKG [Taranta 2008]. Due
to alternative splicing of exon 12, the 
lysosomal targeting motif GYDQL at 
the C-terminus is deleted (figure 1.4b). 
Overexpression of the gene in renal 
HK-2 cells elucidated that CTNS-LKG is 
expressed in the plasma membrane, 
lysosomes, endoplasmatic reticulum 
and in the Golgi apparatus. The 
physiological function of this isoform 
is still elusive, but the expression in 
various tissues implicates a role in 
metabolism.
The identification of CTNS together 
with the availability of molecular 
cloning techniques enabled Kalatzis 
et al. to prove that CTNS was a 
proton driven lysosomal transporter, 
responsible for the cystinotic 
phenotype [Kalatzis 2001]. They 
deleted the lysosomal targeting motif, 
consequently directing CTNS to the cell 
membrane with the intralysosomal side 
towards the extracellular medium. At 
acidic pH, specific cystine transport was 
demonstrated in this in vitro model. 
Furthermore, the lysosomal localization 
was proven by co-localization of GFP- 
tagged CTNS with LAMP-2 [Cherqui
2001]. These elegant studies confirmed 
the ideas postulated by the pioneering 
studies in the late 70's and early 80's 
using artificially loaded lysosomes with 
CDME.
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1.3 Clinical aspects of 
nephropathic cystinosis
Up to now, a century of research 
on the subject of cystinosis has gained 
over 1000 scientific publications, 
but more important, the quality 
of life for cystinosis patients has 
tremendously improved. Much of 
our current knowledge has been 
gained by careful observation of the 
cystinotic phenotype. Additionally, a 
lot of emphasis has been put on early 
diagnosis and improved treatment of 
patients with nephropathic cystinosis.
1.3.1 The phenotype of 
nephropathic cystinosis
Logically, the clinical phenotype 
of cystinotic patients encompasses 
important information regarding 
our knowledge of the pathogenesis 
of cystinosis. Infantile nephropathic 
cystinosis is the most frequent cause 
of inherited Fanconi syndrome, 
characterized by excessive urinary 
excretion of amino acids, phosphate, 
bicarbonate, glucose, sodium, 
potassium, LMW proteins and other 
solutes due to defective renal proximal 
tubular reabsorption [Gahl 2002]. 
Patients are usually asymptomatic at 
birth and have a normal development 
until 3-6 months, when they manifest 
with failure to thrive, vomiting, 
constipation, polyuria and excessive 
thirst, periods of dehydration and
sometimes rickets. Renal loss of 
sodium and potassium may result in 
hyponatremia and hypokalemia, which 
may be life threatening. Hypouricemia, 
decreased plasma carnitine and 
medullary nephrocalcinosis related 
to increased calcium and phosphate 
excretion are also observed [Saleem 
1995; Theodoropoulos 1995]. Total 
protein excretion can reach several 
grams per day and urine contains 
both albumin and LMW proteins. The 
minority of the patients with milder 
forms of cystinosis has less pronounced 
or even absent proximal tubulopathy 
and might be under diagnosed.
Histological studies in serial 
renal biopsies of cystinotic patients 
demonstrated that the typical atrophy 
("swan-neck" deformity) of proximal 
convoluted tubules appeared after 6 
months of life, possibly as a consequence 
of increased apoptosis [Fetterman 1966; 
Mahoney 2000; Chevalier 2008]. This 
corresponds to gradual development of 
renal Fanconi syndrome during the first 
months [Levtchenko 2006a]. Glomeruli 
can appear normal, but contain 
mostly peculiar giant multinucleated 
podocytes [Gubler 1999; Stokes 
2008]. Cystine crystals located in the 
lysosomes or in cytoplasm are seen 
within interstitial cells and rarely 
within podocytes [Gubler 1999]. 
The deterioration of renal disease is 
accompanied by progressive tubulo- 
interstitial lesions, including interstitial 
fibrosis, tubular atrophy and marked
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arteriolar thickening.
Due to renal replacement therapy 
and the administration of cystine 
depleting agent cysteamine, extra-renal 
complications were revealed in patients 
with cystinosis, consequently requiring 
multidisciplinary treatment. Cystine 
crystals in cornea of the eye are present 
in all patients. These crystals can cause 
photophobia and can be recognized 
by an experienced ophthalmologist 
starting from the second year of life 
[Reese 1987]. Posterior segment 
complications associated with retinal 
degeneration can develop, leading to 
significant visual loss starting from the 
second decade of life [Tsilou 2006].
The accumulation of cystine also 
leads to impairment of endocrine 
organs. Hypothyroidism is found 
in approximately 75% of cystinotic 
patients without cysteamine treatment 
[Burke 1978; Gahl 2007]. Impaired 
insulin production can be exacerbated 
by steroid therapy after renal 
transplantation and results in insulin­
dependent diabetes mellitus [Fivush 
1987]. Additionally, two patients were 
recently reported manifesting with 
cholestatic liver disease that could 
be treated with ursodeoxycholic acid 
[Cornelis 2008].
Although little is known about 
psychological complications, a recent 
study showed significantly impaired 
intellectual and motor performance 
in pediatric patients [Ulmer 2009]. 
Furthermore, it is suggested that the
influence of CTNS mutations on brain 
development rather than cystine 
accumulation by itself results in 
cognitive deficits [Trauner 2007].
Vacuolar myopathy, due to 
excessive cystine accumulation in the 
muscle, manifests generally during the 
second decade [Charnas 1994]. Patients 
suffer from progressive muscle wasting 
and reduced strength with restrictive 
ventilatory defects [Anikster 2001]. 
Swallowing difficulties have a direct 
relation with the severity of muscular 
disease and decreased with the number 
of years on cysteamine therapy [Sonies 
2005].
Puberty generally precedes normal 
in females, and several have given 
birth [Reiss 1988]. Males have primary 
hypogonadism and do not always 
complete pubertal development 
[Winkler 1993]. No male cystinotic 
patients are known to have induced 
pregnancy. Even patients adequately 
treated with cysteamine demonstrated 
azoospermia, although sufficient 
spermatogenesis was observed in a 
testis biopsy of one patient, hence, 
opening possibilities for in vitro 
fertilization by TESA [Besouw 2009].
Two major types of cystinotic 
encephalopathy, developing
mostly during the third decade, are 
distinguished. The first presents with 
cerebellar and pyramidal signs, mental 
deterioration and pseudo-bulbar palsy. 
The second is associated with stroke­
like episodes [Broyer 1996].
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The prognosis of patients with 
cystinosis has substantially improved 
during the last decades. The oldest 
patient has yet celebrated his 50th 
birthday. The expectation is that 
patients treated with cysteamine 
starting at early age will reach advanced 
age with a rather good quality of life.
1.3.2 Diagnosis of cystinosis
Cystinosis should be suspected in 
all infants with failure to thrive and 
signs of renal Fanconi syndrome, 
such as aminoaciduria, glucosuria 
and phosphaturia. The minority of 
the patients with a milder form of 
cystinosis and less pronounced or even 
absent proximal tubulopathy can be 
misdiagnosed and present, in advanced 
stage of the disease, with severe 
proteinuria and renal failure.
The detection of the elevated 
intracellular cystine content is the 
corner stone for the diagnosis of 
cystinosis. Intracellular cystine 
measurements are mostly performed 
in either isolated polymorphonuclear 
(PMN) leukocytes or mixed leukocyte 
population. In our opinion, isolated 
PMN are preferred because cystine 
predominantly accumulates in these 
blood cells [Levtchenko 2004].
Several methods have been 
developed to measure intracellular 
cystine levels in the past decades, of 
which HPLC and LC-MS/MS are currently 
used most widely [Graaf-Hess 1999;
Chabli 2007]. LC-MS/MS is the most 
sensitive method available (detection 
as low as 0.02 ^mol cystine/l compared 
to 0.15 ^mol cystine/l using HPLC) and 
has recently been developed for cystine 
determination in granulocytes [Chabli
2007].
Molecular analysis of the CTNS gene 
allows early diagnosis and can be used 
for prenatal diagnosis on chorionic 
villi in order to initiate cysteamine 
treatment as soon as possible after 
birth. Although molecular analysis of 
the CTNS gene is a very solid assay, it 
should be used to confirm the diagnosis 
in combination with demonstration of 
elevated cystine levels in blood cells. 
Mutations in the promotor region 
or introns can also lead to defects in 
CTNS expression and might be missed 
using standard molecular diagnosis of 
the encoding region of CTNS [Taranta
2010].
1.3.3 Treatment of patients with 
cystinosis
The treatment of cystinosis can be 
divided into symptomatic treatment, 
mainly to compensate excessive urinary 
excretion resulting from Fanconi 
syndrome, and specific treatment to 
decrease intracellular cystine levels.
The aim of symptomatic therapy 
in cystinotic patients with Fanconi 
syndrome is maintenance of fluid and 
electrolyte balance, good nutrition 
and prevention of rickets. Serum levels
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of potassium, sodium, bicarbonate 
and phosphate varies substantially 
and should be regularly monitored 
to optimize the dose of supplements. 
Beginning in early childhood, 
1,25-dihydroxycholecalciferol (vitamin 
D) should be administered to prevent 
rickets [Etches 1977]. The excessive 
administration of vitamin D, phosphate 
and bicarbonate may result in severe 
nephrocalcinosis or renal stone 
formation [Theodoropoulos 1995].
Poor appetite, vomiting and oral 
motor dysfunction often require 
nasogastric tube or gastrostomy feeding 
especially in young children [Elenberg 
1998; Trauner 2001]. Treatment with 
growth hormone improves the length in 
children with cystinosis, allowing them 
to catch-up and to maintain normal 
growth [Wuhl 1998]. Levothyroxin 
administration is indicated in patients 
with hypothyroidism and insulin in case 
of diabetes.
Albuminuria in cystinosis is 
responsive to the administration of 
ACE inhibitors, which presumably 
could postpone the development of 
chronic interstitial damage in cystinosis 
[Levtchenko 2003].
The amino thiol cysteamine 
(Cystagon™) depletes lysosomal cystine 
content by a disulfide exchange reaction 
with cystine resulting in the formation of 
cysteine-cysteamine and cysteine [Gahl 
1985]. These thiols exit lysosomes via 
alternative transporters, consequently 
bypassing defective CTNS (figure 1.5).
The administration of cysteamine at 
1.3-1.9 g/m2 in 4 daily doses drastically 
lowers intracellular cystine content, 
postpones the deterioration of renal 
function and the development of 
extra-renal complications [Gahl 2007]. 
It is recommended to administer 
cysteamine every 6 hours including 
a nocturnal intake, to prevent 
elevated cystine levels in the morning 
[Levtchenko 2006b]. The target tissue 
cystine values commonly used are 
the levels measured in heterozygote 
individuals (<0.5 nmol cystine per mg 
protein), but cysteamine administration 
should not exceed 1.95 g/m2 per day to 
prevent the development of adverse 
effects. Monitoring intracellular cystine 
levels in PMN are required in order 
to adjust cysteamine dose. Despite 
careful follow-up and regular cystine 
measurements to maintain levels in the 
heterozygous range, patients are not 
cured from renal dysfunction. Due to 
cysteamine treatment, renal function 
is maintained for an extended period 
compared to untreated patients, with 
development of ESRD generally within 
the second decade of life [Gahl 2007]. 
The maintained decrease in renal 
function despite low cystine levels 
argues against cystine accumulation as 
a direct cause for development of renal 
failure. Since renal replacement therapy 
was introduced for cystinotic patients, 
extra-renal implications have become 
more evident and point towards the 
importance of continued cysteamine
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Figure 1.5. Cysteamine depletes cystine from lysosomes. In the left panel, 
a normal lysosome is presented, where cystine located in the lysosomes is 
exported via cystinosin and lysine via 'system c' transporters. In the cytosol, 
cystine is reduced to two cysteine residues. The middle panel shows a cystinotic 
lysosome, where cystinosin is absent (or dysfunctional), resulting in increased 
levels of lysosomal cystine. Upon cysteamine treatment in the cystinotic 
lysosome, cystine is degraded into cysteine and cysteine-cysteamine, as 
presented in the right panel. Both degradation products can be exported via 
'system c' transporters, encompassing the defective cystinosin.
treatment post-transplantation
[Nesterova 2008].
Topical cysteamine eye drops (0.5% 
cysteamine) are indicated, since orally 
administered cysteamine has no effect 
on corneal cystine crystals. These drops 
are highly effective and are able to 
completely dissolve corneal cystine 
crystals when administered 6 to 12 
times daily within 8 to 41 months, even 
at a later age [Gahl 2000].
Although the beneficial effects of
cysteamine treatment are confirmed 
in several studies, non-compliance with 
the therapy is frequently occurring 
due to its drawbacks, such as bad odor 
and gastrointestinal discomfort. Other 
adverse effects have recently been 
reported in some patients who were 
treated with very high cysteamine 
doses (personal communications). 
These consisted of skin lesions (striae, 
vascular tumors on the elbows), bone 
pain, muscular weakness and vascular
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complications. Histological analysis of 
the skin in one patient demonstrated 
irregularities of the elastin network and 
collagen fibers.
Bad breath (halitosis) is mainly 
caused by dimethylsulphide in the 
expired air after cysteamine intake 
[Besouw 2007]. Currently, few research 
focused on the production of novel 
prodrugs, to overcome side effects, 
which might result in better compliance 
[McCaughan 2008]. Gastro-intestinal 
discomfort, caused by the stimulation 
of H+ secretion in the stomach, can 
be improved by the administration 
of proton-pump inhibitors or enteric- 
coated cysteamine, which also prolongs 
the effect of cysteamine [Dohil 2006; 
Fidler 2007]. The beneficial use of 
enteric-coated cysteamine has recently 
proven to be effective in decreasing 
the cysteamine therapy to a twice- 
daily dose [Dohil 2010]. Moreover, 
leukocyte cystine levels were within the 
heterozygote range using only 60% of 
the total previous daily dose. Possibly, 
absorption of cysteamine in small 
intestine is more effective compared 
to the stomach or less cysteamine is 
directly metabolized in liver, causing 
a prolonged effect on the decreased 
cystine levels.
1.4 Models to study the 
pathogenesis of cystinosis
Although the basic mechanism 
of lysosomal cystine accumulation
in cystinosis has been unraveled, 
the pathogenesis is not yet fully 
understood. To gain more insight into 
the development of the disease and 
its underlying mechanisms, several 
research models have been developed 
so far.
1.4.1 Animal models
Since the nature of cystinosis is 
a multi-systemic disease, an animal 
model is required for fundamental 
research of the pathogenesis of affected 
organs. Therefore, the artificial loading 
of lysosomes with cystine using CDME 
was applied to adult rats [Foreman 
1987]. Parenteral administration of 
400 ^mol CDME twice a day resulted in 
symptoms of Fanconi syndrome, such 
as polyuria, phosphaturia, glucosuria 
and aminoaciduria. Remarkably, during 
four days both creatinine clearance and 
intracellular renal cystine levels were 
not affected. This raised the question 
whether cystine accumulation was 
directly responsible for development of 
Fanconi syndrome in CDME treated rats 
and, moreover, suggested a toxic effect 
for CDME loading.
The first ctns'/' knockout model 
was generated from a mixed 129Sv 
and C57BL/6 strain by replacing the 
last four ctns exons [Cherqui 2002]. 
This mutation was reported to result 
in complete abolished CTNS mediated 
transport [Attard 1999]. Although 
cystine accumulation resulted in
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ocular and bone abnormalities, the 
ctns'/' mice did not develop proximal 
tubular dysfunction or renal failure. 
Interestingly, mice aged 15 months 
developed incomplete tubulopathy 
and renal failure when further bred for 
10 generations with C57BL/6 strains, 
but crossing with FVB/N mice did not 
lead to renal disease [Nevo 2009]. This 
suggested that the renal phenotype 
was dependent on genetic background. 
The ocular deficits in these mice were 
reported to be similar to those observed 
in humans [Kalatzis 2007].
To test whether gene transfer 
would be the Holy Grail in the cure 
of cystinosis, Hippert et al. injected 
ctns-/- mice backcrossed on a C57BL/6 
background with adenovirus vector 
expressing human CTNS [Hippert
2008]. Although they found that gene 
transfer could restore lysosomal 
cystine transport function when CTNS 
expressing vectors were injected in 
young mice (one week), this curative 
effect was not observed in older mice 
(four weeks). Very promising data were 
recently obtained with the C57BL/6 
ctns-/- mice, subjected to syngeneic 
bone marrow transplantation of wild 
type mice between two and four 
months of age [Syres 2009]. Next to 
decreased intracellular cystine levels 
of more than 50% in all organs tested 
including kidney, brain and liver, the 
progression of renal disease was 
prevented and corneal cystine crystals 
were decreased.
1.4.2 In vitro research models for 
cystinosis
Much of our current knowledge 
involving the fundamental mechanisms 
of the pathogenesis of cystinosis 
were derived from in vitro cell models 
obtained from either healthy controls 
or patients with cystinosis. The 
pioneering studies in the 60's and 70's 
were performed mainly with human 
cystinotic leukocytes, fibroblasts or 
lymph node cells and used to establish 
lysosomal cystine accumulation as the 
basic defect in cystinosis [Schneider 
1967a; Schneider 1967b; Patrick 1968].
To study the biochemical pathways 
involved in the pathogenesis of the 
renal phenotype of cystinosis, an in 
vitro renal cell model is required. 
Currently, many renal cell models are 
available, each with its own pro's and 
con's, recently reviewed by Bens and 
Vandewalle [Bens 2008]. Commercially 
available cell lines from pig (LLC-PK), 
opossum (OK), or dog (MDCK) have 
shown their utility for membrane 
transport studies, especially since 
these cells are polarized when cultured 
on permeable supportive membranes 
[Gibson 1998; Evers 1996; Markovich 
1995]. To study more specifically human 
transport systems, human proximal 
tubular cell lines have been developed 
such as the HK-2 cell line, which are 
immortalized using e.g. HPV 16 E6/E7 
genes to maintain proliferation. [Ryan
1994].
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In vitro cell models derived from 
healthy subjects have been used to 
study renal physiology and were used to 
gain more insight in the pathogenesis of 
cystinosis using CDME to artificially load 
lysosomes with cystine. Pre-incubation 
of isolated renal tubules with CDME 
resulted in significant increased levels 
of cystine, mimicking the cystinotic 
phenotype [Foreman 1987]. Salmon and 
Baum perfused rabbit proximal tubules 
with CDME, resulting in decreased 
bicarbonate and glucose absorption 
[Salmon 1990]. Furthermore, decreased 
ATP levels were demonstrated upon 
CDME loading in proximal tubules 
[Coor 1991]. Taken together, it 
was suggested that decreased ATP 
levels caused by lysosomal cystine 
accumulation consequently resulted 
in proximal tubular dysfunction. 
Apical reabsorption in the proximal 
tubular epithelium is mainly driven by 
a sodium gradient, accomplished by 
Na,K-ATPase at the basal membrane 
(figure 1.1). Altered intracellular ATP 
levels may decrease Na,K-ATPase 
activity, decrease Na-gradient and 
eventually result in impaired Na- 
dependent reabsorption. Since tubular 
reabsorption of phosphate, amino 
acids, glucose and other compounds in 
the ultra-filtrate is mediated by sodium- 
dependent transporters, decreased 
intracellular ATP levels could ultimately 
lead to Fanconi syndrome.
To study the renal defects observed 
in cystinosis, an in vitro cell model
derived from cystinotic kidney was 
required. One report presented renal 
cell cultures derived from autopsy 
material of two cystinotic patients, 
with cystine levels similar to those of 
cystinotic fibroblasts [Pellett 1984]. 
Since only little cystinotic renal material 
is available, the CDME loading technique 
was assessed in the renal cell line 
LLC-PK1 [Moran 1990]. In this model, 
cystine levels were increased and 
transport of alpha-methyl-glucoside 
was decreased, mimicking the cystinotic 
phenotype. Further, this method was 
used to demonstrate decreased sodium 
dependent transport in the cystine 
loaded renal cell line [Bennun 1992]. 
This was in line with the hypothesis 
of altered ATP metabolism leading to 
Fanconi syndrome in cystinosis.
Alternatively, the use of urine to 
establish epithelial renal cell cultures 
was first reported by Sutherland and 
Bain, who used urine of newborns 
[Sutherland 1972]. This method was 
further developed in the 80's [Hintz 
1984; Detrisac 1983]. Exfoliated renal 
cells in urine were used by Racusen et al. 
to establish a proximal tubular cell line 
of a cystinotic patient [Racusen 1991; 
Racusen 1995]. These cells presented 
with epithelial characteristics and 
cystine levels were increased 100-fold 
compared to control cells. Using cells 
exfoliated in urine, decreased levels 
of GSH were observed in cystinotic 
proximal tubular cells together with 
decreased ATP levels [Laube 2006].
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Additionally, cystinotic proximal 
tubular cells showed increased 
apoptosis rate. Remarkably, the 
observation of increased apoptosis rate 
and decreased GSH were previously 
observed in cystinotic fibroblasts [Chol 
2004; Park 2002]. Decreased GSH levels 
in cystinotic proximal tubular cells 
may point towards involvement of the 
y-glutamyl cycle in the pathogenesis of 
this disease.
1.5 Aim and outline of this 
thesis
Since the first report of a cystinosis 
patient by Abderhalden in 1903, great 
knowledge about the biochemical 
and molecular basis of nephropathic 
cystinosis has been acquired. Due to 
this knowledge, cooperating chemists 
and clinicians have been able to tackle 
the lysosomal cystine accumulation by 
treating patients with the aminothiol 
cysteamine. Although cysteamine 
decreases intracellular cystine levels to 
the heterozygous range, renal proximal 
tubular dysfunction is not cured but still 
followed by a downward spiral leading 
to ESRD in the majority of patients. 
The aim of this thesis is to gain further 
insight in the pathogenesis of cystinosis 
to improve quality of life of cystinotic 
patients.
Little is known about the causative 
effect of cystine accumulation on the 
development of tubular dysfunction. 
Fundamental research to this missing
link demands for suitable study 
material. To overcome the availability 
of renal cystinosis material required 
for studying the proximal tubular 
defects, CDME has been used in the 
last three decades to mimic lysosomal 
cystine accumulation. In chapter 2 the 
reliability of this model with artificial 
cystine loading is discussed.
Alternatively, new proximal tubular 
cell models are presented in this thesis 
that can be used for in vitro research. 
Both models are derived from cells 
exfoliated in urine and to maintain 
cell proliferation transfected using 
either HPV 16 E6/E7 (chapter 3) or a 
combination of SV40T and hTERT genes 
(chapter 4). In detail, the proximal 
tubular characteristics of both models 
are described.
Following studies using fibroblasts 
and animal models, alterations in ATP 
metabolism and/or GSH metabolism 
have been suggested to be involved 
in the pathogenesis of cystinosis. 
Both cellular compounds and their 
metabolic pathways are investigated 
in the studies described in chapters 3 
and 5 using the new developed PTEC 
lines. Additionally, chapter 5 describes 
the influence of cysteamine on ATP and 
GSH metabolism.
Since many studies in cystinosis 
have been performed in cystinotic 
fibroblasts to investigate the ATP 
metabolism, chapters 6 and 7 involve 
careful evaluation of these studies. 
In these chapters, mitochondrial and
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glycolytic ATP production is studied 
using new enzymatic methods, proven 
to be valuable for investigating 
mitochondrial diseases.
LMW proteinuria is one of the 
symptoms present in nephropathic 
cystinosis. The similarities with Dent's 
disease are remarkable, such as 
the development of renal Fanconi 
syndrome and defective lysosomal 
transporters. The expression of multi­
ligand receptors megalin and cubilin 
are studied in chapter 8 using renal 
material obtained from a human 
cystinotic kidney. These histological 
observations are further correlated to 
the urinary protein pattern in cystinosis 
versus healthy control subjects.
A general discussion of the results 
derived from these studies together 
with proposed future perspectives can 
be found in chapter 9. The observations 
presented in this thesis and the 
discussion is summarized in chapter 10.
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Abstract
The ability of CDME to load lysosomes with cystine has been used to establish 
the basic defect in cystinosis: defective cystine exodus from lysosomes. Using 
CDME loading it has been postulated that cystine accumulation in cystinosis affects 
mitochondrial ATP production resulting in defective renal tubular reabsorption. 
Recent studies in cystinotic fibroblasts, however, show normal ATP generation 
capacity. To investigate the effect of CDME in more detail, mitochondrial ATP 
generation, ROS production and viability is compared in fibroblasts loaded with 
CDME to those of cystinotic cells with a defective cystine transporter.
Intracellular cystine levels were comparable in fibroblasts loaded with CDME (1 
mM, 30 min) and cystinotic fibroblasts. Intracellular ATP levels and mitochondrial 
ATP production were decreased in fibroblasts loaded with CDME, but normal in 
cystinotic fibroblasts. Superoxide production was increased with ~300% after 
CDME loading, while no changes were observed in cystinotic fibroblasts. Exposure 
to CDME led to cell death in time and concentration dependent manner.
Our data demonstrate that CDME has a toxic effect on mitochondrial ATP 
production and cell viability. These effects are not observed in cystinotic cells, 
indicating that a more appropriate model is required for studying the pathogenesis 
of cystinosis.
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Introduction
Lysosomal cystine accumulation is 
the hallmark of the lysosomal storage 
disorder cystinosis, caused by a 
defect in the lysosomal cystine carrier 
cystinosin encoded by the CTNS gene 
[Town 1998]. Cystinosis is the most 
common cause of inborn Fanconi 
syndrome, which generally progresses 
towards ESRD during the first decade 
of life when untreated with cystine 
depleting agent cysteamine [Gahl
2002]. Defective cystine exodus from 
cystinotic lysosomes was established as 
the basic defect in cystinosis by using 
a technique of lysosomal loading with 
CDME developed by Goldman and 
Reeves [Goldman 1973; Reeves 1979; 
Gahl 1984]. Subsequently, proximal 
tubular cells loaded with CDME were 
used for studying the pathogenesis of 
cystinosis, because no in vivo or in vitro 
model of cystinosis carrying a defect 
in the CTNS gene was available at that 
time.
CDME loading of rat and rabbit 
isolated proximal tubules, and of LLC- 
PK1 caused defective proximal tubular 
reabsorption, comparable to Fanconi 
syndrome in cystinosis [Bennun 
1992; Foreman 1990; Salmon 1990]. 
Using this model it was postulated 
that altered mitochondrial ATP 
generation could be the underlying 
pathogenic mechanism of cystinosis, 
because CDME loading resulted in a 
dramatic decrease of mitochondrial
ATP production, leading to decreased 
activity of proximal tubular Na,K-ATPase 
[Bennun 1993; Coor 1991; Foreman
1995]. As the majority of proximal 
tubular transporters are Na+-coupled, 
decreased activity of Na,K-ATPase, 
leading to a decreased transmembrane 
Na+ gradient, was suggested to cause 
generalized dysfunction of proximal 
tubular transport in cystinosis [Baum 
1998]. This hypothesis established in 
CDME-loading model has recently been 
challenged by in vitro studies in cells 
derived from cystinotic patients.
Our group extensively studied 
energy metabolism in cultured 
cystinotic fibroblasts. ATP generation 
in these cells appeared to be normal 
under basal and stimulated conditions. 
A moderate decrease of intracellular 
ATP content did not cause alterations 
of Na,K- ATPase activity [Levtchenko 
2006c]. Furthermore, we found normal 
intracellular ATP levels in human 
immortalized PTEC, derived from urine 
of cystinotic patients compared to 
healthy controls [Wilmer 2005]. Similar 
to our results, normal intracellular ATP 
content was demonstrated in primary 
cystinotic PTEC under basal conditions 
by Laube et al. [Laube 2006].
Because the results of the studies 
mentioned above are in disagreement 
with those obtained in proximal tubular 
cells exposed to CDME, we assumed 
that CDME loading could provoke 
effects different from those attributed 
to lysosomal cystine accumulation in
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cells with a deficient lysosomal cystine 
carrier. In concordance with this idea, 
a recent study using the IHKE-1 cell 
line demonstrated that CDME had an 
acute effect on the basal membrane 
potential, possibly due to activated K+ 
conductance [Cetinkaya 2002]. In the 
present study we investigated the effect 
of CDME loading on mitochondrial 
ATP generating capacity, superoxide 
production and viability of control 
fibroblasts compared to cystinotic 
fibroblasts accumulating cystine due 
to a known genetic defect of the CTNS 
gene.
Materials and Methods
Cell cultures
Fibroblasts were cultured from 
skin biopsies after obtaining informed 
consent of healthy controls (n=2) and 
cystinotic patients (n=2) as described 
previously [Levtchenko 2006c]. 
Cystinosis was diagnosed in all patients 
by measuring elevated cystine content 
in polymorphonuclear cells (>0.5 nmol 
cystine/mg protein) and was confirmed 
by molecular analysis of the CTNS gene. 
Both patients carried the common 
homozygous 57 kb deletion of the CTNS 
gene.
Cystine loading and determination of 
intracellular cystine content
Control cells were loaded by adding 
CDME (Fluka) to culture medium at 
a final concentration of 1.0 mM and
incubated for 30 min at 37°C and 5% 
CO2 prior to further analysis. Pilot 
experiments showed that cystine 
concentrations under these conditions 
were in the range observed in 
cystinotic fibroblasts. For concentration 
dependent assays CDME concentration 
ranged from 0.1 to 5.0 mM and for the 
time dependent assay CDME incubation 
time varied from 10 to 120 min. After 
CDME loading, cells were rinsed briefly 
with PBS before harvesting using 
trypsin-EDTA. Following detachment, 
cells were further processed on ice to 
prevent cystine exodus from lysosomes. 
Intracellular cystine levels were 
determined as described previously and 
expressed as nmol cystine/mg protein 
(equal to (% cysteine/mg protein) / 2) 
[Graaf-Hess 1999].
Intracellular ATP content and 
mitochondrial ATP production
After culturing fibroblasts to 
confluence, cells were incubated with 
CDME as indicated above (1.0 mM 
CDME for 30 min) and harvested using 
trypsin-EDTA to determine intracellular 
ATP levels in three independent 
experiments using ATP luminescence 
kit (Roche) as described previously and 
presented as nmol ATP/mg protein 
[Levtchenko 2006c]. Data are expressed 
as mean (+/- SEM).
Mitochondrial ATP production was 
monitored by transfecting fibroblasts 
cultured on acoverslip witha baculovirus 
containing cDNA for mitochondria
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targeted luciferase [Levtchenko 2006c; 
Visch 2004]. Perfusing the transfected 
cells with HEPES-Tris medium (132 mM 
NaCl, 4.2 mM KCl, 1 mM MgCl2, 5.5 
mM D-glucose, 10 mM Hepes, 1 mM 
CaCl2, pH 7.4) supplemented with 5 ^M 
beetle luciferin allowed us to monitor 
mitochondrial ATP production in intact 
cells at 37°C using a photomultiplier 
tube. After stabilisation of the signal, 1 
mM CDME was added to the perfusion 
medium at the indicated time. To 
investigate whether the effect of CDME 
on mitochondrial ATP production in the 
cells was reversible, CDME was removed 
after 15 min from the perfusion medium. 
Results were expressed as a relative 
decrease in luciferase luminescence. 
Concentration dependent effects of 
CDME perfusion (0.2, 0.5, 1.0 and 5.0 
mM) on mitochondrial ATP production 
were determined in one control 
fibroblast cell line. The luminescence 
was normalized to the initial basal 
level for each concentration and set to 
100%. The relative luminescence for 
all CDME concentrations was plotted 
against time.
Measurement of Na,K-ATPase activity 
using 86Rb+
The uptake of 86Rb+, a congener 
of K+, can be used to determine the 
Na,K-ATPase activity in a monolayer of 
fibroblasts. To study the effect of 30 min 
CDME (1 mM) loading on Na,K-ATPase 
activity, we measured 86Rb+ uptake with 
or without inhibitor ouabain (10 mM)
as described previously [Levtchenko 
2006c].
Quantification of mitochondrial 
superoxide levels
Control and cystinotic fibroblasts 
were cultured on coverslips and 
incubated in HEPES-Tris medium 
containing 10 ^M HEt (Molecular 
Probes, Leiden, The Netherlands) for 
10 min at 37oC. HEt is a lipophylic, 
uncharged compound that enters 
the cell and reacts with superoxide to 
form two positively charged products,
2-hydroxyethidium and ethidium, both 
of which emit red fluorescence [Zhao 
2005]. The reaction was stopped by 
thoroughly washing the cells with PBS 
to remove excess HEt. For quantitative 
analysis of the fluorescent HEt oxidation 
products, coverslips were mounted in an 
incubation chamber placed on the stage 
of an inverted microscope (Axiovert 200 
M, Carl Zeiss, Jena, Germany) equipped 
with a Zeiss 40x/1.3 NA fluor objective. 
The cells were excited at 490 nm using 
a monochromator (Polychrome IV, 
TILL Photonics, Gräfelfing, Germany). 
Fluorescence emission light was 
directed by a 525DRLP dichroic mirror 
(Omega Optical Inc., Brattleboro, 
VT, USA) through a 565ALP emission 
filter (Omega) onto a CoolSNAP HQ 
monochrome CCD-camera (Roper 
Scientific, Vianen, The Netherlands). 
Hardware was controlled with 
Metafluor 6.0 software (Universal 
Imaging Corporation, Downingtown,
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PA, USA). Subsequently, control cells 
(n=2) were loaded for 2 hr with 0.5 mM 
CDME and monitored again. Routinely, 
10 fields of view with 2-5 cells each 
were analyzed per coverslip using an 
acquisition time of 100 milliseconds. 
Data are presented as % increase of 
control fibroblast #1 +/- SEM.
Viability assay
The viability of cultured fibroblasts 
and human proximal tubular cell line 
HK-2 after treatment with CDME was 
tested in 96 wells by a fluorescent assay 
using resazurin (0.01%) as a marker 
[Yang 2004]. Subsequent to CDME 
incubations at various concentrations 
and time periods, culture medium was 
aspirated and cells were incubated with 
resazurin for 2.5 hr, prior to measuring 
fluorescence at 590 nm with excitation 
of 560 nm. Viability was expressed as 
% fluorescence compared to vehicle 
control. Additionally, viability was 
tested using Trypan Blue exclusion.
Statistical analysis
Wilcoxon signed ranks test was 
used for comparing intracellular ATP 
levels and Student's-test was used for 
comparing mitochondrial superoxide 
levels between control and cystinotic 
fibroblasts at basic conditions and 
control fibroblasts after CDME loading. 
The differences were considered 
statistically significant at p<0.05.
Results
Cystine accumulation in loaded control 
fibroblasts and unloaded cystinotic 
fibroblasts
The two cystinotic fibroblasts 
accumulated cystine (1.83 and 5.14 
nmol cystine/mg protein) compared to 
two untreated controls (0.09 and 0.09 
nmol cystine/mg protein), consistent 
with defective lysosomal cystine 
transporter in cystinotic cells. Loading 
of control fibroblasts with 1 mM CDME 
for 30 min resulted in an increase of 
intracellular cystine levels (10.36 and 
3.41 nmol cystine/mg protein in control 
#1 and #2, respectively). In preliminary 
CDME loading experiments in the two 
control fibroblasts, we found that 
loading for 10 min resulted in lower 
cystine levels: 0.70 and 0.55 nmol 
cystine/ mg protein, respectively.
Effect of CDME on intracellular ATP 
content and mitochondrial ATP 
production
In three independent experiments, 
intracellular ATP levels in control 
fibroblasts loaded with CDME were 
significantly decreased (p<0.05) after 30 
min incubation with 1 mM CDME, while 
cystinotic cells displayed ATP levels in 
the range of untreated controls (figure 
2.1A). Monitoring luminescence in 
loaded control fibroblasts transfected 
with mitochondria targeted luciferase 
demonstrated an acute decrease in 
mitochondrial ATP levels when cells
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Figure 2.1. CDME loading results in decreased ATP levels and mitochondrial ATP 
production. (A) Intracellular ATP levels were measured using ATP luminescence 
kit of Roche in two control cell lines without and with CDME (1 mM, 30 min) 
and compared with ATP levels of two cell lines derived from cystinotic patients. 
(B) Monitoring mLuc luminescence representing mitochondrial ATP production 
in control fibroblast #1 transfected with mitochondrial targeted luciferase and 
perfused with various concentrations of CDME. Plotted as % luminescence 
compared to basal levels before CDME perfusion. Data are presented as mean 
nmol ATP/mg protein +/- SEM. * significantly different from control fibroblast 
#1 (p<0.05).
were perfused with 1 mM CDME in 
addition to luciferin (figure 2.1B). Within 
10 min, mitochondrial ATP production 
decreased to background levels. The 
effect of CDME on mitochondrial ATP 
production appeared to be dependent 
on its concentration (figure 2.1B). 
When loading cystinotic fibroblasts, 
the effects on mitochondrial ATP 
production were similar to control 
fibroblasts: an acute decrease in 
mitochondrial ATP production during 
CDME perfusion, despite remarkably 
higher cystine levels (data not shown). 
Furthermore, removal of CDME from 
the perfusion medium 15 min after the
exposure did not result in a restoration 
of ATP production during the next 40 
min (data not shown).
Effect of CDME on Na,K-ATPase activity 
The effect of 30 min CDME loading 
in control fibroblasts on 86Rb+ uptake 
was not significantly altered.
Mitochondrial superoxide levels
Using the fluorescent products of 
HEt oxidation, we could measure the 
superoxide levels before and after 
CDME loading of control fibroblasts. 
CDME loading resulted in a significant 
increase in superoxide levels in control
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Figure 2.2. Superoxide production 
is increased following CDME 
loading. Superoxide production in 
two control fibroblasts loaded with 
or without CDME (2 mM, 2 hr) and 
two cystinotic fibroblasts. Relative 
superoxide production is determined 
by measuring fluorescence at 565 nm 
and excitation at 490 nm after HEt 
incubation and compared to control 
fibroblast #1, without CDME loading. 
Data are presented as mean % 
increase of control fibroblast #1 (+/- 
SEM). * Significantly different from 
control fibroblast #1 (p<0.001).
fibroblasts (~300% increase, p<0.001), 
while no significant difference could 
be detected between cystinotic and 
unloaded control cells (figure 2.2).
Viability assay
Incubating control fibroblasts during 
10-120 min with 0.1 -3 mM of CDME 
clearly showed gradual decrease in 
fluorescence of resazurin, indicating 
that viability of the cells was reduced by 
CDME (figure 2.3A). In the fibroblasts, 
30 min incubation with 0.5 mM CDME 
resulted in a viability of at least 85%, 
whereas incubations up to 120 min 
and 3 mM killed more than 90% of the 
cells. Determination of viability using 
Trypan Blue exclusion after incubation 
with 1 mM CDME at the same time 
intervals showed similar results (data 
not shown).
Because proximal tubular cells might 
be more resistant to CDME toxicity, we 
performed the similar experiments in
human HK-2 proximal tubular cell line. 
The results obtained were comparable 
to those obtained in cultured fibroblasts 
(figure 2.3B).
Discussion
CDME loading of proximal tubular 
cells has been extensively used for 
studying the pathogenesis of cystinosis. 
Using this model the hypothesis 
of altered ATP metabolism being 
the keystone in the pathogenesis 
of cystinosis has been postulated 
[Bennun 1993; Coor 1991; Foreman 
1995; Sakarcan 1994]. In this study 
we demonstrated that CDME loading 
immediately reduces mitochondrial 
ATP generation and additionally causes 
extensive superoxide production 
and cell death of the loaded cells. 
These results cannot be attributed 
to lysosomal cystine accumulation, 
because cystinotic fibroblasts
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Figure 2.3. Viability of cultured cells is decreased due to CDME loading.
Concentration and time dependent viability after CDME loading (1 mM) in (A) 
control fibroblasts and (B) control HK-2. Viability is determined using resazurin 
by measuring fluorescence at 590 nm with excitation at 560 nm and expressed 
as % fluorescence compared to vehicle control. Viability is measured after 10, 
30, 60 and 120 min.
displaying comparable intracellular 
cystine content, demonstrated normal 
mitochondrial ATP levels, unchanged 
superoxide production and preserved 
viability compared to unloaded 
control cells. Furthermore, similar to 
our previous study using the same 
fibroblast cell lines, a 3-fold difference 
in cystine concentration in two control 
fibroblasts cultures after CDME loading 
was not associated with remarkable 
differences in ATP levels in the present 
study [Levtchenko 2006c].
In this study we did not explore the 
exact mechanism of CDME toxicity. 
However, we might speculate that the 
toxic effect of CDME could be caused by 
a high oxidative potential of this ester, 
which is hydrolyzed in the lysosomes to 
cystine and methanol and subsequently 
exported from the lysosomes via intact
cystinosin in these cells. Toxic effects 
of methanol, released after CDME 
hydrolysis within the cells, probably 
does not play a major role, because the 
exposure of cells to the equal quantities 
of leucine, tryptophan and alanine ester 
did not produce any measurable toxic 
effect [Bennun 1992; Salmon 1990]. 
Loading cells with millimolar amounts 
of CDME, as it has been done in the 
majority of studies using this ester, 
will thus deliver millimoles of cystine 
to the cytosol. These high cystine 
concentrations can either react with 
free sulphydryl (-SH) groups of proteins 
and polypeptides via a disulphide 
exchange reaction, disturbing their 
function, or can be reduced to cysteine. 
The latter will consume a substantial 
amount of intracellular anti-oxidants 
(e.g. GSH) and make cells prone to
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oxidative damage.
In our study the effect of CDME on 
the mitochondrial ATP generation was 
observed within the first minute after 
the exposure, suggesting a toxic effect 
on the mitochondria. Remarkably, 
the inhibitory effect of CDME on the 
mitochondrial ATP generation was 
irreversible, probably due to the 
permanent oxidative damage of the 
mitochondrial membrane produced by 
this ester. Interestingly, a direct effect 
of CDME on isolated mitochondria 
has already been demonstrated by 
Foreman, who observed a significant 
decline of mitochondrial O2 utilisation 
after CDME exposure using glutamate 
as a substrate, but not with succinate, 
pointing to the initial inhibition of the 
respiratory complex I [Foreman 1995].
Interestingly, in contrast to earlier 
studies we found normal Na,K-ATPase 
activity after CDME loading [Bennun 
1993; Bennun 1992]. The explanation of 
this observation could be that the ~50% 
decrease in ATP levels after 30 min of 
CDME loading in the present study 
might still be sufficient for normal Na,K- 
ATPase activity. Ben-Nun et al. showed 
a decrease in 86Rb+ influx, which was 
measured after 10 hrs of loading with 
1 mM CDME [Bennun 1992]. According 
to our data, cells are not viable after 
such a period and cell death might have 
caused decrease of 86Rb+ influx.
A burst of superoxide after CDME 
loading demonstrated in our study can 
either be attributed to mitochondrial
dysfunction, resulting in increased free 
radical generation or to decreased 
capacity of the cell to deal with 
oxidative stress. Extensive free radical 
damage probably led to cell death, the 
rate of which was dependent on the 
concentration of CDME and the time 
of exposure, as shown by the viability 
experiments. It is striking that only in 
the first pioneering paper of Foreman 
et al., the results of the viability assay 
are mentioned: using Trypan blue 
exclusion test they demonstrated that 
after 10 min exposure to 2 mM CDME 
90% of rat proximal tubuli remained 
viable [Foreman 1987]. These results 
are in concordance with those obtained 
in our study. Longer loading times and 
higher CDME concentrations used by 
others might have reduced cell viability, 
which would influence the outcome. 
Because we could not exclude that 
proximal tubular cells are more 
resistant to CDME toxicity compared to 
fibroblasts, we performed the viability 
assay in human proximal tubular cell 
line HK-2 after exposure to different 
concentrations of CDME. The results 
obtained were similar to those in the 
fibroblasts.
Do the present data mean that the 
hypothesis of altered ATP metabolism 
being a major player in the pathogenesis 
of cystinosis should be rejected? 
Previous studies show a moderate, but 
a significant decrease of intracellular 
ATP content in cultured cystinotic 
fibroblasts, polymorphonuclear cells
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and primary proximal tubular cells 
exposed to hypoxia [Laube 2006; 
Levtchenko 2006c].
Remarkably, in the current study 
ATP levels of cystinotic fibroblasts 
were in the range of control values. 
This discrepancy with our previous 
results could be attributed to a 
biologic variability in a small number 
of observations and an overlap 
between cystinotic and control values 
[Levtchenko, 2006c]. Additionally, 
swollen mitochondria have been 
described in kidney tissue of the 
patients and proximal tubulus cells 
of ctns'1' mice, indicating that ATP 
metabolism may play a role in cystinosis 
[Jackson 1962; Cherqui 2002]. However, 
mitochondrial ATP generation and 
Na,K-ATPase activity was normal in 
cystinotic fibroblasts [Levtchenko 
2006c]. Furthermore, ctns'1' mice model 
exhibit no signs of proximal tubular 
dysfunction [Cherqui 2002]. Because 
cultured fibroblasts preferentially 
use anaerobic glycolysis for the ATP 
production, it can not be excluded 
that cystine accumulation causes 
the alteration of the mitochondrial 
OXPHOS in metabolically active cells 
in vivo [Levtchenko 2006c; Robinson
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1996]. Therefore, studies in human 
cystinotic proximal tubular cells after 
the inhibition of the glycolytic pathway 
and stimulation of the mitochondrial 
respiration will be of paramount 
importance for further exploring of the 
ATP hypothesis. Measurement of ATP 
content in vivo in cystinotic patients 
by magnetic resonance spectroscopy 
might underscore the hypothesis.
In conclusion, CDME loading of 
control fibroblasts resulted in a toxic 
effect on the mitochondrial ATP 
generation. In addition, CDME acted 
in a dose dependent manner on the 
viability of the cells and increase 
superoxide production. These findings 
question the validity of CDME loading 
model for studying the pathogenesis 
of cystinosis and suggest that the 
hypothesis of altered mitochondrial 
respiration obtained in this model 
should be reconsidered. Further studies 
in metabolically active proximal tubular 
cells carrying CTNS gene mutations and 
in vivo measurements of intracellular 
ATP status in cystinotic patients are 
required for definitive confirmation 
or rejection of the hypothesis of ATP 
alterations being the keystone in the 
pathogenesis of cystinosis.
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Abstract
Cystinosis, the most frequent cause of inborn Fanconi syndrome, is characterized 
by the lysosomal cystine accumulation, caused by mutations in the CTNS gene.
To elucidate the pathogenesis of cystinosis, we cultured proximal tubular 
cells from urine of cystinotic patients (n=9) and healthy controls (n=9), followed 
by immortalization with HPV 16 E6/E7. Obtained cell lines displayed basolateral 
polarization, AP activity, presence of aminopeptidase N (CD-13) and megalin, 
confirming their proximal tubular origin.
Cystinotic cell lines exhibited elevated cystine levels (0.86 +/-0.95 versus 0.09 
+/-0.01 nmol/mg protein in controls, p=0.03). GSSG was elevated in cystinotic cells 
(1.16 +/-0.83 versus 0.29 +/-0.18 nmol/mg protein, p=0.04), while total GSH, free 
cysteine and ATP contents were normal in these cells.
In conclusion, elevated GSSG in cystinotic Pgp lines suggests increased oxidative 
stress, which may contribute to tubular dysfunction in cystinosis.
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Introduction
Cystinosis is an autosomal recessive 
disorder caused by mutations in the 
cystinosis gene, CTNS (17p13.2), 
encoding the lysosomal cystine 
transporter protein cystinosin [Town 
1998; Kalatzis 2002]. The hallmark of 
cystinosis is the lysosomal accumulation 
of cystine due to a defective exodus 
into the cytosol [Gahl 2001]. Patients 
with the infantile form of cystinosis 
manifest with severe generalized 
proximal tubular dysfunction (Fanconi 
syndrome), generally appearing during 
the first year of life [Gahl 2001]. When 
untreated with cystine depleting agent 
cysteamine, they develop ESRD around 
the age of 10 years.
Renal proximal tubular reabsorption 
of solutes is performed by symporters 
on the BBM of PTEC. The driving force 
of this transport is a trans-membrane 
sodium gradient established by 
Na,K-ATPase. Based on studies in 
proximal tubular cells loaded with 
CDME, mimicking lysosomal cystine 
accumulation in cystinosis, it was 
hypothesized that reduced ATP 
production in cystinotic cells resulting 
in decreased sodium gradient causes 
a dysfunction of sodium-dependent 
apical transporters [Salmon 1990; 
Coor 1991; Bennun 1993; Foreman 
1995; Baum 1998; Cetinkaya 2002]. 
Thus far this mechanism has not been 
demonstrated in human cystinotic 
material. Furthermore, the possible
link between lysosomal cystine 
accumulation and altered mitochondrial 
function is not clarified.
Recently, it has been suggested that 
disturbances in y-glutamyl cycle, which 
accounts for GSH synthesis, might 
link lysosomal cystine accumulation 
and ATP depletion in cystinosis [Chol 
2004; Levtchenko 2005]. Insufficient 
cellular defense against ROS due to 
GSH deficiency can alter mitochondrial 
OXPHOS [Zhang 1990]. Furthermore, 
disturbed GSH status might reflect 
an increased mitochondrial ROS 
production, as it has been demonstrated 
in mitochondrial disorders [Lenaz
2004]. Increased rate of apoptosis, 
demonstrated in cystinotic fibroblasts 
and proximal tubular cells loaded 
with CDME, is an alternative proposed 
pathogenetic process in cystinosis [Park 
2002].
Studies of the pathogenesis 
of proximal tubular dysfunction 
in cystinosis are hampered by an 
unavailability of human renal cystinotic 
material. This limitation has been 
overcome by developing the technique 
of proximal tubular cell culture deriving 
from urine of patients with cystinosis 
[Racusen 1995; Laube 2005].
In the present study, we established 
and characterized PTEC cell lines 
immortalized with HPV 16 E6/E7 genes 
from urine of 9 cystinotic patients and
9 healthy controls and evaluated for 
the first time intracellular ATP levels 
and intracellular GSH status in human
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Methods
Study population
Urine was collected from 9 patients 
with cystinosis aged 5-15 years. In all 
patients cystinosis manifested with 
renal Fanconi syndrome at the age of 
6-18 months. The diagnosis of cystinosis 
was made by determining elevated 
cystine content of polymorphonuclear 
cells (>0.5 nmol cystine/mg protein) 
and was confirmed in 8 patients by 
molecular analysis of CTNS gene.
Urine of 48 healthy subjects (4­
13 years old) was used for obtaining 
control proximal tubular cells.
Cell culture and immortalization
Urine was collected and within 5 
hours centrifuged (223 xg) for 5min, 
at room temperature. After washing 
in phosphate buffer saline (PBS) and 
a second centrifugation step, urine 
sediment was resuspended in 3ml of 
PTEC culture medium (DMEM-HAM's 
F12; Cambrex Biosciences) containing 
FCS (10%), penicillin (100 U/ml, Gibco), 
streptomycin (100 U/ml, Gibco), 
insulin (5 ^g/ml), transferrin (5 ^g/ml), 
selenium (5 ng/ml), hydrocortisone (36 
ng/ml), epithelial growth factor (10 
ng/ml) and tri-iodothyronine (40 pg/ 
ml) [Detrisac 1984]. The suspension 
was transferred to 25cm2 tissue 
culture flask and placed at 37°C in a 
5% CO2 incubator. The medium was
cystinotic proximal tubular cells. changed every 2-3 days. To maintain 
proliferation, cells at passage number 
4 or less were transfected with 
plasmid DNA, containing the HPV 16 
E6/E7 genes, using the amphotropic 
packaging cell line PA 317 [Ryan 1994].
Characterization of proximal tubular 
epithelial cells
As a positive control, commercially 
available human HK-2 was used (ATCC) 
[Ryan 1994]. As a negative control 
undifferentiated human podocyte cell 
line immortalized with SV40T, kindly 
provided by Dr. M. Saleem, was used 
[Saleem 2002].
Light and electron microscopy
To demonstrate the characteristic 
cobblestone morphology of primary 
cultures phase contrast microscopy 
(Axiolab) was applied. Transmission 
electron microscopy was used to show 
ultrastructural morphology of proximal 
tubule cells. After immortalization and 
growing to confluence, cells were gently 
scraped from flasks, fixed, dehydrated 
and embedded in Epon 812 (Merck) as 
described previously [de Graaf 2004]. 
Semithin (1 ^m) and ultrathin sections 
were cut on an ultratome, Reichert 
Ultracut S (Leica Microsystems). The 
semithin slices were stained with 
toluidine blue and examined using light 
microscopy. The ultrathin specimens 
were contrasted with 4% uranyl acetate 
and lead citrate before examination by 
electron microscopy (Jeol 1200 EX2).
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Enzymatic studies
To confirm proximal tubular origin 
of cultured cells, activity of BBM AP 
was measured in cell suspensions 
(approximately 0.1 x 106 cells) in at 
least two independent experiments 
using BM Chemiluminescence ELISA 
substrate (AP) kit (Roche) according to 
instructions of the manufacturer. To 
quantify activity, a standard curve was 
made with dilutions of Shrimp Alkaline 
Phosphatase (Amersham Biosciences). 
Protein levels were determined using a 
method of Lowry.
Immunological studies
The presence of aminopeptidase N 
(CD-13) on the membrane of cultured 
cells (0.25 x 106) as an indication of 
their proximal tubular origin was 
determined by flow cytometry analysis 
(Coulter XL) with monoclonal mouse- 
anti-human CD13-FITC antibody (Dako) 
with a 1:100 dilution in PBS. Unlabeled 
cell suspensions were used as negative 
controls to evaluate positive staining 
profile.
The presence of PTEC specific 
protein megalin was examined using 
monoclonal antibody 6C5, which 
was a kind gift of Dr. W.S. Argraves 
(Charleston SC, USA) [Kounnas 
1993]. Cells were cultured to semi­
confluence on cover slides and fixed 
using paraformaldehyde (2%). After 
incubation with anti-megalin for 1 hr, 
cells were washed and incubated for a
second hour with goat-anti-mouse-FITC 
conjugate (Dako). Slides were examined 
by immunofluorescence microscopy.
Lectin staining pattern specific for 
proximal tubular cells was examined 
with SJA (Vector Laboratories), LTA 
(Sigma) and ECA (Vector Laboratories) 
by incubating cells with each of the 
lectins (75 ^g/ml) labeled with FITC 
(LTA and ECA) or rhodamine (SJA) for 1 
hr at room temperature [Grupp 2001].
Determination of thiol-amino acids and 
small thiol-peptides
Preparation of cell extracts 
and measurement of intracellular 
thiols (total GSH, GSSG, cystine and 
cysteine) using HPLC were performed 
as described previously [Levtchenko 
2005].
Measurement of total intracellular ATP 
content
Cystinotic and control cell cultures 
were grown to confluence in 75 cm2 
tissue culture flasks (approximately 5.0 
x 106 cells) and detached using trypsin. 
After washing in PBS cell pellets were 
shock frozen in liquid N2 and stored at 
-80°C until ATP determination. Prior 
to ATP determination pellets were 
resuspended on ice in 0.5 ml cold 
PBS. A 25-fold diluted fraction (25 ^l) 
of the suspension was transferred to 
a white microtiter plate and ATP was 
measured using ATP Bioluminescence 
Assay Kit HSII (Roche) according to the 
instructions of the manufacturer. The
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Figure 3.1. (A) Phase contrast image of primary cultures showing cobblestone 
morphology (original magnification 100X). (B) Light microscopy of cultured cells 
stained with methylene blue after scraping from tissue culture flask showing 
bipolar orientation (original magnification 400X). (C) Transmission electron 
microscopic image showing microvilli (black arrows), tight junctions (white 
arrow) and nuclei (asterisks) (original magnification 3000X).
residue of the undiluted cell suspension 
was used for protein determination 
using the method of Lowry.
Statistical analysis
Data (mean, SD) are presented as 
a mean of two separate experiments. 
Unpaired t-test was used for statistical 
analysis. Differences were considered 
statistical significant at p<0.05.
Results
Immortalized exfoliated cells express 
PTEC phenotype
While colonies with cobblestone 
morphology developed in all 9 
collected cystinotic urine samples 
within 2 weeks (figure 3.1A) only 9 out 
of 48 control urine samples showed 
cell proliferation. After immortalization 
with HPV 16 E6/E7, obtained cell lines 
exhibited the presence of microvilli and 
tight junctions, characteristic for PTEC, 
indicating that cultured cells develop
apical and basolateral polarization, 
emphasized with the toluidine blue 
staining (figure 3.1B and 3.1C). High 
activity of AP was detected in both 
cystinotic and control PTEC cultured 
from urine (11456 +/-7135 ^Units/mg 
protein) (figure 3.2). The activity of AP in 
cells derived from urine was about 100 
fold higher compared to commercially 
available HK-2 cell line (143 +/-309) 
and 1000-fold higher compared to the 
podocytes (14 +/-13). Megalin (data not 
shown) and aminopeptidase N (figure
3.3) were present in all examined PTEC 
cultured from urine. Aminopeptidase 
N was not detected on the podocytes. 
Furthermore, the staining with SJA, 
ECA and LTA lectins were all positive 
in obtained PTEC in concordance with 
their proximal origin (data not shown).
Cystinotic cell lines accumulate 
cystine and contain increased oxidized 
glutathione
Cystine levels in cystinotic PTEC
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Figure 3.2. Alkaline phosphatase 
activity in cell suspensions.
Activities (mean values of at least 
two independent experiments) 
quantified using Shrimp Alkaline 
Phosphatase. Data of control PTEC 
(#1 and #2) and cystinosis PTEC (#3 
and #4) are representative for total 
study population. PO, conditionally 
immortalized podocyte.
were significantly elevated compared 
to healthy control cells (0.86 +/-0.95 
versus 0.09 +/-0.01 nmol/mg protein, 
p<0.05), confirming their cystinotic 
phenotype (figure 3.4A).
Total GSH content was below the 
detection limit of 0.10 nmol/mg protein 
in 3 cystinotic PTEC and 4 control 
PTEC. Cystinotic cells demonstrated a 
significant increase of GSSG compared 
to healthy controls (1.16 +/-0.83 versus 
0.29 ±0.18 nmol/mg protein, p<0.05) 
(figure 3.4B). Total GSH (16.77 +/-5.48 
versus 9.85 +/-9.25, p=0.16) and free 
cysteine (11.45 +/-3.94 versus 11.38 
+/-4.07, p=0.97) was not different 
between cystinotic and control PTEC.
A B
CD13-FITC CD13-FITC
Figure 3.3. Fluorescence intensity of mouse-anti-human CD-13-FITC 
(Aminopeptidase N) antibody analyzed by flow cytometry. (A) Cultured PTEC 
cell lines derived from urine and (B) conditionally immortalized podocytes. 
Unlabeled cells are presented in white, labeled cells in black.
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Total intracellular ATP contents are 
comparable between cystinotic and 
control cell lines
Total intracellular ATP content in the 
cultured cells did not differ between 
cystinotic and control PTEC (3.49 +/- 
1.01 versus 4.03 +/-2.62, p=0.56) (figure 
3.5). There was no correlation between 
cystine and ATP contents and between 
ATP and GSH contents in cystinotic and 
control PTEC.
Discussion
In the present study, we developed 
human PTEC lines from urine of 
patients with cystinosis and healthy 
controls. This non-invasive approach is 
used because no other in vitro or in vivo 
model for studying the pathogenesis of
renal disease in cystinosis is available. 
In contrast to previous studies [Racusen 
1995; Laube 2005], we immortalized 
proximal tubular cells with HPV E6/E7, 
allowing us to obtain sufficient material 
for metabolic studies.
The presence of typical proximal 
tubular cell morphology, brush border 
enzyme AP activity, positive staining 
with anti-CD13 and anti-megalin 
antibodies and proximal tubular 
specific lectins pattern confirmed 
proximal origin of obtained cell lines. 
These features were not changed after 
the transfection.
Human podocytes conditionally 
immortalized with SV40T were used as 
a negative control to demonstrate that 
obtained cell lines were not podocytes, 
which also can be exfoliated in urine
Figure 3.4. (A) Cystine content (nmol/mg protein) in control (n=9) versus 
cystinotic (n=9) PTEC cell lines. (B) GSSG content in control (n=6) versus cystinotic 
(n=5) cell lines. *p<0.05.
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Figure 3.5. ATP concentration in 
PTEC cultured from urine of controls 
(n=9) and cystinotic patients (n=9). 
Values are expressed as nmol/mg 
protein, p>0.05.
[Vogelmann 2003]. Anti-CD 13 antibody 
(anti-aminopeptidase N) appeared 
to be an ideal marker to discriminate 
podocytes from proximal tubular cells 
as this marker was positive for all 
tested urinary PTEC cell lines but always 
negative for the podocytes.
Culturing PTEC from urine of healthy 
controls was less successful compared 
to patients with cystinosis (100% 
proliferation in cystinosis versus 19% in 
controls). A possible explanation could 
be that through increased mechanical 
stress in cystinotic patients more viable 
cells are exfoliated.
Our present in vitro model is 
superior to CDME-loading method, 
which only mimics lysosomal cystine
accumulation, since the molecular 
defect in CTNS gene is naturally present 
in cells derived from urine of cystinotic 
patients. Strikingly, in contrast to 
the studies in CDME loaded proximal 
tubular cells [Salmon 1990; Coor 1991; 
Bennun 1993; Foreman 1995; Baum 
1998; Cetinkaya 2002], we found no 
significant difference in intracellular 
ATP, questioning the hypothesis of ATP 
depletion being the cause of defective 
proximal tubular transport.
It might be suggested that higher 
cystine concentrations are necessary 
to cause ATP depletion in cystinotic 
cells, as cystine accumulation in our 
in vitro model was lower compared to 
cystinotic kidney: >15 nmol/mg wet 
weight [Gahl 2001]. Further extensive 
study of mitochondrial ATP synthesis 
in cystinotic proximal tubular cell lines 
are required to answer the question 
whether decreased ATP production is 
responsible for cellular dysfunction in 
cystinosis.
In 8 cell lines (4 cystinotic and 4 
controls) intracellular GSH was depleted 
and could not be quantified because it 
was under the detection levels of the 
assay. A possible explanation of this 
observation is that not all obtained cell 
lines express GSH transporters [Lash 
2005].
The most important finding of this 
study is a significantly elevated GSSG 
content in cystinotic PTEC, which might 
point to increased oxidative stress 
and altered redox status, while total
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GSH was comparable in cystinotic 
and control cells. Increased GSSG 
was already reported by our group 
in primary cystinotic fibroblasts and 
polymorphonuclear cells, while total 
GSH and free cystine were within the 
normal range in all tested cell types 
[Levtchenko 2005]. Concordant with 
our data, Chol et al. have recently 
demonstrated in conditionally 
immortalized cystinotic fibroblasts 
an increased activity of superoxide 
dismutase, converting superoxide 
into H2O2, possibly indicating 
increased oxidative stress [Chol 2004]. 
Interestingly, GSSG can activate pro- 
apoptotic PKC d [Chu 2003] and might 
play a role in increased apoptosis 
demonstrated in cystinotic fibroblasts 
[Park 2002]. Altogether these findings 
indicate that further research should be 
focused on ROS in cystinotic cells.
In conclusion, normal ATP content 
in cystinotic PTEC questions the 
hypothesis of altered ATP synthesis 
as a keystone in the pathogenesis 
of cystinosis. Elevated oxidized GSH 
suggests increased oxidative stress, 
possibly playing a role in cellular 
dysfunction in cystinosis.
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Abstract
Reabsorption of filtered solutes from the glomerular filtrate and excretion 
of waste products and xenobiotics are the main functions of the renal proximal 
tubular epithelium. A human PTEC expressing a range of functional transporters 
can be used as a tool to augment the current knowledge in renal physiology and 
pharmacology. In the present study, we established and characterized a ciPTEC.
The presented ciPTEC was obtained by transfecting and subcloning cells 
exfoliated in urine of a healthy volunteer and proximal tubular origin was confirmed 
morphologically and by expression of aminopeptidase N, ZO-1, AQP1, dppIV and 
multidrug resistance protein 4 together with AP activity. The ciPTEC assembled in 
a tight monolayer with limited diffusion of inulin-FITC. Concentration and time- 
dependent reabsorption of albumin via endocytosis was demonstrated, together 
with sodium-dependent phosphate uptake. Both expression and activity of apical 
efflux transporter Pgp and baso-lateral influx transporter OCT2 were shown in 
ciPTEC.
This established human ciPTEC expressing multiple endogenous organic ion 
transporters mimicking renal reabsorption and excretion is a powerful tool for 
future in vitro transport studies in pharmacology and physiology.
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Introduction
In the kidney, the proximal 
tubular epithelium is responsible 
for reabsorption of filtered solutes 
and excretion of waste products and 
xenobiotics. Numerous solutes, such 
as phosphate, urate and amino acids, 
are filtered in the glomerulus and 
reabsorbed in the proximal tubules by 
active sodium coupled transport, driven 
by an electrochemical gradient [Madsen 
KM 2008]. Other compounds of the 
glomerular filtrate, such as albumin 
and LMW proteins, are reabsorbed by 
receptor mediated endocytosis [Gekle 
2005]. The excretion of metabolic 
waste products or drugs is facilitated 
by multiple organic ion transporters 
mediating uptake from blood at the 
basolateral membrane and efflux 
across the apical membrane of PTEC 
[Russel 2002].
The function and regulation of 
these transport systems is subject of 
physiological and pharmacological 
research and requires a suitable in vitro 
cell model. In the last two decades, 
a variety of human and animal renal 
tubular cell lines have been used for 
this purpose, recently reviewed by 
Bens et al. [Bens 2008]. Currently 
available human PTEC have variable 
characteristics or express only few 
transporters, such as the commercially 
available HK-2 cell line, obtained from 
renal cortex and transfected with 
recombinant HPV16 E6/E7 genes [Ryan
1994; Racusen 1997]. On the other 
hand, primary PTEC, isolated from either 
human or animal kidney material, can 
only yield a limited amount of material, 
as proliferation stops at a few passages 
and cells dedifferentiate [Terryn 2007; 
Weiland 2007; Brown 2008]. The 
development of a human cell model 
with proximal tubular characteristics, 
including multiple influx and efflux 
transporters, would be useful to extend 
the current knowledge of renal solute 
reabsorption and drug excretion.
To overcome the limited availability 
of functional human PTEC, the 
combination of culturing exfoliated 
cells from human urine followed 
by immortalization steps can be 
applied [Racusen 1995; Wilmer 2005]. 
Infection using both temperature 
sensitive mutant U19tsA58 of SV40 
large T antigen (SV40T) and the 
essential catalytic subunit of hTERT 
has recently proven to be effective 
for the development of conditionally 
immortalized podocytes and human 
glomerular endothelial cells as well 
as for the immortalization of human 
fibroblasts [Saleem 2002; Satchell 
2006; O'Hare 2001]. Transfection with 
SV40T allows cells to proliferate at 
permissive low temperature of 33 C, 
while the inactivation of large T antigen 
at 37 C results in minor changes in 
gene expression [Stamps 1994]. The 
hTERT vector expresses telomerase 
activity to maintain telomere length, 
preventing the occurrence of replicative
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senescence [Bodnar 1998].
Using a non-invasive technique of 
obtaining renal material from urine, 
we have developed human ciPTEC 
from a healthy volunteer. This cell 
line can be maintained for at least 45 
passages and presents proximal tubular 
characteristics when cultured at the 
non-permissive temperature of 3 7 C  
for 10 days. The uptake of albumin and 
phosphate, as well as activities of the 
ABC transporter Pgp (MDR1/4BCB1) 
and OCT2 (SLC22A2) are demonstrated.
Materials and methods
Primary cell culture
Primary cells were cultured as 
described before by collecting mid 
stream urine after signing of informed 
consent by the parents of healthy 
volunteers with no clinical history 
of renal disease, nor with any other 
chronic disease. Urine sediment was 
transferred to supplemented DMEM- 
HAM's F12 medium (Lonza; Basel, 
Switzerland), and cultured at 37°C, 5% 
CO2 [Wilmer 2005].
Immortalization and subcloning
Primary cells were infected with 
SV40T and hTERT vectors containing 
respectively G418 or hygromycin 
resistance as described before [Satchell 
2006; O'Hare 2001]. Subconfluent 
cell layers were transferred to 33°C 
and selected using G418 (400 ^g/ml; 
Sigma-Aldrich) and hygromycin B (25
^g/ml; Sigma-Aldrich) for 10 days. To 
obtain a homogenous cell culture, cells 
were subcloned using irradiated NIH 
3T3 fibroblast as non-dividing feeder 
cells [Saleem 2002]. After culturing for 
two weeks at 33°C, single cell clones 
were visible and picked using cloning 
discs drained in trypsin/EDTA. For 
the following experiments, cells were 
cultured at 33°C to 70% confluency, 
followed by maturation for 10 days 
at 37°C during which the cells formed 
a confluent monolayer. Propagation 
of cells was maintained by reseeding 
the cells at a dilution of 1:3 to 1:6 at 
33°C. Experimental procedures were 
performed on the cloned cells between 
passages 15 and 40.
Morphology of ciPTEC was 
investigated using phase contrast 
microscopy. Additionally, cells cultured 
for 10 days at 37°C were scraped off 
flask using a rubber policeman and 
embedded in paraffin for electron 
microscopy analysis.
Characterization of ciPTEC
To investigate the epithelial origin 
of cells, confluent monolayers were 
fixed using 2% paraformaldehyde, 
permeabilized in PBS-Tween (0.1%) 
and incubated with antibodies against 
the tight junction protein ZO-1 (1:25 
dilution; Zymed Laboratories, South 
San Francisco, CA, USA). Following 
secondary goat-anti-rabbit-Alexa488 
conjugate (Dako, Glostrup, Denmark) 
and DAPI (Molecular Probes,
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Invitrogen) to stain nuclei, cells were 
analyzed using immuno-fluorescence 
microscopy. The presence of BBM 
protein aminopeptidase N using 
mouse-anti-human CD13-FITC antibody 
(Dako) and endothelial marker CD31- 
FITC (Dako) was detected as described 
previously [Wilmer 2005]. Additionally, 
a sample of stained cells was transferred 
to a glass slide by cytospin (1000 xg, 
10 min) and analyzed using immuno­
fluorescence microscopy. AP activity 
was determined in at least three 
independent experiments using BM 
Chemiluminescence ELISA substrate 
(AP) kit (Roche Diagnostics, Mannheim, 
Germany) as described before [Wilmer 
2005]. Values are compared to HK-2 
cell line using SAP as positive control 
and expressed as mean +/- SEM.
To investigate whether the 
monolayers assembled sufficiently 
tight for transport studies, ciPTEC 
was cultured on Transwell®-Clear 
polyester membranes (Corning Costar 
Corporation, Cambridge, MA, USA) for 
10 days at 37°C. Both apical and basal 
compartments were washed in HEPES- 
Tris buffer (Hepes-Tris (10 mM), NaCl 
(132 mM), KCl (4.2 mM), CaCl2 (1 mM), 
MgCl2 (1 mM), D-glucose (5.5 mM), pH 
7.4), prior to the addition of 0.1 mg/ml 
inulin-FITC (Sigma-Aldrich) to the apical 
compartment. Inulin-FITC diffusion 
through the monolayer was monitored 
for 2 hours by sampling 100^l of both 
apical and basal compartments and 
measuring fluorescence at 485 nm with
emission at 535 nm. Data are expressed 
as mean +/- SEM.
PAGE and Western Blotting
Cellular homogenates of cells 
cultured for various days at 37°C were 
made by scraping cells off using a 
rubber policeman from 75 cm2 tissue 
culture flask and lyzed in 400 ^l RIPA 
buffer containing Igepal CA630 (1%), 
Na-deoxycholate (0.5%), SDS (0.1%), 
PMSF (0.01%), aprotinin (3%) and Na- 
orthovanadate (1 mM). Expression of 
SV40T antigen in cell homogenates 
was analyzed by Western blotting using 
reduced 12% SDS-PAGE and blotted 
onto a PVDF membrane (Immobilon, 
Millipore; Bedford, MA, USA). 
Membranes were incubated with SV40T 
antibody (1:400 dilution; Santa Cruz 
Biotechnology, Santa Cruz CA, USA) 
and GAPDH (1:5.000 dilution; Abcam, 
Cambridge, UK) as a house-keeping 
antigen, followed by incubation with 
goat-anti-mouse-HRP conjugate (Dako) 
and visualization using Pierce ECL 
Western blotting substrate (Thermo 
Fisher Scientific, Waltham MA, USA).
Cellular homogenates matured 
for 10 days at 37°C were analyzed as 
described above using 6 or 12% SDS- 
PAGE as indicated, using the following 
antibodies: rabbit anti-AQP1 (1:4000; 
12%; Chemicon Intl, Millipore), 
rabbit anti-OCT2 (1:500; 12%, Alpha 
Diagnostics, San Antonio TX, USA), 
rabbit anti-CD26 (dppIV; 1:200, 12%; 
Santa Cruz Biotechnology), rabbit anti­
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multidrug resistance protein 4 [van 
Aubel 2002] (MRP4, ABCC4; 1:5000; 
6%), mouse anti-Pgp (1:200; 6%; Dako) 
goat-anti-mouse-HRP conjugate (Dako) 
and goat-anti-rabbit-HRP conjugate 
(Dako). Human kidney homogenate in 
RIPA buffer was used as control.
Albumin uptake by endocytosis
The ability of ciPTEC to reabsorb 
albumin was investigated by the 
incubation of confluent monolayers 
in 24 well plates with 50 ^g/ml BSA- 
FITC (Sigma-Aldrich) for 30 min at 37°C 
unless described otherwise. Uptake 
was arrested using ice-cold PBS and 
cells were detached using trypsin, 
fixed by paraformaldehyde (0.5%) in 
PBS and analyzed using flow cytometry 
or immuno-fluorescence microscopy. 
Concentration- and temperature- 
dependent uptake, was investigated 
using a concentration range BSA-FITC 
(0; 3.7; 11; 33; 100; 300 ng/ml) at 37°C 
and on ice for 30 min. Uptake inhibition 
was studied in three independent 
experiments by incubating the cells 
with BSA-FITC (50 ^g/ml) in addition 
of excess unlabelled BSA (10 mg/ml) or 
recombinant RAP (1 ^M), which was a 
kind gift of Dr. M. Nielsen (University 
of Aarhus, Denmark). Uptake inhibition 
by RAP was further examined using a 
dilution range of RAP. BSA uptake in 
saturation experiments are plotted as 
mean fluorescence intensity and in 
inhibition experiments as mean (+/- 
SEM) percentage uptake compared to
control condition.
Sodium-dependent phosphate uptake 
Phosphate uptake was performed 
in confluent monolayers using 32PO4 
(Perkin Elmer, Waltham MA, USA) as 
described earlier [Malmstrom 1988]. 
Cells cultured for 10 days at 37°C were 
incubated with 0.2 mM KH2PO4 (10 
^Ci/ml) for 5 min in four independent 
experiments, in the presence of 137 
mM sodium or 137 mM N-methyl-D- 
glucamine (NMDG) to study sodium- 
dependent transport. Additionally, 
time- (0.5; 1; 2; 5; 10; 15; 30 or 60 min) 
and concentration-dependent (0.02; 
0.07; 0.22; 0.66 or 2 mM PO4) uptake 
was studied. Data are expressed as 
mean +/- SEM.
OCT2 activity
Transport of xenobiotics across 
the basolateral membrane was 
investigated in ciPTEC by measuring 
the activity and expression of OCT2 
using a method adapted from Brown et 
al. [Brown 2008]. Cells were grown on 
Transwell®-Clear polyester membranes 
as described before. Activity of OCT2 
was measured by incubating 1 
fluorescent OCT2 substrate ASP 
(Invitrogen) in Hepes-Tris buffer for 1 
min at 37°C at the basal compartment. 
To inhibit OCT2 mediated uptake, 
cells were exposed to 100 ^M TPA at 
both apical and basal compartments 
for 10min prior to uptake of ASP. 
Additionally, one set of experiments
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was performed at 4°C. After incubation, 
transport was arrested using 1 mM 
ice-cold TPA. Cells were homogenized 
using 250 ^l Hepes-Tris-Triton (0.1%) 
buffer for 30 min, followed by analyzing 
fluorescence intensity (excitation 450 
nm, emission 642 nm) using Victor3 
Multiplate Reader (Perkin Elmer Inc.). 
Data are expressed as mean +/- SEM.
Pgp activity
The activity of the ABC- efflux 
transporter Pgp was assessed by 
measuring the accumulation of calcein 
as describe before [van de Water 2007]. 
Briefly, matured cells were incubated in 
two independent experiments for 1 hr 
at 37°C with lipophylic non-fluorescent 
Pgp substrate calcein-AM (Invitrogen) 
in the presence or absence of inhibitor 
PSC-833, which was a kind gift from 
Novartis Pharma (Basel, Switzerland). 
Intracellularly, calcein-AM is 
metabolized by esterase activity to the 
fluorescence calcein. Fluorescence of
cell lysates was measured at 488 nm 
with emission at 518 nm. Fluorescence 
is expressed as mean +/- SEM.
Statistical analysis
Michaelis-Menten curve fitting for 
calculation of K and V values wasm max
performed by non-linear regression 
analysis using GraphPad Prism 4.03 
software. Differences in substrate 
transport in presence or absence of 
inhibitors or unlabelled analogues were 
assessed by a paired t-test.
Results
Cell culture and morphology
Approximately 10% of the 38 
collected mid stream urine sediments 
from 31 healthy volunteers contained 
viable cells with the ability to proliferate 
into single cell colonies. Primary 
cultures showed heterogeneous 
morphology (figure 4.1A). Cell cultures 
infected with SV40T and hTERT were
Figure 4.1. Morphology of ciPTEC. (A) Representative phase contrast image 
of primary cells with heterogeneous morphology before immortalization and 
subcloning. Bar 50 ^m (B) Phase contrast image of confluent monolayers at 
passage 35 after immortalization, subcloning and maturation for 10 days at 37°C. 
Bar 50 ^m (C) Electron microscopy image of ciPTEC at passage 21 demonstrating 
microvilli. Bar 1 ^m
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antibiotic-resistant to hygromycin 
B and G418, indicating successful 
immortalization. Antibiotic resistance 
was maintained in ciPTEC for at least 
40 passages, suggesting expression 
of SV40T and hTERT remained over 
time during proliferation at 33°C. 
Proliferation was maintained at 
33°C and cells transferred to 37°C at 
70% confluency grew into confluent 
monolayers within 10 days, while SV40T 
antigen expression gradually decreased 
(figure 4.2). Subcloning of immortalized 
cells resulted in a cell culture with 
homogenous cobblestone morphology 
(figure 4.1B). Electron microscopy 
(EM) analysis showed moderate 
formation of microvilli and endocytic 
vesicles (figure 4.1C). Proliferation 
of clones could be maintained for 
at least 45 passages. Routinely, cell 
morphology was monitored by phase- 
contrast microscopy at each passage, 
which showed no marked difference 
up to passage 40. To investigate the 
viability of the cells during maturation 
at 37°C for 10 days, a resazurin assay 
was performed [Yang 2004; O'Brien 
2000] showing intact viability during 
the maturation stage (data not 
shown). Successfully immortalized 
cell lines obtained from two donors 
were subcloned, resulting in 15 and
9 clones respectively. These clones 
were characterized for expression of 
aminopeptidase N, Pgp, AQP1 and 
dppIV expression (data not shown). 
Based on these results, one clone from
Figure 4.2. Expression of SV40T 
in ciPTEC. Cell homogenates from 
ciPTEC cultured for various times 
at 37°C were analyzed for SV40T 
antigen expression using Western 
blotting. House-keeping protein 
GAPDH was used as control.
one donor (female, 12 years) expressing 
the markers mentioned above, was 
designated ciPTEC and selected for 
further investigation.
Characterization of ciPTEC
Since a mixture of cell types can be 
exfoliated in urine, a characterization 
study was performed after subcloning 
the cell line to confirm its proximal 
tubular origin [Dorrenhaus 2000]. At 
37°C, monolayers of the subclones 
expressed ZO-1 protein, indicating 
the epithelial origin of cells with 
development of tight junctions (figure 
4.3A). Formation of tight monolayers 
was further supported by the inulin- 
FITC diffusion experiments. Cells 
grown on permeable filter supports 
assembled to a monolayer, with 13.2% 
(+/-1.1) diffusion of inulin-FITC after 2 
hr incubation at 37°C. Proximal tubular 
specific BBM enzyme aminopeptidase 
N (CD13) was detected using flow 
cytometry and immuno-fluorescence 
microscopy (figure 4.3B and C). The
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CD13-FITC
Figure 4.3. Proximal tubular epithelial origin of ciPTEC. (A) Expression of 
epithelial marker ZO-1 was analyzed in confluent monolayers after 10 days of 
maturation at 37°C indicating the formation of tight junctions. Aminopeptidase 
N was detected using incubation of ciPTEC with anti-CD13-FITC and analyzed 
by (B) flow cytometry (white histogram, negative control; black histogram 
incubation with CD13-FITC) and (C) immuno fluorescence microscopy.
Bars 20 /um
Figure 4.4. Western blotting of 
ciPTEC. Expression of proximal 
tubule specific proteins aquaporin-1 
(AQP1), dipeptidyl peptidase IV 
(dppIV) and multi resistant protein 4 
(m RP4, ABCC4) in cell homogenates 
of ciPTEC were compared with 
expression in human kidney 
homogenate (huKid) by Western 
blotting.
activity of BBM enzyme AP was 
investigated and compared to activity 
in HK-2 cell lines (ATCC; Manassas VA, 
USA). In ciPTEC the activity of AP was 
0.96 +/- 0.21 and in HK-2 0.59 +/- 0.03 
mUnits SAP/mg protein. Endothelial 
marker CD31 did not bind to ciPTEC 
(data not shown). CiPTEC could be 
clearly distinguished from human 
podocyte cell line [Saleem 2002] due 
to differences in morphology, the 
presence of CD13 antigen and AP 
activity [Wilmer 2005].
The presence of proximal tubular 
specific transporters and enzymes 
AQP1, dppIV and MRP4 was 
demonstrated in cells cultured for 10 
days at 37°C (figure 4.4). Cells originating 
from distal tubules or collecting ducts 
were excluded by positive expression 
of AQP1 in ciPTEC [Nielsen 1999]. The 
variations in molecular size between
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ciPTEC and human kidney MRP4 was 
likely to be due to a difference in 
glycosylation of this ABC-transporter 
[El-Sheikh 2008].
Albumin uptake in ciPTEC
The reabsorption of albumin was 
analyzed using FITC labelled BSA uptake 
in ciPTEC between passage number 20­
25. The results indicate that uptake
0J
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Figure 4.5. Albumin uptake in ciPTEC. Albumin uptake in ciPTEC was analyzed 
using BSA-FITC. (A) Uptake of BSA was concentration- and temperature- 
dependent (black line, 37°C; dashed line, 4°C); data are expressed as means 
of duplo experiments. (B) BSA-FITC was located in intracellular vesicles. Bar 10 
^m (C) Uptake of BSA-FITC (50 ^g/ml) was inhibited by RAP in a concentration- 
dependent manner. Data are expressed as means of duplo experiments. (D) 
Uptake was significantly inhibited by 1 ^M RAP (p<0.05; grey bar) or excess 
unlabelled BSA (XS BSA, 200-fold; p<0.01; white bar). Data are means of three 
independent experiments (+/- SEM) and expressed as relative uptake compared 
to normal BSA-FITC uptake.
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was concentration- and temperature- 
dependent, suggesting active and 
specific transport of BSA in ciPTEC 
(figure 4.5A). Kinetic analysis of BSA- 
FITC uptake resulted in an apparent 
Km of 126 ^g/ml. To investigate the 
mechanism of BSA uptake, localization 
of BSA-FITC was analyzed and uptake 
was performed in presence of RAP, a 
known inhibitor of albumin endocytosis 
by binding to multi-ligand receptor 
megalin [Zhai 2000], or excess 
unlabelled BSA. The vesicular pattern of 
BSA-FITC indicates uptake via endocytic 
vesicles (figure 4.5B). Additionally, 
RAP inhibited the uptake of BSA-FITC 
in a concentration-dependent manner 
(figure 4.5C). BSA-FITC uptake was
significantly inhibited in the presence 
of 1 nM RAP (p<0.05) or 200-fold excess 
unlabelled FITC (p<0.01) by 41% and 
54%, respectively (figure 4.5D).
Sodium-dependent phosphate uptake 
The uptake of phosphate in PTEC 
is mediated by the sodium-dependent 
transporters NaPi-IIa (SLC 34A1) and 
NaPi-IIc (SLC34A3) [Forster 2006]. 
In the presented ciPTEC, the uptake 
of 32PO4 was concentration and 
sodium-dependent (figure 4.6A). 
Maximum phosphate uptake rate 
(Vmax) was 1717 pmol/24 well/5min 
and an apparent Km of 0.12 mM was 
calculated. In the absence of sodium, 
uptake was significantly decreased by
0.0 0.5 1.0 1.5 2.0 Na NMDG
Pi concentration (mM)
Figure 4.6. Sodium-dependent phosphate uptake. In ciPTEC, uptake of 32PO4 
(Pi) was analyzed in the presence and absence of sodium in four independent 
experiments. (A) Uptake of Pi was concentration-dependent and sodium- 
dependent (in presence of sodium, black line; with NMDG as sodium 
replacement, dashed line). (B) Uptake of 0.2 mM Pi was significantly decreased 
(p<0.001) in the absence of sodium (NMDG).
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Figure 4.7. OCT2 activity 
in ciPTEC. (A) Presence 
of OCT2 was shown 
using Western blotting 
of ciPTEC homogenates. 
(B) Activity of OCT2 was 
analyzed by measuring 
the fluorescence of 
transported ASP in 
absence (black bar) or 
presence (white bar) 
of OCT2 inhibitor TPA. 
Additionally, uptake 
was performed at 4°C 
(grey bar). Uptake was 
significantly decreased 
in ciPTEC in presence 
of TPA (p<0.05) or at 
4°C (p<0.01). Data are 
expressed as mean 
values +/- SEM of three 
experiments.
approximately 86% (p<0.001; figure 
4.6B). Phosphate uptake was performed 
at passage numbers ranging from 30 to 
39 with comparable results, suggesting 
sodium-dependent phosphate uptake 
remains functional at higher passage 
numbers.
Organic cation transport activity
The ability of ciPTEC to transport 
xenobiotics was studied by the 
expression and activity of the 
basolateral transporter OCT2 and 
the apical efflux ABC transporter 
Pgp. Western blotting using cell 
homogenates of ciPTEC cultured at 37°C 
clearly showed presence of OCT2 (figure 
4.7A) and Pgp (figure 4.8A). Expression 
of both transporters was confirmed by
Western blotting in cell homogenates 
of passage number 40, indicating 
tubular characteristics remained over 
time. Basolateral exposure to ASP was 
internalized by ciPTEC cultured on 
supporting membranes. This transport 
could be significantly inhibited using 
OCT2 inhibitor TPA (p<0.05) or when 
uptake was performed at 4°C (p<0.01) 
by respectively 36 and 30% (figure 
4.7B). Significantly more intracellular 
fluorescent calcein accumulated 
when cells were incubated with PSC- 
833 (ratio 1.6; p<0.001; figure 4.8B), 
indicating Pgp-dependent transport 
activity in ciPTEC. To determine 
whether Pgp activity remained over 
time during proliferation, the calcein 
assay was performed in cells of up
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Figure 4.8.
P-glycoprotein activity 
in ciPTEC. (A) Presence 
of Pgp was shown using 
Western blotting of 
ciPTEC homogenates. 
(B) Activity of Pgp was 
analyzed by measuring 
the fluorescence of 
accumulated calcein 
in absence (white bar) 
or presence (black bar) 
of Pgp inhibitor PSC. 
Accumulation was 
significantly increased 
in ciPTEC in presence 
of PSC (p<0.001). Data 
are expressed as mean 
values +/- SEM of three 
experiments.
to passage number 39. This resulted 
in active export of calcein, which 
could be inhibited by PSC-833 (ratio
2.3), indicating Pgp was functionally 
expressed at a high passage number.
Discussion
We developed a human conditionally 
immortalized proximal tubular cell 
line from urine of a healthy volunteer 
expressing transporters involved in 
renal reabsorption and excretion. 
The immortalization of non-invasively 
collected cells using SV40T and hTERT 
vectors enabled us to produce human 
cells maintaining proximal tubular 
characteristics, proliferating for at 
least 45 passages. Expression of SV40T 
decreased gradually in ciPTEC cultured 
for 10 days at 37°C, minimizing the 
influence of the transfection on cellular
metabolism. Subcloning improved 
homogeneity of the cell line as is shown 
by the decrease in morphological 
variations, possibly caused by the 
exfoliation of various cell types 
originating from the renal-urinary tract 
into urine [Dorrenhaus 2000].
For culturing renal cells from 
urine we have used the methodology 
described by Racusen et al. [Racusen 
1995]. They developed conditionally 
immortalized PTEC clones from urine 
of two patients with nephropathic 
cystinosis, an inherited disorder of 
proximal tubular transport due to 
lysosomal cystine accumulation [Gahl 
2002]. These cells represent a suitable 
model for studying the pathogenesis 
of cystinosis. Obviously, such studies 
require healthy control cells obtained by 
the same methodology as described in
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this study. Culturing PTEC from control 
urine is hampered by low amounts 
of viable exfoliated cells in urine of 
healthy volunteers. In the present 
study, the success rate for culturing 
proliferating cells was approximately 
10%. Interestingly, only some urine 
portions from a few subjects contained 
viable PTEC with variable morphology.
It could be argued that cells 
exfoliated in urine are not an ideal 
source for the establishment of a PTEC 
cell line, since cell damage could have 
resulted in their detachment from 
the tubular basement membrane. 
However, the detailed characterization 
of the ciPTEC presented here, including 
viability, proliferation capacity, 
formation of a tight monolayer 
and preserved proximal tubular 
characteristics, indicates the feasibility 
of using urinary cells as a source for 
obtaining human renal material for in 
vitro research. Furthermore, studying 
the pathogenesis of inherited proximal 
tubular disorders, which is often 
hampered by the limited availability 
of renal tissue, can be facilitated by 
collecting affected cells from urine of 
these patients [Detrisac 1984; Racusen 
1995; Detrisac 1983].
In pharmacology and toxicology, 
the availability of a cell model of 
human origin expressing a broad 
range of functional transporters is of 
paramount importance. More specific, 
the ciPTEC presented here is the first 
human cell line with expression of
MRP4, in concert with expression and 
activity of OCT2 and Pgp. Probably due 
to different glycosylation, MRP4 in 
ciPTEC on Western blot showed a band 
at different size compared to human 
kidney. Therefore, we have confirmed 
MRP4 expression by quantitative 
PCR after RNA isolation from ciPTEC. 
Together with the formation of a tight 
monolayer, as was observed using the 
inulin diffusion experiments, these 
features make ciPTEC a valuable tool 
for identification of substrates and 
inhibitors of renal drug excretion 
and the prediction of potential drug- 
drug interactions in pharmacological 
research. Next to functional organic 
cation excretion, the human ciPTEC 
maintain sodium-dependent phosphate 
uptake, as well as albumin endocytosis 
sensitive to inhibition by RAP. The 
apparent Km calculated for sodium- 
dependent phosphate transport in 
ciPTEC (0.12 mM) was approximately 
one-third of the apical phosphate 
transport value demonstrated in OK 
cells (0.37 mM) [Reshkin 1990]. This 
suggests a higher affinity for phosphate 
in ciPTEC compared to currently 
available cell models.
The reabsorption of albumin by 
ciPTEC in this study is most likely 
receptor mediated endocytosis 
transport, since it is sensitive to RAP 
inhibition and the intracellular vesicular 
pattern of BSA-FITC. Inhibition of BSA- 
FITC in ciPTEC is similar to the inhibition 
found earlier in OK cells [Zhai 2000],
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while the apparent Km calculated for 
ciPTEC (126 ^g/ml) was approximately 
6 times higher than the value reported 
for OK cells (20 ^g/ml) [Gekle 1996]. 
Although it would be obvious to link 
this transport to the multi-ligand 
receptor megalin, we could not identify 
this receptor by Western blot nor by 
immunofluorescence techniques (data 
not shown) [Birn 2006]. This suggests 
involvement of alternative albumin 
reabsorption mechanisms [Gekle 2005].
In conclusion, the present study 
introduces the first human cell line 
featuring functional sodium-dependent 
and endocytosis mediated reabsorption 
together with functional secretion 
capacity by Pgp and OCT2 and combined 
expression of MRP4. The capacity of 
ciPTEC to proliferate for extended 
passages with maintained functional 
transport, allows standardized and 
high-throughput investigation of renal 
drug handling in pharmacological 
research.
Chapter 4
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Abstract
Recent evidence implies that impaired metabolism of glutathione has a role 
in the pathogenesis of nephropathic cystinosis. This recessive inherited disorder 
is characterized by lysosomal cystine accumulation and results in renal Fanconi 
syndrome progressing to end stage renal disease in the majority of patients. The 
most common treatment involves intracellular cystine depletion by cysteamine, 
delaying the development of end stage renal disease by a yet elusive mechanism.
Here, we show that after 10 days of maturation at 37°C, conditionally 
immortalized proximal tubular epithelial cells from cystinotic patients displayed 
in addition to the expected increase in cystine, an increase in cysteine and a 
decrease in glutathione redox status and intracellular ATP levels. No differences 
were observed with respect to protein turnover, cytosolic and mitochondrial ATP 
production, total glutathione levels, reactive oxygen species production, protein 
oxidation and lipid peroxidation. Cysteamine treatment increased total glutathione 
in both control and cystinotic cells and normalized cystine levels and glutathione 
redox status in cystinotic cells.
Our data implicate that cysteamine may protect renal function in cystinosis by 
increasing total glutathione and restoring glutathione redox status. This beneficial 
effect points to a potential role of cysteamine as anti-oxidant for other renal 
disorders associated with enhanced oxidative stress.
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Introduction
Since cysteamine therapy has 
become available for patients with 
nephropathic cystinosis (MIM219800) 
in the early 80's, quality of life for 
these patients has greatly improved 
[Yudkoff 1981; Gahl 2003]. The most 
frequent and most severe form, 
infantile cystinosis, is characterized 
by the development of renal Fanconi 
syndrome in the first year of life and 
leads to end stage renal disease in the 
first decade of life when untreated 
[Gahl 2001]. Mutations in the CTNS 
gene, encoding for lysosomal cystine 
transporter cystinosin are the cause 
of cystinosis [Town 1998]. Lysosomal 
accumulation of cystine, which is the 
hallmark of this autosomal recessive 
disorder, can be depleted by the 
amino-thiol cysteamine [Gahl 1985]. 
Although treatment with cysteamine 
substantially decreases intracellular 
cystine accumulation, renal Fanconi 
syndrome is not cured, but end stage 
renal disease is only postponed in 
the majority of the patients. Several 
mechanisms have been postulated to 
link lysosomal cystine accumulation in 
cystinosis with renal tubular defects, 
such as impaired ATP synthesis [Coor 
1991; Levtchenko 2006c], involvement 
of altered glutathione (GSH) 
metabolism [Chol 2004; Levtchenko 
2005] and increased apoptosis rate 
[Park 2006; Sansanwal 2009].
Decreased levels of total GSH in
cystinotic fibroblasts during exponential 
growth were first reported by Chol 
et al. [Chol 2004]. This finding was 
confirmed in primary proximal tubular 
cells derived from urine [Laube 2006]. 
In contrast, normal total GSH levels 
but increased oxidized GSH (GSSG) 
levels have been reported in cystinotic 
fibroblasts grown to confluence, 
in polymorphonuclear cells and in 
proximal tubular cells immortalized with 
HPV E6/E7 [Mannucci 2006; Levtchenko 
2005; Wilmer 2005]. Together with the 
finding of elevated urinary 5-oxoproline 
(pyroglutamic acid), a precursor for 
GSH synthesis, these data suggested 
that impaired lysosomal cystine efflux 
in cystinosis affects GSH metabolism, 
likely via impairment of y-glutamyl cycle 
[Rizzo 1999]. Alterations in GSSG/2GSH 
ratio affect intracellular metabolic 
functions and point towards increased 
intracellular oxidation [Schafer 2001].
In addition to alterations in ATP- 
dependent GSH synthesis, decreased 
intracellular ATP levels have been 
reported in cells loaded with cystine 
dimethylester (CDME) [Coor 1991]. 
Coor et al. used this model to postulate 
that decreased ATP synthesis accounts 
for decreased sodium gradient and, 
consequently, influences tubular 
reabsorption in cystinosis. Despite the 
limitations of the CDME model [Wilmer 
2007], this hypothesis is still pending, 
since decreased ATP levels in cystinotic 
fibroblasts and proximal tubule cells 
were reported [Levtchenko 2006c;
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Laube 2006]. More recently, decreased 
ATP generation capacity was shown in 
cystinotic renal proximal tubular cells 
[Sansanwal 2010].
Despite extensive research, definite 
conclusions whether alterations in GSH 
and/or ATP status are involved the 
pathogenesis of cystinosis are lacking. 
In addition, the question remains why 
cysteamine treatment postpones the 
progression of renal disease and has no 
curative effect on Fanconi syndrome. 
This study focuses on the influence 
of cysteamine on both GSH and ATP 
metabolism using a recently developed 
conditionally immortalized proximal 
tubular epithelial cell line (ciPTEC) 
[Racusen 1995; Wilmer 2010]. Here, 
4 control and 10 cystinotic ciPTEC lines 
with different mutations in the CTNS 
gene were developed, using identical 
methodology. This allowed a valuable 
comparison of their metabolic status in 
presence and absence of cysteamine to 
improve our insight in the mechanism 
of cysteamine efficacy in cystinosis.
Materials and Methods
Cell culture
Primary cell lines were cultured 
from urine of 4 healthy controls (age 
60-152 months old) and 10 patients 
with cystinosis (age 11-209 months 
old) after approval of the study design 
by the Institutional Review Board and 
obtaining of written informed consent 
by the parents of all subjects as described
previously [Wilmer 2010]. Diagnosis 
of cystinosis was made by measuring 
elevated intracellular cystine levels 
in polymorphonuclear granulocytes 
and confirmed by molecular analysis 
of the CTNS gene (table 5.1). Control 
cell lines were obtained from pediatric 
healthy volunteers with no clinical 
history of renal disease, nor with any 
other chronic disease. To maintain 
cell proliferation, primary cell lines 
were transfected with SV40T ts A58 
(SV40T) and human telomerase 
reverse transcriptase (hTERT) followed 
by subcloning procedures to obtain 
homozygous cell populations [Bodnar 
1998; Stamps 1994; Wilmer 2010]. 
Proximal tubular origin of subcloned 
conditionally immortalized cell lines was 
confirmed by demonstrating presence 
of aminopeptidase N, aquaporin1, 
P-glycoprotein and dipeptidyl peptidase 
IV. Additionally, P-glycoprotein 
transport activity, endocytic albumin 
uptake, sodium-dependent phosphate 
transport and alkaline phosphatase 
activity was determined to confirm 
proximal tubular origin. Of each donor, 
one subclone was selected on the basis 
of expression pattern and activity of the 
proximal tubular characteristics and 
used for further experiments, unless 
mentioned otherwise. Routinely, 
cells were maintained at permissive 
temperature of 33°C (proliferating 
cells). To decrease expression of SV40T, 
cells were transferred to 37°C and 
allowed to mature for up to 10 days
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(matured cells).
Cell proliferation
To compare cell proliferation rate 
between control (n=4) and cystinotic 
(n=6) cell lines, cells were counted 
at several stages up to 10 days of 
maturation at 37°C. Data are expressed 
as percentage increase in cell number 
when transferred from 33°C to 37°C. 
Additionally, total intracellular protein 
content was measured using Biorad 
Protein assay (Biorad Laboratories, 
Germany) during maturation of cells 
cultured in 24 well plates.
Protein synthesis was determined 
at day 10 of maturation by measuring 
3H-Leucine (3H-Leu) incorporation. 
Control and cystinotic ciPTEC were 
cultured in triplo in 24 well plates in 
the presence of 3H-Leu (3 ^Ci/ml; GE 
Healthcare, UK) supplemented tissue 
culture medium for 2, 6, 16 and 24 hrs. 
Cells were washed using ice-cold PBS 
and proteins were precipitated using 
10% (w/v) trichloroacetic acid. Proteins 
were dissolved in 400 ^l NaOH (0.3 
M) and subsequently to neutralization 
with 80^l HCl (1.5 M) radioactivity 
was measured using a TriCarb liquid 
scintillation counter (Perkin Elmer, 
USA). Using specific activity of 3H-Leu, 
incorporation of Leu was calculated 
and expressed as pmol/mg protein. 
Cell cycle analysis was performed on 
proliferating and matured cells (control 
n=3; cystinosis n=6), by harvesting 
cells using trypsin and fixation in 70 %
(v/v) ice-cold ethanol. Subsequently, 
cells were stained using propidium 
iodide (10 ^g/ml) in citrate buffer (0.2 
M Na2HPO4, 0.1 M citric acid) in the 
presence of RNAse (5 ^g/ml). Cell cycle 
was determined by flow cytometry and 
presented as percentage of the cells in 
the S-phase of mitosis.
Thiols and disulfide determination 
Matured ciPTEC were harvested 
using trypsine/EDTA, washed twice in 
PBS and pellets were shock frozen in 
liquid nitrogen and stored at -80°C until 
further processing. Intracellular content 
of cysteine, cystine, GSH and GSSG was 
measured using HPLC as described 
before [Levtchenko 2005]. Cystine 
levels were measured in all control 
(n=4) and cystinotic (n=10) ciPTEC after 
maturation for 10 days at 37°C. To test 
the effect of cysteamine on intracellular 
cystine levels, we performed a series of 
experiments varying its concentration 
(0.2; 1; 2 mM) and time of incubation 
(0.5; 1; 2; 4; 8; 16; 24; 48 hrs). To study 
the effect of long-term cysteamine 
treatment (1 mM) on intracellular thiol 
and disulfide levels, control (n=4) and 
cystinotic (n=7) ciPTEC were incubated 
in the presence of 1 mM cysteamine 
for 48 hours during which cysteamine 
supplemented culture medium was 
refreshed every 6 hours. Data are 
expressed as nmol thiol/mg protein 
(+/- SEM).
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Redox status calculation
Redox status (Eh) of GSSG/2GSH 
pool was calculated using the Nernst 
equation according to Schafer and 
Buettner [Schafer 2001]:
(Eh (mV) = E0 - RT/nF log ([GSH]2/ 
[GSSG]),
where E0 for pH 7.4 = -264 mV; RT/ 
nF = 30 and concentrations for GSH and 
GSSG in M are calculated assuming that 
1 mg protein corresponds to a cellular 
volume of 5 ^l [L'Allemain 1984].
Determination of ROS and oxidation 
status
Possible alterations in reactive 
oxygen species (ROS) formation in 
cystinotic ciPTEC were analysed using 
the probes 5-(and-6)-chloromethyl-2,7- 
dichlorodihydrofluorescein diacetate 
acetyl ester (CM-H2DCFDA), for 
measurement of superoxide-derived 
ROS levels, and hydroethidine (HEt), 
for measurement of intracellular 
superoxide levels [Verkaart 2007a]. 
Measurements were performed in 
matured control (n=4) and cystinotic 
(n=10) ciPTEC.
The production of superoxide- 
derived ROS was detected in ciPTEC 
in a 96 well assay [Scharstuhl 2009]. 
Matured ciPTEC were washed in HEPES- 
Tris buffer (NaCl (132 mM), KCl (4.2 mM), 
CaCl2 (1 mM), MgCl2 (1 mM), D-glucose 
(5.5 mM), Hepes (10 mM), pH7.4 using 
Tris) and incubated for 15 min in the 
dark with 80 ^l CM-H2DCFDA (10 ^M). 
Esterase hydrolyzes CM-H2DCFDA to
form intracellular trapped CM-H2DCF, 
which can oxidize to fluorescent CM- 
DCF by the action of ROS. Cells were 
washed twice in HEPES-Tris buffer and 
incubated in the absence and presence 
of H2O2 (0; 10; 100 and 1000 ^M) to 
stimulate oxidation. Formation of CM- 
DCF as a marker for ROS production was 
monitored immediately and monitored 
for 15 min on Victor3V multilabel 
counter (ex464 nm, em530 nm; Wallac, 
Perkin Elmer). Additionally, one set of 
samples was pre-incubated with 1 mM 
cysteamine for 2.5 hrs at 37°C. Basal 
ROS production and ROS production 
as a result of H2O2 stimulation was 
calculated as the slope of fluorescence 
intensity increase versus time and 
expressed as oxidation rate (+/- SEM) 
with untreated cells set at 100% after 
correction for protein content.
Intracellular superoxide levels were 
measured in matured ciPTEC cultured 
in 24 well plates loaded with HEt (10 
^M) in HEPES-Tris buffer for 15 min in 
presence or absence of the positive 
control rotenone (100 nM). Rotenone 
stimulates superoxide production by 
inhibiting complex I of the oxidative 
phosphorylation system [Koopman
2005]. The fluorescent oxidation 
products of non-fluorescent HEt, 
2-hydroxyethidium and ethidium, were 
detected in ciPTEC using flow cytometry 
after harvesting the cells using trypsine/ 
EDTA and washing in PBS. Additionally, 
one set of samples was pre-incubated 
with cysteamine (1 mM) for 2.5 hours in
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culture medium. Data are expressed as 
mean fluorescence intensity (+/- SEM).
Possible changes in protein 
oxidation and lipid peroxidation were 
investigated by determining the 
amount of butylated protein and F2- 
isoprostane, respectively. Oxidative 
stress can lead to the introduction of 
carbonyl groups in proteins, detectable 
by immunoblotting using the Oxyblot™ 
protein oxidation detection kit 
(Millipore, USA). Matured ciPTEC of 4 
controls and 7 patients were examined 
according to the manufacturer's 
protocol. After immunoblotting and 
development using ECL Western 
blotting substrate (Thermo Fisher 
Scientific, USA), pixel intensity for each 
cell line was analysed using ImagePro 
(MediaCybernetics) and corrected for 
GAPDH expression.
Intracellular concentrations of 
F2-isoprostanes (8-iso-prostaglandin 
F2a VI; iPF2a-VI) were determined as 
marker of oxidative stress using LC-MS/ 
MS. Briefly, butylated hydroxytoluene 
(0.08% (v/v)) was added to cell pellets to 
prevent auto-oxidation, and deuterated 
internal standard (0.2 ng iPF2a-d4, 
Cayman) was added to correct for loss 
during sample preparation. Then, the 
cells were sonicated for 3x10 sec at 4°C 
to lyse the cells. Afterwards, KOH was 
added (final concentration of 1.3 M) 
and the lysate was incubated for 1 hr at 
40°C. Formic acid (20% (v/v)) was added 
to adjust to pH 4.5 and samples were 
prepared using solid-phase extraction
as reported previously [Roest 2008]. 
The eluate was dried under a stream 
of nitrogen at room temperature and 
redissolved in 100 ^l acetonitrile (10% 
(w/v)). F2-isoprostanes were analyzed 
by a 4000 Qtrap (PE Sciex, Canada) 
MS. The concentration of iPF2a-VI was 
calculated using a standard curve of 
iPF2a-VI (Cayman) and corrected for 
amount of protein. Data are expressed 
as ng/mg protein.
ATP metabolism
Intracellular ATP levels were 
measured in control (21 separate 
clones of 4 donors) and cystinotic (50 
separate clones of 10 donors) matured 
ciPTEC using ATP Bioluminescence 
Assay Kit HSII (Roche, Germany) as 
described before [Wilmer 2005]. The 
effect of cysteamine on intracellular 
ATP levels was determined in cystinotic 
ciPTEC (n=4) cultured in presence of 
cysteamine (1 mM) for 48 hours, with 
medium replacement every 6 hours.
Mitochondrial and cytosolic 
ATP production were measured by 
transfecting proliferating ciPTEC with 
baculovirus containing cDNA for 
mitochondria targeted luciferase or 
luciferase without targeting sequence 
as described before [Valsecchi 2009]. 
Briefly, proliferating ciPTEC (control 
n=2, cystinosis n=2; both measured in 
4-fold) were cultured on coverslips and 
transfected for expression of cytosolic 
or mitochondrial luciferase. After two 
additional days of culturing at 37°C,
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ATP production in intact ciPTEC was 
determined by perfusing the cells 
with 25 ^M luciferin in Hepes-Tris 
buffer and measuring the luciferase 
luminescence using photomultiplier 
tube. After reaching a stable signal, 
cells were perfused with digitonin 
(DIG; 100 ^M) and excess ATP (10 
mM). Permeabilization of cellular 
membranes by DIG in the presence 
of excess ATP resulted in a peak in 
luminescence signal, which was limited 
by total luciferase present in the cells. 
Basal cytosolic and mitochondrial ATP 
production are expressed as percentage 
of the peak in luminescence after DIG 
treatment (+/- SEM).
Cytosolic ATP production from 
glycolysis was measured by determining 
pyruvate production in conditioned 
cultured medium of ciPTEC [Yang 2004; 
Levtchenko 2006c]. Briefly, matured 
ciPTEC (control n=5; cystinosis n=8) were 
cultured in serum-free culture medium 
for 2.5 hrs in presence or absence of 
glycolysis inhibitors sodium iodoacetate 
(SIA; 0.02 mM) or deoxy-glucose (DOG; 
100 mM). Pyruvate production was 
subsequently measured in culture 
medium using lactate dehydrogenase 
(100 U/ml; Roche, Germany) after 
addition of NAD+ (2 mM; Roche, 
Germany) at pH 9.5. Formation of 
NADH is directly correlated to glycolytic 
pyruvate production and was analyzed 
by measuring the absorbance at 340 
nm on Victor3V Multilabel Counter 
(Wallac, Perking Elmer, USA).
Phosphate transport and content
Intracellular phosphate levels 
were determined in duplo in cell 
pellets of matured control (n=3) and 
cystinotic (n=6) ciPTEC to test whether 
decreased ATP levels could be a result 
of decreased phosphate availability. 
Data are expressed as mM phosphate 
/ mg protein +/- SEM. Furthermore, 
alterations in sodium-dependent 
phosphate uptake in cystinotic ciPTEC 
were investigated using radio-labeled 
32PO4 as describe before [Wilmer 2010]. 
Experiments were performed with a 
pre-incubation of cysteamine (1 mM) 
for 2 hours, followed by the uptake 
of K2HPO4 (0.22 mM) in presence or 
absence of cysteamine.
Statistical analysis
To compare cystinotic and control 
ciPTEC, unpaired Student's t-test was 
used for statistical analysis. In the 
experiments involving the effect of 
cysteamine treatment in each cell line a 
paired Student's t-test was used.
Results
Cell Culture and proliferation
Primary cell lines derived from urine 
were successfully transfected using 
SV40T and hTERT vectors as described 
before [Wilmer 2010]. This resulted 
in 4 control and 10 cystinotic ciPTEC 
(table 5.1) presenting proximal tubular 
characteristics. Transfection with 
SV40T resulted in cell lines proliferating
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cell line 1age
(months)
sex mutation
cys1 78 m [57kb del]+[57kb del]
cys2 129 m [57kb del]+[57kb del]
cys3 134 f [c. 141-24T>C]+ [c. 141-24T>C]2
cys4 50 m [57kb del]+[57kb del]
cys5 47 m [57kb del]+[57kb del]
cys6 174 m [57kb del]+[c.696insC]
cys7 11 f [57kb del]+[c.927_928insG]
cys8 78 f [57kb del]+[c.del18_21GACT]
cys9 96 f [57kb del]+[c.665A>G]
cys10 209 m [57kb del]+[57kb del]
Table 5.1. Clinical 
information and 
CTNS mutation 
of the patients 
from whom 
ciPTEC were 
derived. ND, not 
detected in the 
coding region 
or promotor of 
CTNS gene; m, 
male; f, female
age in months at collection of urine 
[Taranta, 2010]
at 33°C, while the disappearance of the 
SV40T antigen expression at 37°C during
10 days resulted in cell maturation. The 
additional transfection using hTERT 
prevented the occurrence of replicative 
senescence.
Proliferation of control and 
cystinotic ciPTEC was monitored for 10 
days at 37°C by cell count and protein 
determination. Both control and 
cystinotic ciPTEC proliferated similarly 
up to ~3 days (figure 5.1A). At this 
stage, SV40T expression was decreased 
as previously shown [Wilmer 2010]. 
The total cell population was doubled 
at the end of the maturation period 
in both cell populations. Intracellular 
protein content of both control and 
cystinotic ciPTEC reached a plateau at 
day 6 of maturation (figure 5.1B). Both 
control and cystinotic ciPTEC readily 
incorporated 3H-Leu between day 8-10 
of maturation, indicating the absence
of any difference in protein synthesis 
(figure 5.1C). Cell cycle analysis using 
propidium iodide staining indicated 
that control and cystinotic cells had 
similar stages of cell division. During 
proliferation, 11.0 % (+/- 0.5) of 
control ciPTEC compared to 12.8 % 
(+/- 2.5) of cystinotic ciPTEC were in 
the S-phase of the cell cycle. After 10 
days of maturation these values were 
decreased to 3.0 % (+/- 0.8; p<0.01) and
5.0 % (+/- 0.7; p<0.05), respectively. No 
significant differences in cell division 
rate nor in intracellular protein content 
or incorporation were observed 
between control and cystinotic ciPTEC, 
allowing the expression of metabolic 
measurements as a function of protein 
content in further assays.
Intracellular thiol and disulfide content 
Intracellular cystine levels in 
matured ciPTEC were significantly
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Figure 5.1. Cell proliferation of 
control and cystinotic ciPTEC. (A) Cell 
proliferation decreasesat approximately 
3 days after raising the temperature 
to 37°C to induce cell maturation. (B) 
Protein content as expressed per well 
plateaus at approximately 6 days after 
maturation induction. (C) Twenty-four 
hour incorporation of 3H-Leu measured 
at day 9 of maturation. Matured control 
(closed circles) and cystinotic (open 
circles) ciPTEC show no differences in 
cell number and protein synthesis.
increased in cystinotic compared to 
control ciPTEC (5.2 +/-0.7 versus 0.14 
+/-0.02, respectively; p<0.01; figure 
5.2A). The dose-dependent effect of 
cysteamine on intracellular cystine 
levels in cystinotic cell lines was 
determined, demonstrating that 1 mM 
cysteamine normalized the cystine 
content within 30 min after addition 
and for a period up to 8 hours (data not 
shown). By refreshing the cysteamine 
supplemented culture medium every 
6 hours during 48 hours, cystine levels 
in cystinotic ciPTEC were maintained in 
the control range (0.26 +/-0.07, p=0.23; 
figure 5.2B). Free cysteine levels were 
also significantly increased in cystinotic 
ciPTEC (7.2 +/- 1.2 versus 2.4 +/- 0.5, 
p<0.05). Similarly, free cysteine levels 
were normalized upon cysteamine 
treatment (2.1 +/- 0.5, p=0.87; figure 
5.3A).
Total GSH levels were similar in 
cystinotic and control ciPTEC (34 +/- 
5 and 35 +/- 6, respectively, p=0.86; 
figure 5.3B). Remarkably, due to
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Figure 5.2. Cystine accumulation in ciPTEC. (A) HPLC analysis reveals significantly 
elevated cystine levels in matured cystinotic ciPTEC (p<0.01). (B) Treatment with 
1 mM cysteamine for 2 days (replacement every 6 hours), restores cystine levels 
in cystinotic ciPTEC. ** p<0.01.
cysteamine treatment for 2 days, total 
GSH levels were markedly increased 
in both control (63 +/- 10, p<0.05) and 
cystinotic (95 +/- 19; p<0.01) ciPTEC, 
suggesting that cysteamine treatment 
increased cellular capacity to deal with 
oxidative stress (figure 5.3B).
GSSG levels were significantly 
increased in cystinotic cells (0.15 +/- 
0.04 versus 0.66 +/-0.16; p<0.05). 
Cysteamine treatment tended to 
increase GSSG in both control and 
cystinotic ciPTEC, however this effect 
was not statistically significant in 
cystinotic cells. Using the Nernst 
equation according to Schafer and
Buettner [Schafer 2001], we estimated 
the redox status of the GSSG/2GSH 
couple in ciPTEC. Our calculations 
revealed that the reduction potential 
was significantly less negative in 
matured cystinotic ciPTEC (-270 +/-4 
versus -251 +/-1; p<0.01; figure 5.3C). 
The reduction potential in cystinotic 
ciPTEC was restored to control values 
upon cysteamine treatment (-269 +/-3; 
p=0.43).
Intracellular ROS production and 
oxidation status
To investigate whether increased 
redox status was a result of increase
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Figure 5.3. Intracellular thiol levels 
in ciPTEC. (A) Free cysteine levels 
are increased in untreated cystinotic 
ciPTEC and decreased upon cysteamine 
treatment for 2 days (cysteamine). (B) 
Total GSH levels are similar in control 
and cystinotic ciPTEC and increased 
upon cysteamine treatment. (C) Redox 
status (Eh (mV)), calculated using 
the Nernst equation, is decreased in 
cystinotic cells. Cysteamine treatment 
restores the redox status in cystinotic 
cells. Black bars, control; white bars, 
cystinosis. * p<0.05; ** p<0.01.
in ROS production, oxidation was 
measured under basal and stressed 
conditions using probes sensitive 
for intracellular superoxide levels 
HEt or superoxide-derived ROS (CM- 
H2DCFDA). Oxidation of CM-H2DCFDA 
to CM-DCF occurred linear in time 
and dose-dependently increased upon 
addition of H2O2 (figure 5.4A). Basal 
oxidation of CM-H2DCF did not differ 
between control and cystinotic ciPTEC 
(fluorescence intensities of 2515 +/- 
97 and 1988 +/-381, respectively; 
p=0.40; figure 5.4B). Although higher 
concentrations of H2O2 tended to 
increase the formation of CM-DCF in 
cystinotic cells, this effect did not reach 
statistical significance (p values of 
0.46, 0.22 and 0.10 for 10, 100 or 1000 
^M H2O2, respectively; figure 5.4C). 
Treatment of control and cystinotic cells 
with 1 mM cysteamine for 2.5 hr did not 
alter basal and/or H2O2-stimulated CM- 
H2DCFDA oxidation (data not shown).
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No alterations in HEt oxidation were 
observed in control versus cystinotic 
ciPTEC (1.3 +/-0.4 versus 3.4 (+/-1.1), 
p=0.27; figure 5.4D). The addition 
of rotenone, a potent stimulator for
mitochondrial ROS production, caused 
a significant increase in HEt oxidation 
levels (p<0.05). Cysteamine treatment 
for 2.5 hr did not alter HEt oxidation in 
control and/or cystinotic cells (data not
Figure 5.4. Intracellular ROS production in ciPTEC. (A) Control ciPTEC, cultured 
in a plate reader format and loaded with CM-H2DCFDA, show a linear increase 
in fluorescent CM-DCF, reflecting oxidation by ROS. Oxidation of CM-H2DCF is 
dose-dependently increased by H2O2. (B) CM-H2DCFDA oxidation is not altered in 
cystinotic ciPTEC. (C) Control and cystinotic ciPTEC are equally sensitive to H2O2- 
stimulated oxidation of CM-H2DCF. (D) Flow cytometric analysis of hydroethidine 
(HEt) oxidation, showing the absence of any statistically significant difference 
between control and cystinotic ciPTEC.
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shown). Using the Oxyblot™ protein 
oxidation detection kit, we investigated 
possible changes in protein oxidation 
between control and cystinotic ciPTEC. 
However, no differences were detected 
(intensity values of 0.67 +/-0.05 and 
0.82 +/-0.07, respectively; p=0.19). In 
addition, iPF2a-VI , one of the major 
F2-isoprostanes, was determined as a 
marker for fatty acid oxidation. Levels 
of iPF2a-VI were comparable in control 
(0.33 +/-0.1) and cystinotic ciPTEC (0.35 
+/-0.1; p=0.79).
ATP metabolism
Intracellular ATP levels were 
measured in 21 clones of the 4 control 
matured ciPTEC and 50 clones of the
10 cystinotic ciPTEC. ATP levels were 
significantly decreased in cystinotic 
ciPTEC (2.25 +/- 0.36 versus 1.35 +/- 
0.12; p<0.01), indicating alterations in 
ATP metabolism (figure 5.5A). Although 
in 5 cystinotic ciPTEC there was a trend 
towards an increase in intracellular ATP 
after 48 hours of cysteamine treatment, 
this increase did not reach statistical 
significance (p=0.08; figure 5.5B). To 
determine whether decreased ATP 
levels were a result of reduced ATP 
production, glycolysis and oxidative 
phosphorylation were investigated in 
intact matured cells expressing either 
cytosolic or mitochondria targeted 
luciferase. Neither cytosolic (glycolysis) 
nor mitochondrial (oxidative 
phosphorylation) ATP production was 
altered in cystinotic cells (p values
of 0.18 and 0.60, respectively; figure 
5.5C). Since cultured ciPTEC are mainly 
glycolytic, we further explored the 
glycolytic activity by determining the 
effect of glycolysis inhibitors DOG 
and SIA. Both inhibitors significantly 
decreased the production of pyruvate 
in control (DOG: p<0.05; SIA: p<0.05) 
and cystinotic (DOG: p<0.05; SIA: 
p<0.01) ciPTEC. Pyruvate production 
was similar in control and cystinotic 
cells (figure 5.5D).
Next, we addressed the possibility 
that decreased ATP levels could be 
caused by a decreased phosphate 
availability. Measurement of 
intracellular phosphate revealed 
the absence of any difference 
between control and cystinotic ciPTEC 
(0.22 +/-0.04 versus 0.18 +/-0.01, 
respectively; p=0.18). Additionally, 
sodium dependent phosphate uptake 
was determined in ciPTEC, using 
radio-labeled 32PO4 The presence of 
cysteamine (1 mM) did not affect 
phosphate uptake (figure 5.6).
Discussion
In this study, 4 control and 10 
cystinotic conditionally immortalized 
human cell lines were developed from 
urine of age matched donors using 
exfoliated cells of proximal tubular 
origin. Using this model, altered GSH 
redox status and decreased ATP levels 
were observed. Moreover, treatment 
with the cystine depleting agent
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Figure 5.5. ATP metabolism in ciPTEC. (A) Intracellular levels of ATP are
significantly decreased cystinotic ciPTEC. (B) Treatment of cystinotic ciPTEC with 
1 mM cysteamine for 48 hours tends to increase intracellular ATP (p=0.08). (C) 
Measurement of cytosolic and mitochondrial ATP production using cytosolic 
and mitochondrial targeted luciferase, respectively. During luciferin perfusion, 
ATP-dependent luminescence is monitored as a measure of ATP production. 
Cystinotic ciPTEC display normal cytosolic and mitochondrial ATP production. 
(D) Pyruvate production as a measure of cytosolic ATP production in matured 
ciPTEC incubated in the absence or presence of deoxy-glucose (DOG) and 
sodium iodo-acetate (SIA), two potent inhibitors of glycolysis. Both inhibitors 
significantly decrease glycolytic activity to the same extent in control and 
cystinotic ciPTEC. Black bars, control; white bars, cystinosis * p<0.05
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Figure 5.6. 
phosphate
Sodium-dependent 
uptake in ciPTEC.
Uptake of 32PO42-was measured in 
the present or absence cysteamine 
(1 mM). Cysteamine treatment 
has no effect on 32PO42- uptake in 
control and cystinotic cells. Black 
bars, control; white bars, cystinosis
cysteamine increased intracellular total 
GSH levels and restored the GSH redox 
status of the cystinotic cells.
The advantage of the presented 
cell models of cystinosis with different 
mutations in CTNS gene is sufficient 
cystine accumulation, which is ~37-fold 
higher compared to control cells, which 
approaches the levels measured in 
renal tissue [Gahl 2001]. Furthermore, 
cystine levels in cystinotic ciPTEC are 
approximately 6-fold higher compared 
to a previous reported cystinotic PTEC, 
immortalized using HPV 16 E6/E7 
genes [Wilmer 2005]. Probably, the 
maturation at 37°C, causing decreased 
cell proliferation, allowed the cells to
accumulate more cystine. Additionally, 
in this study both cystinotic and control 
cell lines were established using the 
same methodology from pediatric 
donors, after similar passage number 
and in identical phases of the cell cycle, 
allowing a valuable comparison of their 
metabolic status.
In the present study, the effect of 
cysteamine on GSH status was studied 
for the first time in a renal cystinotic 
cell model. Remarkably, total levels 
of GSH increased and the GSH redox 
status normalized upon cysteamine 
treatment. In addition to depleting 
cystine levels, this indicates that 
cysteamine acts as an antioxidant, 
hence, is a protective agent against 
oxidative stress. This mechanism 
may underlie the protective action of 
cysteamine against the development 
of interstitial fibrosis, which leads to 
end stage renal disease in cystinosis. 
As cysteamine restores the GSH redox 
status, this agent may have beneficial 
effects in other disorders associated 
with increased peroxidation, as 
oxidative damage has been proposed 
to be involved in the pathogenesis in 
chronic kidney disease [Santangelo 
2004; Shah 2007].
It has been suggested that limited 
cysteine availability due to dysfunctional 
cystine efflux from lysosomes in 
cystinosis was responsible for 
decreased GSH synthesis via y-glutamyl 
cycle. Contrasting this assumption, we 
and others demonstrated increased
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intracellular levels of cysteine indicating 
that limited cysteine availability is not 
the cause for alterations in y-glutamyl 
cycle [Bellomo 2010; Vitvitsky 2009]. 
Elevated free cysteine levels in cystinotic 
cells can derive from the extracellular 
medium or synthesis from methionine. 
Interestingly, a recent study by 
Bellomo et al. showed that intracellular 
cysteine levels regulate the CTNS gene 
expression [Bellomo 2010]. Silencing 
of the CTNS gene was associated with 
an increase in intracellular cysteine 
comparable to our results in cystinotic 
ciPTEC. Interestingly, Foreman et al. 
demonstrated increased cysteine in 
CDME loaded rats, which developed 
renal Fanconi syndrome, without 
elevated levels of cystine [Foreman 
1987]. The significance of elevated 
cysteine in cystinotic proximal tubular 
cells should be further investigated.
The formation of GSH from 
lysosomally accumulated cystine upon 
cysteamine treatment can only partially 
explain elevated GSH levels, regarding 
the stochiometry. Free intracellular 
cysteine (7.2 mole/mg protein) and 
intracellular cystine (equal to 2 x 5.2 
mole/mg protein = 10.4 mole cysteine/ 
mg protein) in cystinotic ciPTEC are 
3.5-fold lower than required for the 
increase of GSH (95 -  34 = 61 mole 
cysteine/mg protein) upon cysteamine 
treatment. Possibly, proximal tubular 
GSH transporters can be activated by 
cysteamine, as tubular GSH levels in 
vivo are mainly dependent on uptake at
the apical and basolateral membrane 
via specific transporters [Lash 2005; 
Frey 2007].
In the cystinotic ciPTEC model, the 
GSH pool is still sufficient to protect 
proteins and fatty acids from oxidative 
damage as shown in this study. 
However, in vivo increased protein 
concentration in the tubular lumen 
can exaggerate oxidative stress leading 
to progressive tubulo-interstitial 
inflammation [Zandi-Nejad 2004]. 
In this in vivo situation, intracellular 
GSH availability can be of significant 
importance and, therefore, optimal 
cysteamine treatment protecting 
against peroxidation can improve 
renal function. In addition, due to the 
prominent role of the mitochondrial 
ATP production, an increased ROS 
production compared to the in vitro 
model can be expected requiring more 
GSH as protection.
In contrast with our results, a 
recent study in fibroblasts showed 
intact redox status as presented by 
GSSG/2GSH ratio, with normal total 
GSH levels [Vitvitsky 2009]. The latter 
study correctly pointed towards the 
difficulties in measuring disulfides and 
mentioned a possible underestimation 
of the total GSH pool in the fibroblasts 
previously measured by our group 
[Levtchenko 2005]. Taken into account 
that 1 mg protein corresponds to a cell 
volume of 5 ^l [L'Allemain 1984], the 
levels measured in matured control 
ciPTEC are 35 nmol GSH / mg protein
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/ 5^l and equals to 7 mM. Hence, GSH 
levels measured in cultured ciPTEC 
in the current study are comparable 
to the levels measured in tubular 
cells in vivo, which are reported to 
be in the range of 5 mM [Lash 2005]. 
Furthermore, in the current study, the 
cysteine pool is about 10-fold lower 
than the GSH pool in control ciPTEC, 
which is comparable to other studies 
[Vitvitsky 2009; Bellomo 2010]. The 
observed variability in the intracellular 
thiol concentration between 
individuals points to the necessity 
to analyze sufficient number of cell 
lines for making statistically valuable 
comparisons. The study by Vivitsky et 
al. was probably underpowered for 
demonstrating differences in metabolic 
status between cystinotic and control 
cells.
In this study, decreased levels of 
intracellular ATP in cystinotic ciPTEC 
were observed. Both glycolytic and 
mitochondrial ATP production were 
intact, suggesting that decreased ATP 
levels were a result of increased ATP 
consumption. Since the ATP levels 
in controls versus cystinotic ciPTEC 
were overlapping, we doubt whether 
decreased ATP levels are primarily 
involved in the pathogenesis of 
cystinosis. Furthermore, intracellular 
phosphate levels were shown to be 
intact, which is in contrast to earlier 
findings using the CDME model of 
cystinosis [Coor 1991; Bajaj 1996]. 
The artificial loading with CDME was
recently used by Figueiredo et al. to 
demonstrate decreased adenylate 
cyclase activity [Figueiredo 2009]. They 
suggested that cystine inhibition of 
this enzyme, catalyzing the phosphate 
transfer between ATP and AMP, 
could be partially responsible for the 
observed ATP decrease in cystinotic 
cells. In our present study, we showed 
that cysteamine treatment had 
no significant effect on ATP levels, 
implicating that elevated cystine 
levels are not directly associated with 
decreased ATP levels. Moreover, these 
findings demonstrate again that the 
CDME loading technique is of limited 
value in studying the pathogenesis 
of cystinosis [Wilmer 2007]. Taken 
together, the current data suggest that 
the pending hypothesis of decreased 
ATP generation as an underlying cause 
of Fanconi syndrome in cystinosis 
should be reconsidered.
In line with normal mitochondrial 
ATP production, we found normal 
ROS generation in cystinotic cells. 
Because mitochondria are major 
sources of ROS and as enhanced 
ROS production was demonstrated 
in mitochondrial disorders [Verkaart 
2007b], normal superoxide and lipid 
peroxidation levels indirectly indicate 
an intact mitochondrial function in 
cystinotic ciPTEC. These observations 
are in contrast to recent findings 
by Sansanwal et al., who reported 
decreased mitochondrial complex I 
activity together with increased ROS
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production in RPTE cells derived from 
cystinotic patients [Sansanwal 2010]. 
Although the RPTE cells in their study 
were obtained and immortalized using 
a similar method as described in our 
study using the temperature sensitive 
SV40T antigen [Racusen 1995], control 
cell lines used in their study were 
prepared without transfection (RPTE) 
or by transfection using HPV 16 E6/ 
E7 (HK-2). It could be argued whether 
comparison using control cells that 
have been differently obtained is 
appropriate.
Taken together, the identical 
preparation of four control and 
ten cystinotic ciPTEC in the present 
study allows valid and detailed in 
vitro investigation of cell metabolism 
involved in the pathogenesis of 
cystinosis. Using this model, increased 
oxidation of GSH was demonstrated 
resulting in altered intracellular redox 
status in cystinotic cells. Cysteamine 
increased intracellular GSH levels and 
restored redox status of GSSG/2GSH 
couple. This mechanism may be 
responsible for better conservation 
of renal function in cystinotic patients 
treated with cysteamine. The increase 
of intracellular GSH in control cells 
upon cysteamine treatment points to 
the possibility of using this amino thiol 
in other renal disorders associated with 
enhanced oxidative stress.
Chapter 5
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Abstract
Cystinosis is an autosomal recessive lysosomal storage disorder caused by a 
defect in the lysosomal cystine carrier cystinosin. Cystinosis is the most common 
cause of inherited Fanconi syndrome leading to renal failure, in which the 
pathogenesis is still enigmatic. Based on studies of proximal tubules loaded with 
CDME, altered mitochondrial ATP production was proposed to be an underlying 
pathologic mechanism. Thus far, however, experimental evidence supporting this 
hypothesis in humans is lacking. In this study, energy metabolism was extensively 
investigated in primary fibroblasts derived from eight healthy subjects and eight 
patients with cystinosis. Patient's fibroblasts accumulated marked amounts 
of cystine and displayed a significant decrease in intracellular ATP content. 
Remarkably, overall energy-generating capacity, activity of respiratory chain 
complexes, ouabain-dependent rubidium uptake reflecting Na,K-ATPase activity, 
and bradykinin-stimulated mitochondrial ATP production were all normal in these 
cells. In conclusion, the data presented demonstrate that mitochondrial energy- 
generating capacity and Na,K-ATPase activity are intact in cultured cystinotic 
fibroblasts, thus questioning the idea of altered mitochondrial ATP synthesis as a 
keystone for the pathogenesis of cystinosis.
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Introduction
Cystinosis is an autosomal recessive 
lysosomal storage disorder caused 
by a defect in the lysosomal cystine 
carrier cystinosin, encoded by the 
CTNS gene (17p13.2) [Kalatzis 2001]. 
Intralysosomal accumulation of 
cystine virtually in all tissues leads 
to a multiorgan disease with kidneys 
being clinically first affected. Patients 
with cystinosis mostly present 
with generalized proximal tubular 
dysfunction (Fanconi syndrome) 
during the first year of life and, when 
untreated with the cystine-depleting 
agent cysteamine, develop end-stage 
renal disease before the age of 10 year 
[Gahl 2002].
Because proximal tubular cells are 
highly metabolic active [Klahr 1992], 
the appearance of Fanconi syndrome as 
a first clinical sign in cystinosis points to 
disturbances in energy metabolism in 
these patients. This idea is substantiated 
by the occurrence of Fanconi syndrome 
in patients with mitochondrial disorders 
[Niaudet 1996].
Although lysosomal accumulation of 
cystine in cystinosis was demonstrated 
already in the 1960s [Schulman 1969], 
studies on the pathogenesis of this 
disease were initially hampered by the 
absence of a proper in vitro model of 
lysosomal cystine accumulation. This 
issue was solved with the introduction 
of dimethyl esters of amino acids, 
which readily passed the lysosomal
membrane and, once inside the 
organelle, were rapidly degraded by 
lysosomal hydrolases to yield free 
amino acid and methanol thus allowing 
amino acid loading of the lysosomes 
[Goldman 1973; Reeves 1979]. 
CDME loading of intact leukocytes, 
cultured lymphoblasts, and fibroblasts 
established defective cystine exodus 
from the lysosomes as basic defect in 
cystinosis [Gahl 1982b; Jonas 1982; 
Pisoni 1985].
Subsequently, CDME loading of 
proximal tubular cells was used for 
studying the pathogenesis of Fanconi 
syndrome in cystinosis. Foreman et al. 
[Foreman 1987] demonstrated that 
incubation of rat cortical tubules with 
CDME increased intracellular cystine 
concentrations to values comparable 
to those measured in patients with 
cystinosis and inhibited active amino 
acid and glucose transport. CDME 
loading of rabbit proximal tubules 
perfused in vitro resulted in a decreased 
transepithelial potential difference 
and inhibition of volume absorption 
and active glucose and bicarbonate 
transport, mimicking renal Fanconi 
syndrome in cystinosis [Salmon 1990].
ATP depletion was postulated to 
be responsible for inhibition of active 
transport in proximal tubular cells as 
dramatic decreases in ATP content and 
mitochondrial respiration rate were 
demonstrated after CDME loading 
[Coor 1991; Baum 1998]. Because most 
proximal tubular transport is sodium
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coupled, less fuel for the Na,K-ATPase 
on the basolateral membrane will lower 
the sodium electrochemical gradient, 
thus inhibiting transport across the 
apical membrane. Consistent with this 
idea, cystine-loaded LLC-PK1 showed 
a diminished activity of Na,K-ATPase, 
demonstrated by reduced rubidium 
uptake, leading to increased sodium and 
decreased potassium concentrations 
inside the cells [Bennun 1993].
Although ATP depletion as a 
keystone for the pathogenesis of 
cystinosis is well documented in the 
CDME loading model, it has not yet been 
proved in human cystinotic tissues. 
Furthermore, the possible link between 
intralysosomal cystine accumulation 
and ATP depletion is still unknown.
Cultured cystinotic skin fibroblasts 
are known to accumulate cystine 
[Guillet 1998] and are easily available 
via skin biopsy in patients with 
cystinosis. Because a metabolic defect 
caused by cystine accumulation has to 
be present in all body tissues, we used 
cystinotic fibroblasts to investigate 
the energy metabolism in cystinosis. 
The latter was done by determining 
total intracellular ATP content; overall 
mitochondrial energy-generating 
capacity; activity of mitochondrial 
respiratory chain complexes I, II, III, 
and IV; maximal bradykinin-stimulated 
mitochondrial ATP production; and 
ouabain-dependent rubidium uptake 
in primary skin fibroblasts derived from 
patients with cystinosis compared with
control fibroblasts.
Materials and Methods
Patients
The study was approved by 
Institutional Review Board. Skin 
biopsies were performed after 
obtaining informed consent from 
eight patients with cystinosis before 
starting of cysteamine therapy and in 
eight healthy subjects. In all patients, 
cystinosis manifested with renal Fanconi 
syndrome at the age of 6-18 mo. The 
diagnosis of cystinosis was made by 
measuring an elevated cystine content 
in polymorphonuclear leukocytes (>0.5 
nmol cystine/mg protein) and was 
confirmed by molecular analysis of 
CTNS gene in all patients.
Fibroblast cell culture, isolation of 
polymorphonuclear leukocytes, and 
intracellular cystine measurements.
Skin fibroblasts were cultured 
in custom made M199 medium 
with Tween-20 (5 mg/l, Gibco) 
supplemented with fetal calf serum 
(10%), penicillin (100 U/ml, Gibco), 
and streptomycin (100 U/ml, Gibco). 
Polymorphonuclear leukocytes were 
isolated as described previously 
[Levtchenko 2004]. Intracellular cystine 
was determined by high-performance 
liquid chromatography and expressed 
as nmol cystine/mg protein [Levtchenko 
2004] .
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Measurement of total intracellular ATP 
content
Cystinotic and control fibroblasts 
were grown to confluence in 75-cm2 
tissue culture flasks (approximately
1.0 x 106 cells) and detached using 
trypsin. After washing in phosphate- 
buffered saline (PBS), cell pellets 
were divided into two portions for 
duplicate experiments, shock frozen 
in liquid N2, and stored at -80°C until 
use. Before ATP determination, 
pellets were resuspended on ice in 
0.5 ml cold PBS. A 25-fold diluted 
fraction (25 ^l) of the suspension was 
transferred to a transparent microtiter 
plate and ATP was measured using 
ATP Bioluminescence Assay Kit HSII 
(Roche®) according to the instructions 
of the manufacturer. The residue of 
the undiluted cell suspension was used 
for protein determination using the 
method of Lowry. Data are represented 
as mean of two separate experiments 
in nmol ATP/mg protein.
Analysis of metabolic origin of 
intracellular ATP
To investigate the metabolic origin of 
intracellular ATP in cultured fibroblasts, 
we measured the total intracellular 
ATP content after specific inhibition 
of glycolysis or the OXPHOS pathway. 
To inhibit glycolysis, fibroblasts were 
incubated for 5 h at 37°C with 0.3 mM 
SIA, an inhibitor of glyceraldehyde-3- 
phosphate dehydrogenase or 50 mM 
DOG, a competitor of glucose. Glycolytic
activity was determined in a 96-well 
plate assay by lactate production and 
was more than 80% decreased by SIA 
and DOG compared with the control 
conditions without the inhibitors [Yang 
2004]. The inhibition of mitochondrial 
ATP production was achieved by 
incubating fibroblasts for 5 hr at 37°C 
with 1 rotenone, which is a specific 
inhibitor of complex I, or with 1 ^g/ 
ml antimycin A, a specific inhibitor of 
complex III, inhibiting both succinate and 
NADH-dependent respiration[Dickman 
1990]. The viability of the cells 
after the inhibition of glycolysis or 
mitochondrial ATP production was 
assessed in a fluorescence assay using 
resazurin (0.01%) as a marker [Yang 
2004]. Following incubations with 
each of the inhibitors and with vehicle 
controls, intracellular ATP content was 
determined.
Measurement of overall oxidative 
phosphorylation activity in intact 
mitochondria.
Intact mitochondria were isolated 
from fresh cultured fibroblasts 
(approximately 20 x 106 cells) according 
to Bentlage et al. [Bentlage 1996] 
and suspended in SEF buffer (0.25 M 
sucrose, 10 mM K2PO4, 2 mM EDTA, 
pH 7.4). Overall energy-generating 
capacity was determined by measuring 
14CO2 production rates from oxidation 
of 14C-labeled substrates ([1-14C]- 
pyruvate, [U-14C]-malate, [1,4-14C]- 
succinate, and [1-14C 2-oxoglutarate) in
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combination with several cosubstrates. 
Oxidation rates were normalized 
against CS activity and expressed as 
nmol 14CO2/h [Trijbels 2004].
Measurement of the activity of 
respiratory chain complexes (I-IV) in 
intact mitochondria.
Intact mitochondria were isolated as 
described above, aliquoted for separate 
measurements of the respiratory 
chain complexes, and stored at -80°C. 
With slight modifications, complex I 
(NADH:Q1 oxidoreductase) activity was 
determined spectrophotometrically by 
monitoring NADH oxidation at 340 nm 
as described by Fischer et al. [Fischer 
1986]. Activity of complex III (coenzyme 
Q10: cytochrome c oxidoreductase) 
was determined by measuring the 
reduction of cytochrome c at 550 
nm with reduced decyl ubiquinone 
as an artificial substrate according 
to Bentlage et al. [Bentlage 1996]. 
Complex II+III (succinate:cytochrome 
c-oxidoreductase; SCC) activity was 
determined spectrophotometrically 
at 550 nm by measuring reduction 
of cytochrome c using succinate as a 
substrate in the presence of rotenone 
and KCN to inhibit complex I activity and 
eliminate reoxidation of cytochrome c, 
respectively [Fischer 1985]. Complex 
IV (COX) activity was determined by 
the method described by Cooperstein 
and Lazarow [Cooperstein 1951]. 
Mitochondrial CS activity was measured 
by a method described by Srere et al.
[Srere P.A. 1963] and expressed as mU/ 
mg protein. Activities of complexes I, II, 
and III are expressed as mU/U COX after 
normalization of the activity of complex 
IV against that of CS.
Luminescence monitoring of bradykinin 
stimulated mitochondrial ATP 
production in intact fibroblasts.
To monitor mitochondrial ATP 
production, 25,000 fibroblasts were 
seeded on a 13 x 2-mm glass coverslip 
and cultured for 24 h. Cells were then 
infected with a baculovirus containing 
the cDNA for mitochondria targeted 
luciferase generated as described by 
Visch et al. [Visch 2004]. The cDNA 
was kindly provided by Dr. G. A. Rutter 
[Ainscow 2001]. After 48 h of culture in 
the presence of 1.75 mM Na-butyrate, 
the coverslip was placed in the 
thermostated (37°C) luminometer and 
perfused (3 ml/min) with a HEPES-Tris 
medium (132 mM NaCl, 4.2 mM KCl, 1 
mM MgCl2, 5.5 mM d-glucose, 10 mM 
HEPES, 1 mM CaCl2, pH 7.4) containing 
beetle 5 ^M luciferin (Promega). 
Luciferase luminescence was monitored 
continuously using a custom-built setup 
that consisted of a light-shielded low- 
noise photomultiplier tube (PMT) with a 
built-in H7360-1 amplifier-discriminator 
(Hamamatsu Photonics K. K., Shizuoka- 
Ken, Japan). PMT output was monitored 
in time using a PCI-6601 photon 
counting board (National Instruments, 
Austin, TX) coupled with an IBM- 
compatible computer using custom-
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written software (Drs. S. P. Srinivas 
and W. van Driessche, Laboratory of 
Physiology, K.U. Leuven, Belgium). Light 
output was recorded at 2-s intervals, 
after which the traces were smoothed 
offline by using a 3-point moving 
average (Origin Pro 6.1, OriginLab 
Corporation, Northampton, MA). 
Typically, light output from a coverslip 
of fibroblasts expressing mitochondrial 
luciferase was 500-1500 counts/s with 
a background of 15 counts/s. At the 
indicated time, 1 ^M bradykinin was 
included in the perfusion medium for 
maximal stimulation of mitochondrial 
ATP production. Bradykinin releases 
Ca2+ from the endoplasmic reticulum 
leading to a rapid increase in cytosolic 
and consequently intramitochondrial 
Ca2+ concentration, which, in turn, 
leads to an increase in activity of the 
pyruvate dehydrogenase system, 
2-oxoglutarate dehydrogenase, and 
isocitrate dehydrogenase [Jouaville 
1999]. Results are expressed as the 
percentage increase in luciferase 
luminescence.
Measurement of the activity of Na,K- 
ATPase by Rb+ influx.
86Rubidium (86Rb+), a congener of 
K+, uptake was measured to determine 
Na,K-ATPase activity in cystinotic 
and control fibroblasts as previously 
described [Munzer 1994]. Briefly, cells 
were grown to 40%-60% confluence in 
24-well plates, washed three times with 
Rb+-transport medium (140 mM choline
chloride, 6 mM NaCl, 0.5 mM MgCl2, 5 
mM glucose, 4 mM Na-Tris; pH 7.4) and 
preincubated in 180 ^l of this medium 
with or without 10 mM ouabain, a 
specific Na,K-ATPase inhibitor, for 5 min 
at 37°C. Uptake was started by adding 
20 ^l of a mixture of KCl (5 mM) and 
15 ^Ci/ml 86Rb+ (8.6 ^M), followed by 
30 min of incubation at 37°C. Then, the 
medium was removed and cells were 
washed three times with ice-cold Rb- 
transport medium. After solubilization 
in 0.5 ml NaOH (0.2 M) for 40 min, 
0.4 ml was used for liquid scintillation 
counting (Packerd). Ouabain-sensitive 
86Rb+ uptake was expressed in nmol/mg 
protein/h. Control experiments with 10 
^M bumetanide (inhibitor of Na+,K+,2Cl- 
cotransporter) showed no significant 
ouabain-insensitive uptake (data not 
shown).
Statistical analysis
The Mann-Whitney U test was 
used for the comparison of values 
from cystinotic and control cells. The 
correlation between two variables 
was estimated by a Spearman rank 
correlation method. The differences 
were considered statistically significant 
at p < 0.05.
Results
The intracellular cystine content 
was significantly elevated in cystinotic 
fibroblasts (median 4.3, range 2.7-5.5 
versus median 0.2, range 0.1-0.3 nmol/
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cystinosis controls
(n=8) (n=8) p-value
cystine (nmol / mg protein) 4.3 (2.7 - 5.45) 0.2 (0.1 - 0.3) <0.001
ATP (nmol / mg protein) 38.8 (26.9 - 72.1) 51.5 (44.7 - 58.5) < 0.05
complex I (mU / mU COX) 158 (91 - 223) 162 (97 - 220) 0.3
complex II (mU / mU COX) 922 (685 - 1139) 982 (744 - 1230) 0.9
complex III (mU / mU COX) 1513 (1179 - 2000) 1429 (1300 - 1841) 0.8
complex IV (mU / U CS) 957 (846 - 1281) 930 (764 -1151) 0.4
Na+-K+ ATP-ase (nmol / mg protein / h) 50.8 (32.1 - 89.0) 60.5 ( 45.6 - 95.0) 0.3
Table 6.1. Intracellular contents of cystine, ATP and activity of respiratory chain 
enzyme complexes I, II, III, IV, Na,K-ATPase in cultured skin fibroblasts
mg protein, p<0.001).
Data on intracellular ATP content; 
activity of mitochondrial respiratory 
chain enzyme complexes I, II, III, and IV; 
and Na,K-ATPase activity are presented 
in table 6.1.
Total intracellular ATP content and 
metabolic origin of intracellular ATP
The total ATP content in fibroblasts 
derived from patients with cystinosis 
was decreased compared with the 
healthy controls (median 38.8, range 
26.9-72.1 versus median 51.5, range 
44.7-58.5 nmol/mg protein, p < 0.05). 
No significant correlation could be 
detected between intracellular cystine 
accumulation and intracellular ATP 
content (figure 6.1). Additionally we 
determined intracellular ATP content in 
polymorphonuclear leukocytes isolated 
directly from patients with cystinosis (n 
= 15) treated with cysteamine (40-60 
mg/kg/d) and compared the values with 
those derived from control subjects (n = 
18). As in cultured cystinotic fibroblasts,
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Figure 6.1. Intracellular cystine 
and ATP content in fibroblasts of 
patients with cystinosis (n=8, r=- 
0.45, p=0.3).
we detected a significant decrease of 
intracellular ATP content in cystinotic 
versus control cells (median 317, 
range 149-1141 versus median, 557, 
range 207-1101 nmol/mg protein, p < 
0.05) and no correlation between the 
intracellular cystine and ATP content 
(figure 6.2).
To investigate the relative
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Figure 6.2. Intracellular cystine and 
ATP content in PMN cells of patients 
with cystinosis (n=15, r=-0.02, 
p=0.9).
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Figure 6.3. Decrease of intracellular 
ATP content (mean, SD) after 
inhibition of glycolysis (SIA, DOG) 
and respiratory chain complexes 
(ROT, ANT) in control (n=5) and 
cystinotic (n=4) fibroblast cell lines 
(p>0.05).
contribution of glycolysis and 
mitochondrial OXPHOS for ATP 
synthesis in cultured fibroblasts, we 
determined the intracellular ATP 
content after incubation of the cells 
with the inhibitors of glycolysis (SIA, 
DOG) and respiratory chain complexes 
(rotenone and antimycin A). Before 
determination of intracellular ATP 
content, a cell viability test was 
performed showing that, under the 
used conditions, the majority of cells 
(>90%) remained viable (data not 
shown).
As demonstrated in figure 6.3, 
inhibition of the glycolysis resulted 
in a remarkable decrease (>80%) of 
intracellular ATP content compared 
with vehicle control in both cystinotic 
and control fibroblasts. After the 
inhibition of complex I by rotenone 
or complex III by antimycin, less than 
30% decline of initial intracellular ATP 
content was observed in cystinotic 
and control fibroblasts. Cystinotic 
fibroblasts exhibited a slightly more 
pronounced decline of intracellular 
ATP content due to the inhibition of 
respiratory chain complexes, but the 
difference with controls did not reach 
statistical significance (figure 6.3).
Overall energy-generating capacity and 
activity of respiratory chain complexes 
of isolated mitochondria and ATP 
production rate in intact cells
As shown in table 6.2, comparable 
overall oxidation rates of [1-14C]-
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cystinosis controls p-value
n=4 n=4
[1-14C]-pyruvate+malate
14[1- C]-pyruvate+ carnitine
[ 1-14C]-2-oxogl utarate
[U-14C]-malate+pyruvate
14[1,4- C]-succinate+pyruvate
922 (717-1332) 706 (567-1278) 0.3
801 (690-1252) 664 (550-1326) 0.3
454 (276-539) 291 (226-488) 0.3
430 (374-1517) 469 (317-1368) 0.9
232 (191-325) 261 (216-286) 0.7
Table 6.2. 14CO2 production rate (nmol/14CO2/h) from [14C] citric cycle 
intermediates in cultured skin fibroblasts
pyruvate, [1-14C]-2-oxoglutarate,
[U-14C]-malate, and [1,4-14C]-succinate 
in isolated mitochondria were detected 
in cystinotic (n = 4) and control 
fibroblasts (n = 4). The activity of 
individual mitochondrial respiratory 
chain complexes did not differ between 
cystinotic and control cells (table 6.1). 
Furthermore, maximal bradykinin- 
induced increase of mitochondrial ATP 
production measured in intact cells by 
intramitochondrial luciferase probe 
was not different between cystinotic 
(n = 3) and control (n = 4) fibroblasts 
(figure 6.4).
Na,K-ATPase activity
Although the activity of Na,K- 
ATPase, measured by ouabain-sensitive 
Rb influx, was slightly decreased in 
cystinotic cells (median 50.8, range 
32.1-67.0 versus median 60.5, 45.6-95.0 
nmol/mg protein/h), this difference 
was not statistically significant (table 
6.1).
40-1
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control cystinosis
Figure 6.4. Maximal bradykinin- 
induced increase in mitochondrial 
ATP production (mean, SD) in 
control (n=4) and cystinotic (n=3) 
fibroblast cell lines (p>0.05).
Discussion
Cystinosis is the most frequent cause 
of inherited Fanconi syndrome, leading 
to renal failure, the pathogenesis of 
which is still unknown. Based on the 
studies of rat and rabbit proximal 
tubular suspensions or cultured
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proximal tubular cells loaded with 
CDME, intracellular ATP depletion 
with subsequent decrease of Na,K- 
ATPase activity has been proposed to 
be the underlying biologic mechanism 
of cellular dysfunction in cystinosis 
[Salmon 1990; Coor 1991; Baum 
1998; Bennun 1993]. Inhibited energy 
metabolism, however, has not yet been 
demonstrated in human cystinotic 
material. Here, for the first time, we 
attempted to confirm such an alteration 
of intracellular ATP status and OXPHOS 
in cystinosis by an extensive study 
of the energy metabolism in human 
cystinotic fibroblasts. Intracellular ATP 
content was decreased in fibroblasts 
derived from patients with cystinosis 
compared with the controls. Because 
the metabolism of cultured cells could 
be influenced by ex vivo growth and 
because of the overlap of ATP ranges 
between cystinotic and control cells, we 
additionally determined intracellular 
ATP content in polymorphonuclear 
leukocytes immediately isolated from 
freshly drawn blood. Interestingly, in 
agreement with the fibroblast data, 
intracellular ATP was also decreased in 
polymorphonuclear leukocytes of the 
patients compared with the controls, 
despite the fact that their cystine 
values were decreased compared 
with the fibroblasts due to cysteamine 
treatment.
Intracellular ATP is produced by 
cytosolic glycolysis and mitochondrial 
OXPHOS. In vivo studies demonstrated
that energy of mammalian kidneys 
is mostly derived from the oxidative 
metabolism. The activity of glycolytic 
enzymes in proximal tubules is 
minimal [Klahr 1992]. In contrast, 
the contribution of OXPHOS for ATP 
production is limited in cultured skin 
fibroblasts [Robinson 1996], which 
was confirmed in this study. Cystinotic 
fibroblasts were, however, chosen 
as the subject of our study because 
they accumulate cystine in vitro and 
therefore will exhibit the metabolic 
consequences thereof. Second, 
cultured fibroblasts from patients with 
mitochondrial disorders have been 
successfully used to demonstrate 
reduced ATP production and deficient 
OXPHOS activity [Visch 2004; Loeffen 
2000; Ugalde 2004]. Additionally, an 
inhibited activity of Na,K-ATPase after 
CDME loading has been demonstrated 
in cultured LLC-PK1 cells [Bennun 1993], 
despite the fact that these cells are also 
predominantly glycolytic [Felder 2002].
Several approaches were used 
to investigate mitochondrial ATP- 
generating capacity of cystinotic and 
control fibroblasts. Initial experiments 
were performed in isolated 
mitochondria. Overall mitochondrial 
energy-generating capacity, as well as 
the activity of individual mitochondrial 
respiratory chain complexes (I, II, III, 
IV), was comparable between cystinotic 
and control cells, providing evidence 
that intracellular cystine accumulation 
did not cause an evident mitochondrial
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defect.
Assuming that the presence of 
high lysosomal cystine content in the 
cell is obligatory for the alteration 
of OXPHOS, additional experiments 
were performed in intact cells to study 
bradykinin-stimulated mitochondrial 
ATP production. These experiments, 
however, did not reveal any difference 
between cystinotic and control 
fibroblasts. In summary, altered 
mitochondrial ATP-generating capacity 
was not responsible for decreased ATP 
content in cystinotic fibroblasts.
The slightly more pronounced 
decline of intracellular ATP after the 
inhibition of the respiratory chain 
complexes in cystinotic fibroblasts 
might indicate the inhibition of 
glycolytic activity or a relative higher 
contribution of the OXPHOS system. 
Elevated ATP consumption could be an 
alternative explanation of decreased 
ATP content in cystinotic cells; however, 
this possibility was not examined in this 
study.
Finally, we examined whether 
intracellular ATP decrease in cultured 
fibroblasts caused a functional 
inhibition of the activity of Na,K- 
ATPase. The conditions of rubidium 
uptake experiments (low sodium and 
physiologic potassium concentrations 
in the medium) were carefully selected 
to stimulate the maximal activity of 
Na,K-ATPase, which was found to be 
comparable in cystinotic and control 
cells. This might be different in proximal
tubular cells because Na,K-ATPase 
activity in fibroblasts is trivial compared 
with proximal tubular cells in vivo [Klahr 
1992].
How do we reconcile our findings 
with the results obtained in proximal 
tubules loaded with CDME? It is not 
excluded that CDME loading can 
provoke effects different from those 
attributed to cystine accumulation 
in cells with a deficient lysosomal 
cystine carrier. In concordance with 
this idea, recent work on human IHKE-
1 cells demonstrated that CDME itself 
had an acute (within 1 min) effect on 
the basal membrane potential (an 
initial depolarization followed by a 
more pronounced repolarization). 
This effect was distinct from those on 
Na+-dependent alanine transporter, 
which was inhibited after at least 30 
min of incubation with CDME. As the 
hyperpolarization induced by CDME 
could be blocked by Ba2+, the authors 
concluded that CDME activated a K+ 
conductance [Cetinkaya 2002].
It is also possible that CDME can 
directly affect the mitochondrial 
respiration because the incubation 
of isolated mitochondria with CDME 
resulted in reduced mitochondrial
0 2 consumption with glutamate as 
substrate, but not with succinate, by 
which electrons enter the electron 
transport chain beyond complex I at 
the level of coenzyme Q10, suggesting 
the direct inhibition of complex I by 
CDME [Foreman 1995].
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An increase in intracellular cysteine 
concentration was demonstrated 
in vivo in rats after 4 days of 
intraperitoneal CDME injections and 
in rabbit proximal tubules loaded with 
CDME in vitro probably as a result of 
reduction of cystine to cysteine in the 
cytosol [Foreman 1987]. To determine 
whether cystine or its breakdown 
product cysteine was responsible 
for alterations in proximal tubular 
transport, the effect of cysteine 
dimethyl ester loading was studied. 
Strikingly, cysteine ester could indeed 
inhibit volume absorption, glucose 
and bicarbonate transport in rabbit 
proximal tubules in a concentration- 
dependent manner, while methyl 
esters of leucine and tryptophan had 
no effect on these parameters [Salmon
1990]. In contrast to CDME, cysteine 
ester loading, however, did not affect 
the O2 consumption rate, despite a 
remarkable increase in intracellular 
cysteine concentration [Sakarcan
1994].
More research is required for the 
understanding of the pathogenesis of 
cystinosis. This research should further 
explore already introduced alternative 
pathogenic mechanisms of the disease 
as enhanced apoptosis and possibly 
increased reactive oxygen cell damage 
[Park 2002; Chol 2004; Levtchenko
2005]. New techniques such as 
microarrays and proteomics applied 
in human in vitro models of cystinosis 
might help to create new ideas for
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the future studies. Human proximal 
tubular cells from cystinotic patients 
can be cultured in vitro [Laube 2005] 
and possibly represent an excellent 
model for studying the pathogenesis of 
the disease. However, the metabolism 
of these cells can be influenced by ex 
vivo growth. In addition, cultures from 
urine cells might contain other than 
proximal tubular epithelial renal cells, 
including glomerular podocytes, which 
can be exfoliated to urine. This would 
mean that before the transport and 
metabolic studies, the cells from urine 
should be cloned to obtain a pure 
proximal cell culture.
In conclusion, intracellular ATP 
depletion in cultured human cystinotic 
fibroblasts is not caused by the 
alteration of mitochondrial OXPHOS 
and does not result in a functional 
inhibition of Na,K-ATPase activity. Study 
of proximal tubular cells derived from 
patients with cystinosis is required to 
explain the discrepancy of our results 
with those obtained in CDME loading 
model of cystinosis.
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Abstract
Alterations in ATP metabolism have been proposed to be involved in the 
pathogenesis of cystinosis, the most common form of inherited Fanconi syndrome. 
A recent study showed normal activity of respiratory chain complexes I-IV with 
decreased ATP levels in cystinotic fibroblasts. Here, we show normal complex V 
expression and activity in mitochondria of cystinotic fibroblasts. This indicates that 
alterations in mitochondrial OXPHOS enzymes are not responsible for ATP decrease 
in cystinotic fibroblasts.
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Introduction
The autosomal recessive disorder 
cystinosis is caused by mutations in 
the CTNS gene (17p13.2), resulting 
in the defective lysosomal cystine 
transporter cystinosin [Town 1998]. 
The consequential elevated cystine 
levels in the lysosomes lead to renal 
tubular dysfunction by mechanisms 
that are still elusive. Based on results 
of studies in cells loaded with CDME, 
it was hypothesized that defects in 
mitochondrial ATP generating capacity 
are involved, resulting in decreased 
Na,K-ATPase activity [Coor 1991; 
Baum 1998]. This ATP-driven proton 
pump generates a transmembrane 
Na+ gradient, required for tubular 
reabsorption of essential solutes such 
as amino acids, phosphate and glucose 
in proximal tubules of the kidney. 
From this perspective, mitochondrial 
dysfunction is a possible cause of renal 
Fanconi syndrome in cystinosis [Baum 
1998].
Recently our group extensively 
studied ATP metabolism in cystinotic 
fibroblasts and demonstrated slightly 
decreased intracellular ATP levels, 
but an intact Na,K-ATPase activity, 
hormone stimulated mitochondrial 
ATP production and normal activity 
of respiratory chain complexes I-IV 
[Levtchenko 2006c]. The activity of 
mitochondrial enzyme complex V, the 
ATP synthase complex of the OXPHOS 
system, could not be measured at the
time of these studies, because lack 
of sensitivity of the assay. At present, 
we complete this study in cystinotic 
fibroblasts by measuring complex V 
activity using an enzymatic assay. In 
addition, we examined the expression 
and assembly status of complex V by 
Western blot analysis in a blue native 
gel.
Materials and methods
Fibroblast culture
Patient (n=8) and control (n=9) 
fibroblasts wereobtained afterinformed 
consent and subsequently cultured 
as described previously [Levtchenko 
2006c]. The study was approved by the 
Institutional Review Board of Radboud 
University Medical Centre. All patients 
were diagnosed with cystinosis by 
measuring elevated cystine levels in 
isolated polymorphonuclear cells (>0.5 
nmol cystine/mg protein) by HPLC 
and confirmed by molecular analysis. 
Previous data showed elevated levels 
of cystine in cystinotic fibroblasts 
compared to controls (4.3 +/-1.1 
versus 0.2 +/-0.1 nmol/mg protein) 
and decreased ATP levels in cystinotic 
fibroblasts (35.9 +/-16.7 versus 51.7 
+/-4.5 nmol/mg protein) [Levtchenko 
2006c]. Approximately 10 x 106 cells 
were harvested using trypsin and 
divided in two samples for protein 
expression analysis and enzyme activity 
assay, respectively.
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Expression of complex V
A mitochondrial enriched fraction 
was prepared in PBS by incubating 
the cells for 10 minutes on ice in 2 
mg/ml digitonin and subsequently 
centrifugation at 10000 xg for 10 min 
at 4°C [Nijtmans 2002]. Supernatant 
was discarded and pellet was washed 
with PBS. The pellet was resuspended 
in aminocaproic acid (1.5 M) in Bis-Tris 
buffer (75 mM, pH 7.0) supplemented 
with 2% lauryl maltoside to dissolve 
the mitochondrial inner membranes, 
followed by a second centrifugation 
step at 10000 xg for 30 minutes at 4°C. 
An aliquot of the supernatant was used 
for protein determination using Protein 
Assay (Biorad, Germany), followed by 
the addition of sample buffer containing 
Serva Blue G. Blue-native 5-15 % gels 
were loaded with sample aliquots 
proportional to 20 ^g protein and after 
PAGE transferred onto a nitrocellulose 
membrane using standard methods. 
Complex V was detected using 
antibodies against the alpha subunit of 
ATPase (Invitrogen, USA) and visualized 
using ECL Western Blotting substrate 
(Pierce, Thermo Scientific, USA) after 
incubation with secondary goat-anti- 
mouse antibodies with HRP conjugate 
(Dako, Denmark). Finally, complex II 
was detected as loading control using 
antibodies against the complex II 70 
kDa subunit (SDHA; Invitrogen, USA).
Complex V enzyme activity
Mitochondrial fractions of control 
and cystinotic fibroblasts were prepared 
as described before. [Bentlage 1996] 
Complex V activity was determined 
in presence and absence of specific 
inhibitor oligomycin (8 mg/ml) in 
mitochondrial fractions incubated with 
ATP (5 mM) as substrate [Morava 2006]. 
Briefly, the ADP generated by complex
V reacts with phosphoenolpyruvic acid 
(1 mM) to pyruvate in the presence of 
pyruvate kinase (1.5 U /ml). Pyruvate 
oxidizes with NADH (250 ^M) to lactate 
and NAD+ in the presence of lactate 
dehydrogenase (2.5 U/ml). This reaction 
was monitored spectrophotometrically 
at 340 nm for 8 min and used to 
determine complex V activity. 
Complex V activities were normalized 
to complex IV enzyme activity, which 
was measured as described previously 
and expressed in mU / mU complex IV 
activity [Cooperstein 1951].
Results
Blue native gel electrophoresis in 
combination with immuno blotting was 
used here to study the assembly and 
stability of the ATP generating complex
V [Nijtmans 2002]. Using native 
electrophoresis without reducing 
agents, complex V consisting of at least 
16 subunits remains fully assembled. 
Western blot analysis of three control 
and four cystinotic mitochondrial 
enriched fractions showed similar
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Figure 7.1. Complex V expression 
and activity in fibroblasts. (A)
Expression of complex V and loading 
control complex II was determined 
in enriched mitochondrial fractions 
of control (n=3) and cystinotic 
(n=4) fibroblasts using blue native 
gel electrophoresis. (B) Complex V 
activity was measured in isolated 
mitochondria of control (n=9) and 
cystinotic (n=8) fibroblasts using an 
enzymatic assay and normalized to 
complex IV activity (B). Control and 
patient's samples loaded in figure A 
correspond to numbers indicated in 
figure B.
complex V expression compared to 
complex II expression, indicating intact 
stability (figure 7.1A). The equal size of 
complex V bands and the absence of 
a band representing unassembled F1- 
ATPase, indicate complete assembly of 
complex V [Morava 2006].
To study whether the activity of 
complex V in cystinotic fibroblast was 
intact, we performed an enzymatic 
analysis in isolated mitochondria and 
normalized the values using complex
IV activity, which were earlier found 
to be normal in cystinotic fibroblasts 
[Levtchenko 2006c]. Enzymatic 
analysis of complex V was normal in all 
cystinotic fibroblast cell cultures (mean 
0.82; SD 0.31 in control versus 0.65; SD 
0.30 in cystinosis; p=0.45, figure 7.1B). 
Additionally, we found no significant 
correlation between decreased ATP 
levels and complex V activity (data not 
shown).
Discussion
The data presented here complete 
our previous study on ATP metabolism 
in cystinotic fibroblasts [Levtchenko 
2006c]. In addition to the decreased ATP 
levels and normal Na,K-ATPase activity 
we found recently normal activity of 
complex I-IV in isolated mitochondria of 
cystinotic patients compared to healthy 
controls. In the present study, the 
ATP generating enzyme complex V of 
the OXPHOS system was investigated. 
We used an enzymatic method to 
measure hydrolase activity of complex
V which is used in diagnosing complex
V deficient patients [Morava 2006]. 
Here, we found normal expression, 
intact assembly and activity of complex
V in cystinotic fibroblasts with elevated
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cystine levels compared to fibroblasts 
derived from healthy controls. 
Together with our previous data, the 
present study further indicates that 
mitochondrial ATP generating capacity 
in cystinotic fibroblasts is not altered. 
Consequentially, the decreased 
intracellular ATP levels in cystinotic 
fibroblasts are not caused by alterations 
in mitochondrial ATP production and 
require further explanation.
This raises the idea that ATP levels 
might be decreased by alterations in 
glycolysis, the main source for ATP 
production in cultured fibroblasts 
[Robinson 1996]. An increased ATP 
consumption in cystinotic cells is an 
alternative explanation. However, the 
determination of ATP usage in intact 
cells is not feasible at the moment, as 
far as we know.
Alternative mechanisms involved 
in the pathogenesis of cystinosis 
can interfere with intracellular 
ATP levels. Cystinotic cells present 
alterations in GSH metabolism [Chol 
2004; Levtchenko 2005; Laube 2006; 
Mannucci 2006], which can result 
in enhanced oxidative cell damage. 
Furthermore, increased cysteinylation 
of pro-apoptotic protein kinase C 5, 
make cystinotic cells more sensitive 
for apoptotic stimuli [Park 2006]. An 
increase in mitochondrial and cytosolic 
ROS decreased intracellular ATP and 
increased sensitivity to apoptosis may 
all cooperate in the pathogenesis of 
cystinosis in a complex mechanism.
Moreover, we still miss the link between 
cystine accumulation within lysosomes 
and down-stream pathogenetic 
events. Further investigations in 
human cystinotic proximal tubular cells 
[Laube 2005; Wilmer 2005] or in the 
ctns-/- mouse model [Cherqui 2002] will 
generate new information in the next 
future.
It could be argued that measuring 
citric acid cycle intermediate lactate 
could be used to confirm mitochondrial 
alterations in patients with cystinosis. 
Although urinary excretion of lactate 
and hydroxybutirate is elevated 
in cystinotic patients, it remains 
questionable whether this can be 
attributed to mitochondrial dysfunction 
or reduced reabsorption due to altered 
proximal tubular function or due to 
both mechanisms [Thirumurugan 
2004]. Thirumurugan et al. showed in 
their study increased lactate/creatinine 
ratio in several children with Fanconi 
syndrome, including cystinotic patients. 
Interestingly, a transplanted cystinotic 
patient had lactate/creatinine ratio 
comparable to non-Fanconi renal 
controls. In patients with mitochondrial 
disorders urinary lactate was elevated 
in some, but not in all patients [Touati 
1997]. This suggests that increased 
urinary lactate levels are not specific for 
identifying patients with mitochondrial 
disorders. Measuring ATP metabolism in 
patients with cystinosis by non-invasive 
magnetic resonance spectroscopy 
technique might answer the question
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whether ATP levels are decreased in 
vivo in cystinotic patients.
In conclusion, cystinotic fibroblasts 
with elevated cystine levels and 
decreased ATP levels have intact activity 
of all respiratory chain complexes (I-IV) 
and complex V. Whether decreased 
ATP levels are responsible for renal 
tubular dysfunction in cystinosis needs 
further investigation.
Chapter 7
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Abstract
Nephropathic cystinosis is the most common cause of inherited renal Fanconi 
syndrome caused by mutations in lysosomal cystine carrier CTNS that result 
in lysosomal cystine accumulation throughout the body. How defects in CTNS 
cause proximal tubular dysfunction is not known. We hypothesized that cystine 
accumulation could cause disturbed proximal tubular endocytosis by megalin and 
cubilin.
Megalin, cubilin and their ligands were studied in kidney tissue by 
immunohistochemistry. Urinary protein excretion pattern was evaluated. Kidney 
tissue of a patient with cystinosis was compared with MCNS tissue, ESRD tissue 
and control renal tissue. Urine of 7 cystinotic patients was compared to 6 control 
samples.
Expression of megalin, cubilin and ligands (transferrin, albumin, DBP, a lm , RBP 
and ß2m) in convoluted proximal tubules of cystinotic kidney was comparable to the 
other kidney specimens. In straight tubules, the LMW proteins were only present in 
cystinotic kidney. Next to LMW proteins and albumin, urinary excretion of IgG was 
increased in cystinotic patients with Fanconi syndrome compared to controls. This 
was observed already at early age, suggesting enhanced glomerular permeability 
in cystinosis. This study is essentially observational and the immunohistochemical 
data are based on one cystinotic kidney.
Our findings indicate that LMW proteinuria in cystinosis is not caused by 
decreased megalin and cubilin expression and that glomerular damage might be 
present already at early stages of the disease.
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Introduction
Proteinuria is a common feature of 
diverse nephropathies and is generally 
divided in glomerular and tubular 
types according to the size of proteins 
detected in urine. The glomerular 
filtration barrier almost completely 
restricts HMW proteins (>100 kDa) 
such as IgG (150 kDa) and, depending 
on charge and shape, allows the sieving 
of only small amounts of IMW proteins 
such as albumin (67 kDa). Increased 
permeability of the filtration barrier 
allows these proteins to enter the 
glomerular ultra filtrate and results in 
glomerular proteinuria. Glomerular 
proteinuria may be selective or non- 
selective. Selective proteinuria is 
characterized by the predominance 
of IMW as compared to HMW 
proteins. Tubular proteinuria is mainly 
characterized by extensive excretion 
of LMW proteins (<40 kDa) [Guignard 
2003].
In physiological conditions, LMW 
proteins filtered across the glomerular 
barrier are almost completely 
reabsorbed in the renal proximal tubule 
by receptor-mediated endocytosis. The 
reabsorption of proteins in proximal 
tubules involves initial binding to 
the multi-ligand endocytic receptors 
megalin and cubilin, highly expressed 
at the BBM of proximal tubules 
collaborating in the uptake of their 
ligands. Ligands are dissociated from 
the receptors in intracellular vesicles
and are further degraded by lysosomal 
enzymes to LMW fragments and amino 
acids. Megalin and cubilin are recycled 
to the apical membrane [Christensen 
2002; Birn 2006].
Patients presenting with generalized 
proximal tubular dysfunction, so called 
De Toni-Debré-Fanconi syndrome, 
suffer from LMW proteinuria and 
albuminuria together with increased 
sodium, potassium and bicarbonate 
excretion, aminoaciduria, glucosuria, 
hypercalciuria, hyperuricosuria and 
phosphaturia. Nephropathic cystinosis 
is the most common cause of inherited 
renal Fanconi syndrome in children, 
progressing towards renal failure due 
to interstitial fibrosis [Gahl 2002]. 
This autosomal recessive disorder is 
caused by mutations in the CTNS gene 
(17p13.2), encoding the lysosomal 
cystine carrier cystinosin, which leads 
to lysosomal accumulation of cystine 
in all tissues [Town 1998]. Although 
the genetic defect of cystinosis has 
been elucidated, the cellular pathways 
involved in defective proximal tubular 
reabsorption and subsequently ESRD 
remain enigmatic.
The degree of proximal tubular 
dysfunction in patients with 
nephropathic cystinosis is variable. 
Patients with the most severe infantile 
cystinosis (MIM 219800) develop 
full-blown Fanconi syndrome during 
the first year of life and mainly have 
truncating mutations in the CTNS gene, 
while patients with the intermediate
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or juvenile form of the disease (MIM 
219900), characterized by less severe 
proximal tubular dysfunction and slower 
disease progression rate, generally 
have milder mutations allowing some 
CTNS activity [Kalatzis 2004]. In a recent 
study, 8 of 14 patients with non-infantile 
cystinosis had Fanconi syndrome, while 
proteinuria was present in all patients 
[Servais 2008].
Defective endocytosis of proteins 
in the proximal tubules has been 
demonstrated to cause LMW 
proteinuria and albuminuria in several 
clinical and experimental conditions 
[Obermuller 2001; Birn 2000; Tojo 
2001; Wahlstedt-Froberg 2003] and is 
most extensively documented in Dent's 
disease [Piwon 2000; Christensen 
2003]. This disorder (MIM 300009) is 
caused by mutations in the CLCN5 gene, 
encoding the endosomal chloride­
proton exchanger CLC-5 [Picollo 2005]. 
Similar to cystinosis, Dent's disease 
manifests with Fanconi syndrome and is 
further characterized by nephrolithiasis 
and nephrocalcinosis [Ludwig 2006]. 
Patients with Dent's disease and clcn5'/' 
mice have a reduced expression of 
megalin and cubilin at the BBM of renal 
proximal tubules, which is suggested to 
be the cause of LMW proteinuria and 
albuminuria [Santo 2004; Christensen
2003]. Furthermore, urinary megalin 
deficiency in Dent's patients and 
clcn5'/' mice suggest a defect in the 
recycling pathway of megalin [Norden 
2002].
Remarkably, decreased urinary 
excretion of megalin has also been 
demonstrated in patients with Lowe 
syndrome [Norden 2002]. This 
syndrome (MIM 309000) is caused by 
mutations in the OCRL1 gene encoding 
phosphatidylinositol 4,5-biphosphate-
5-phosphatase. Patients with Lowe 
syndrome also develop renal Fanconi 
syndrome, combined with severe 
psychomotor delay and congenital 
cataract [Suchy 1995].
Because proteinuria is a predictor 
of progression in various renal diseases 
[Zandi-Nejad 2004], we were interested 
in unraveling the mechanism of 
proteinuria in patients with cystinosis 
suffering from progressive tubulo- 
interstitial damage leading to renal 
failure [Gubler 1999]. Analogous to 
Dent's disease and Lowe syndrome, 
we hypothesized that alterations in 
megalin and cubilin expression could 
cause proteinuria in cystinosis. In 
order to investigate this hypothesis, 
we examined renal tissue and urine 
of patients with cystinosis for the 
presence of megalin, cubilin and their 
ligands by immunohistochemistry and 
immunoblotting.
Methods
Patients and controls
Cystinotic renal tissue was obtained 
from nephrectomized kidney of an 8 
year old boy with infantile nephropathic 
cystinosis due to homozygous c.922Gins
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in the CTNS gene, two months after renal 
transplantation. Nephrectomy of his 
native kidney was performed because 
of persisting Fanconi syndrome with 
excessive losses of fluid and electrolytes. 
Prior to nephrectomy urinary protein 
excretion was 830 mg/l. The renal graft 
of this cystinosis patient was lost due to 
chronic rejection and nephrectomized
5 years after transplantation with signs 
of ESRD. We used this ESRD graft for 
immunohistochemistry in this study.
Control renal tissue was obtained 
from a healthy adult male, 43 years 
old. Additionally, renal tissue from an 8 
year old male patient with MCNS was 
examined. At the moment of biopsy he 
had proteinuria (980 mg/l) comparable 
to the degree of proteinuria in the 
cystinotic patient.
After obtaining informed consent, 
urine was collected from 7 patients with 
nephropathic cystinosis and 6 healthy 
controls (all subjects < 16 years old). 
The diagnosis of cystinosis was made 
in all patients by measuring elevated 
cystine content in polymorphonuclear 
cells using HPLC [Levtchenko 2004]and 
confirmed by molecular analysis of the 
CTNS gene. The common 57 kb deletion 
[Touchman 2000] was present in 5 of
7 patients. All patients, except patient
3, had infantile form of cystinosis with 
full-blown renal Fanconi syndrome; 
patient 3 had juvenile cystinosis with 
proteinuria and mild proximal tubular 
dysfunction. Patient 7 had ESRD, native 
kidneys in situ and was on peritoneal
dialysis. Additional clinical data on the 
patients are provided in table 8.1.
Biochemical urine examination
Standardized biochemical laboratory 
methods were used to analyze freshly 
collected urine samples of patients 
and controls. Creatinine is analyzed 
enzymatically, levels of total protein 
(mg/mg creatinine) was analyzed using 
the method of Lowry, amino acids (^g/ 
mg creatinine) were measured on a 
JEOL JLC-500/V AminoTac equipment 
(Jeol Ltd. Tokyo, Japan) using lithium 
buffers for separation according to the 
ion exchange column chromatography 
principle [Parvy 1988]. Phosphate levels 
inserum and urine was determined using 
the ammonium molybdate method 
followed by calculation of TPR. Glucose 
(^g/mg creatinine) was measured 
using liquid chromatography followed 
by mass spectrometry. Albumin (mg/ 
mg creatinine) levels were determined 
using bromcresol purple method and 
a1m (^g/mg creatinine) and total 
IgG levels (mg/mg creatinine) were 
determined using the nephelometric 
assay [Lehrnbecher 1998]. Accordingly, 
creatinine clearance (ml/min/1.37 
m2) was calculated using the Schwartz 
formula [Schwartz 1987]. Additionally, 
the selectivity index of proteinuria 
was calculated (renal clearance of 
IgG divided by renal clearance of 
transferrin) and considered selective 
for values <0.1 and aselective >0.2 
[Cameron 1966].
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creatinine protein / creatinine phosphate glucose albumin aim IgG
Patient Age Mutations clearance /creatinine (Mg/mg) reabsorption /creatinine /creatinine /creatinine /creatinine selectivity
No. (y) CTNS gene (ml/min/1,73 m2) (mg/mg) gly ala leu (%) (Mg/mg) (mg/mg) (Mg/mg) (mg/mg) Index
1 1 [57kb del]+[c.927_928insG] 104 4,77 2931 2708 455 30 26060 1,08 1040 0,21 0,78
2 1 [c.681 G>A]+[c. 1015G>A] 122 1,95 5989 2803 240 41 30260 0,53 920 0,17 0,78
3* 9 [57kb del]+[c. 198_218del23] 85 2,30 242 91 7 92 185 1,70 30 0,11 0,38
4 9 [57kb del]+[57kb del] 28 8,84 1302 1122 791 17 60521 3,66 700 0,23 0,44
5 11 [57kb del]+[57kb del] 79 3,18 1362 925 132 33 20704 1,04 340 0,12 0,52
6 13 [57kb del]+[57kb del] 23 6,01 968 700 75 14 5485 3,76 500 0,37 0,50
■J** 15 [c.141-24T>C]+ [c.141-24T>C] 9 2,74 1024 1016 245 8 9290 1,25 460 0,14 0,60
0-18 yr <0,18 >90 0.04-0.11
1-2 yr 73-236 32-102 3-20 10-734 <148
7-10 yr 56-157 13-51 3-19 16-67 <19
10-13 yr 42-109 17-49 3-16 16-67 <27
13-18 yr 29-115 13-54 2-13 16-67 <27
* Patient 3 has no signs of Fanconi syndrome 
** Patient 7 is on dialysis therapy
Table 8.1. Clinical data for patients with cystinosis. Proteins and solutes measured according to standardized laboratory 
protocols as described in Methods. Creatinine clearance calculated using the Schwartz formula, a im , a  1-microglobulin; IgG, 
immunoglobulin G; gly, glycine; ala, alanine; leu, leucine; ND, not determined; kb, kilobase; del, deletion.
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Morphological analysis of cystinotic 
kidney
Subsequent to nephrectomy, 
the cystinotic kidney was sectioned 
and imbedded in paraffin. Ultra 
morphological structures were analyzed 
using electron microscopy (EM).
Antibodies
The primary antibodies used in 
this study were polyclonal sheep-anti- 
rat megalin [Moestrup 1993], rabbit- 
anti-rat cubilin[Le Panse S. 1995], 
rabbit-anti-human transferrin (DAKO, 
Denmark), rabbit-anti-human albumin 
(DAKO, Glostrup, Denmark), rabbit- 
anti-human-DBP (DAKO, Glostrup, 
Denmark), rabbit-anti-human-alm 
(DAKO, Glostrup, Denmark), rabbit- 
anti-human- RBP (DAKO, Glostrup, 
Denmark), goat-anti-mouse-ß2m, 
Research Diagnostics, Concord MA, 
USA). The secondary antibodies used 
in this study were goat-anti-rabbit, 
goat-anti-sheep or rabbit-anti-goat 
peroxidase-conjugated antibodies 
purchased from DAKO.
Immunohistochemistry
Semi thin (2 ^m) paraffin sections 
were obtained from cystinotic, 
MCNS, ESRD and control kidneys and 
preincubated with PBS, glycine (50 
mM), pH 7.4, supplemented with 
bovine serum albumin (BSA, 1 %) or 
milk (0.1 %) when incubated further 
with albumin antibodies. Subsequently, 
sections were incubated for 1hr at room
temperature with primary antibodies 
at the following dilutions: megalin 
(1:5,000), cubilin (1:500), transferrin 
(1:10,000), albumin (1:40,000), 
DBP (1:4,000), a1m (1:10,000), RBP 
(1:8,000) and ß2m (1:4,000). Following 
incubation with peroxidase-conjugated 
secondary antibodies, staining was 
visualized using diaminobenzidine with 
H2O2 (0.03 %).
Urine sample collection and sample 
preparation
After collection urine samples were 
immediately stored at -80 °C until 
further determinations. Aliquots were 
used to determine creatinine and 
protein levels according to standardized 
biochemical analysis as mentioned 
above. After thawing samples on ice, 
protease inhibitors PMSF (0.5 mM) 
and leupeptin-HCl (1 ^M) were added 
together with NaN3 (3 mM) and samples 
were vortexed extensively. All samples 
were normalized for creatinine values 
and volumes were adjusted accordingly 
using isolation buffer (sucrose 0.25 
mM, tri-ethanolamine 10 mM, PMSF 
0.5 mM and leupeptin-HCl 1 ^M, pH 
7.4) to a final concentration of 34 ^g 
creatinine/l. Subsequently, urine was 
centrifuged at 15,500 xg for 15 min at 
4 °C. The supernatant was saved and 
stored for a maximum of two weeks at 
-20 °C until further processing.
For determination of megalin 
and cubilin in urine, samples were 
pretreated as mentioned above.
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Subsequently, a volume of the samples 
was dialyzed and lyophilized with 
equivalent creatinine amounts [Norden 
2002]. Samples were reconstituted in 
200 ^l isolation buffer and immediately 
further processed.
SDS-PAGE and immunoblotting
Urine samples were separated 
using non-reduced 12 % (albumin, DBP 
and ß2m) or 3-16 % (megalin, cubilin, 
transferrin, a1m and RBP) SDS-PAGE 
after adding Laemmli loading buffer. 
Samples were normalized for creatinine 
concentrations and the final amount of 
protein was proportional to 0.34 
creatinine/lane (3 nmol). Immunoblots 
with lyophilized samples were loaded 
with 28.3 ^g creatinine/lane (250 
nmol) for detection of megalin and 
cubilin. Proteins were blotted onto 
a nitrocellulose membrane and 
incubated overnight with primary 
antibodies (megalin (1:5,000), cubilin 
(1:2,000), transferrin (1:2,000), albumin 
(1:1,000), DBP (1:500), a1m (1:1,500) 
and RBP (1:500). After incubation with 
peroxidase-conjugated secondary 
antibodies, proteins were visualized 
using ECL.
Results
Biochemical urine examination
All cystinotic patients suffered from 
proteinuria and albuminuria, including 
patient 3 without full-blown Fanconi 
syndrome (table 8.1). The presence of
pronounced amino aciduria, glucosuria, 
LMW protein a1m and reduced TPR 
confirms full blown renal Fanconi 
syndrome in patients 1-2 and 4-7. 
Furthermore, high molecular weight 
protein IgG was increased in all patients, 
even in patients at 1 year of age. The 
selectivity index was >0.2 in all patients, 
indicating that the patients had non- 
selective glomerular proteinuria.
Morphology of cystinotic renal tissue
By light microscopy, some glomeruli 
appeared normal, but most contained 
peculiar giant multinucleated 
podocytes. The tubules were 
moderately atrophic and some regions 
of interstitial fibrosis were observed 
(figure 8.1A). EM revealed irregular 
thickening of glomerular basement 
membrane and the effacement of 
podocyte foot processes (figure 
8.1B). Remarkably, the contours of a 
cytoplasmic cystine crystal dissolved by 
the routine tissue processing are seen.
Three different regions of the 
cystinotic kidney with intact glomeruli 
and surrounding tubules were selected 
for further immunohistochemical 
examination of megalin and cubilin 
expression and presence of their 
ligands. In the cortex of the kidney, 
both convoluted proximal tubules 
in the cortical labyrinth and straight 
proximal tubules in the medullary rays 
were examined.
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Immunohistochemistry of cystinotic 
renal tissue
Staining for megalin and cubilin 
showed abundant brush border 
expression of these endocytic receptors 
in intact regions of both cystinotic 
and control convoluted and straight 
proximal tubules (figure 8.2). The 
positive staining for both megalin and 
cubilin could be observed in all three 
studied regions of the cystinotic kidney.
Immunohistochemical studies using 
antibodies against the ligands of megalin 
and cubilin (transferrin, albumin, DBP, 
a1m, RBP and ß2m) demonstrated 
the presence of these ligands in apical 
endocytic vesicles and at the BBM of 
the convoluted tubules in the cortical 
labyrinth of both control and cystinosis 
kidney sections (figure 8.2; staining of 
DBP, a1m and RBP is not shown). In 
straight proximal tubules the staining 
for all ligands was enhanced in cystinotic 
tissue, but absent (DBP, a1m, RBP and 
ß2m) or less abundant (transferrin and 
albumin) in the medullary rays of control 
tissue. The presence of the endocytic 
receptors megalin and cubilin and all 
examined ligands in different segments 
in control and cystinotic kidney tissue is 
scored by two independent observers 
and presented in table 8.2.
Immunohistochemistry of MCNS and 
ESRD kidney
To distinguish changes attributed 
to proteinuria from those attributed to 
cystinosis, we compared the results of
cystinotic tissue with that of a kidney 
with increased glomerular permeability 
due to known glomerular disease, MCNS, 
having proteinuria (980 mg/l) at the 
time of biopsy within the same range as 
the cystinotic patient (830 mg/l) at the 
moment of nephrectomy. The rejected 
kidney after transplantation in the 
cystinosis patient was included in this 
study to distinguish between ESRD and 
cystinosis. The immunohistochemical 
examinations showed that megalin, 
cubilin and all of their examined ligands 
were located in convoluted tubules in 
the cortical labyrinth of both kidneys, 
similar to control and cystinotic kidney 
(figure 8.3 and table 8.2). Surprisingly, 
in the straight tubules no endocytic 
vesicles containing DBP, a1m, RBP or 
ß2m were present in the MCNS kidney, 
which is comparable to the control 
kidney, but different from cystinotic 
kidney. Remarkable were the dense 
albumin vesicles located basolateral in 
the proximal tubules in both convoluted 
and straight tubules of the MCNS kidney. 
In contrast to the cystinotic kidney, no 
endocytic vesicles containing albumin, 
transferrin and ß2m were observed in 
the straight tubules of the ESRD kidney.
Immunoblot of urine fractions
After normalizing urine samples 
for creatinine concentration, urine 
was centrifuged and supernatant 
was further analyzed. Proteins were 
separated using non-reduced PAGE 
and immunoblotted using antibodies
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control cystinosis NS ESRD
convoluted straight convoluted straight convoluted straight convoluted straight
megalin + + ++ ++ + + + +
cubilin + + ++ ++ + + + +
transferrin ++ +/- ++ ++ + + ++ +
albumin ++ ++ +++ +++ +++ ++ ++ ++
DBP + +/- ++ ++ +/- -
aim + - ++ ++ + -
RBP + - ++ ++ +/- -
ß2m + - ++ ++ + - +/- +/-
Table 8.2. Qualitative evaluation of the presence of megalin, cubilin, and their 
ligands in control, cystinotic, MCNS, and ESRD kidney tissue. Intensity scored 
by 2 independent observers for both convoluted tubules in the cortical labyrinth 
and straight tubules in the medullary ray. MCNS, minimal change nephrotic 
syndrome; ESRD, end-stage renal disease; DBP, vitamin D-binding protein; RBP, 
retinol-binding protein; ND, not determined.
against the ligands transferrin, albumin, 
DBP, a1m and RBP. Large quantities 
of transferrin, albumin and DBP were 
observed in all cystinotic patients. 
LMW proteins a1m and RBP were 
abundantly present in all patients with 
renal Fanconi syndrome. Both ligands 
were only slightly increased compared 
to 6 controls in patient 3 with juvenile 
cystinosis (figure 8.4). Small amounts of 
albumin and transferrin and almost no 
LMW proteins were detected in control 
urines. After loading the equivalent of 
0.34 ^g creatinine, megalin and cubilin 
could not be found in patient's or control 
urines (data not shown). Subsequent 
to dialysis and lyophylization of urine 
samples, the equivalent of 28.3 
creatinine was loaded and megalin was 
detected in both control and cystinotic 
urine samples (data not shown).
Discussion
Nephropathic cystinosis is 
characterized by LMW proteinuria, 
albuminuria and various degrees 
of defective Na+-coupled transport. 
Assuming the similarity with other 
proximal tubular disorders such as 
Dent's disease and Lowe syndrome, we 
hypothesized that deficient function 
of the endocytotic receptors megalin 
and cubilin could be responsible for 
enhanced urinary loss of proteins in 
cystinosis. Interestingly, the present 
study demonstrated abundant megalin 
and cubilin expression at the BBM of 
proximal tubules in cystinotic renal 
tissue. Furthermore, we found the 
presence of megalin and/or cubilin 
ligands (transferrin, albumin, DBP, a lm , 
RBP and ß2m) in intracellular vesicles of 
cystinotic proximal tubules, suggesting
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Figure 8.1. Morphological characteristics of the cystinotic kidney. (page 131)
(A) Some regions of interstitial fibrosis are observed. (B) Electron microscopic 
image shows giant multinuclear podocytes with effacement of podocyte foot 
processes (arrows). *Cytoplasmatic cystine crystal.
control_______________  _______________ cystinosis
cortical labyrinth medullary ray cortical labyrinth medullary ray
Figure 8.2. Immunohistochemical staining of control and cystinotic renal 
tissue. Semithin sections are treated with antibodies against megalin, cubilin, 
transferrin, albumin and ß2-microglobulin (ß2m). Both the receptors megalin 
and cubilin are expressed on the brush border of the convoluted and straight 
proximal tubules in control and cystinotic tissue. In convoluted proximal tubules 
of the cortical labyrinth, the ligands transferrin, albumin, and ß2m are present 
in apical vesicles in both control and cystinotic kidney. Staining for the ligands 
in straight proximal tubules in the medullary ray is more abundant in cystinotic 
tissue.
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Figure 8.3. Immunohistochemical staining of minimal change nephrotic 
syndrome (MCNS) and end-stage renal disease (ESRD) kidney samples.
Sections are incubated with antibodies against megalin, cubilin, albumin, and 
ß2-microglobulin (ß2m). In the cortical labyrinth, all antibodies show positive 
apical staining. ß2m is absent in straight proximal tubules of MCNS kidney 
specimens, whereas megalin, cubilin, and albumin are abundantly observed in 
both kidney specimens. Remarkably, albumin also is present in basal vesicles of 
convoluted proximal tubules of MCNS kidney specimens (arrows).
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Figure 8.4. Western blotting of urine fractions from controls and patients 
with cystinosis. Transferrin, albumin, vitamin D-binding protein (DBP), a1- 
microglobulin (a1m), and retinol-binding protein (RBP) are detected in urine 
from patients with cystinosis, but not or less abundantly in control samples. 
Low-molecular-weight excretion is lower in patient 3 (with juvenile cystinosis). 
All samples are normalized for creatinine concentrations (0.34 ^g of creatinine/ 
lane). Human kidney (huKid) homogenate is simultaneously loaded as a control.
that these ligands are reabsorbed via 
megalin-cubilin mediated endocytosis. 
These results are distinct from those 
in Dent's disease and Lowe syndrome, 
indicating a different pathogenic 
mechanism leading to proteinuria in 
cystinosis. This is further emphasized by 
the finding of relatively normal megalin 
levels in the urine of cystinotic patients 
which is comparable to patients with 
Autosomal Dominant form of renal 
Fanconi syndrome, but contrasting 
to the decrease of megalin in urine of 
patients with Dent's disease and Lowe 
syndrome [Norden 2002].
Because renal biopsies are not
performed for establishing the diagnosis 
of cystinosis, renal tissue of cystinotic 
patients is generally not available. Our 
histological findings are based on the 
examination of the nephrectomized 
native kidney from a transplanted 
patient. The examined kidney was still 
functioning after renal transplantation, 
which was the reason for nephrectomy. 
Immunohistochemical staining was 
performed in selected intact kidney 
regions without obvious signs of 
pronounced tubulointerstitial and 
glomerular damage, and therefore 
reflects changes, which can be 
attributed to cystinosis rather than
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to ESRD, further indicated by the 
observations in the ESRD kidney, which 
did not have the cystinotic phenotype.
To evaluate further the mechanism 
of proteinuria in cystinosis, we 
extensively studied urinary protein 
excretion pattern in cystinotic patients 
with different degrees of renal damage. 
Surprisingly, we have found enhanced 
urinary loss of HMW protein IgG in 
cystinotic children starting from early 
age with normal glomerular filtration 
rate. Low amounts of IgG can be found 
in urine of healthy persons and patients 
with proximal tubular disorders, 
because a small fraction of IgG can cross 
the glomerular filter [Tencer 1998] 
and is partially reabsorbed in proximal 
tubules [Takahashi 2004]. The IgG levels 
found in cystinotic patients (range 0.11­
0.37 mg/mg creatinine) were elevated 
compared to controls and to values 
found by Norden et al. in the tubular 
disorders Dent's disease (0.049 mg/mg 
creatinine) and Lowe syndrome (0.054 
mg/mg creatinine) [Norden 2001]. The 
observation of elevated HMW protein 
IgG levels suggests increased glomerular 
permeability in cystinosis. Our previous 
finding of successful treatment by 
angiotensin-converting enzyme
inhibitor enalapril for diminishing 
albuminuria in cystinosis also suggests 
the glomerular origin of proteinuria 
in cystinosis.[Levtchenko 2003] Since 
patients with juvenile cystinosis (such 
as patient 3 in this study) present 
pronounced proteinuria without overt
proximal tubular dysfunction, it could 
be argued that glomerular disease in 
cystinosis is independent from proximal 
tubular damage. Another argument for 
glomerular damage in cystinosis are the 
morphological changes observed in the 
present and previous studies by others 
[Gubler 1999]. In cystinotic kidney 
podocyte foot processes effacement 
and the presence of characteristic multi­
nucleated podocytes are observed, 
suggesting that cystine accumulation 
causes podocyte dysfunction, which 
can result in glomerular proteinuria. 
This idea is further supported by earlier 
deterioration of glomerular filtration in 
cystinosis compared to patients with 
Dent's disease [Ludwig 2006].
Elevated excretion of LMW proteins 
in patients with pure glomerular 
disease such as MCNS indicates that 
an 'overload' albumin can inhibit the 
reabsorption of LMW proteins in renal 
proximal tubules [Peterson 1969; 
Johansson 1972; Tomlinson 1997]. The 
presence of "aselective" proteinuria 
in cystinosis, indicative for higher 
clearances of HMW proteins compared 
to IMW proteins, might point to more 
pronounced defect of the filtration 
barrier in cystinosis compared to MCNS.
To definitively resolve the question 
whether glomerular permeability is 
increased in cystinosis, the filtration 
of HMW proteins in cystinotic patients 
shouldbefurtherstudied bydetermining 
the Ficoll sieving coefficients [Rippe
2006]. However, performing these
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poses ethical problems. The recently 
developed ctns'/' mice could be used 
to study the glomerular permeability 
more extensively, although these mice 
do not manifest with Fanconi syndrome 
[Cherqui 2002].
Although megalin and cubilin are 
expressed at the BBM of proximal 
tubules in cystinosis, our data cannot 
exclude that LMW proteinuria is caused 
by a decreased recycling rate of these 
endocytic receptors. One could argue 
that cystine accumulation in lysosomes 
has an impact on the rate of the 
endocytic mechanism. The observation 
of vesicles containing megalin and 
cubilin ligands in straight proximal 
tubules in cystinosis but not in MCNS 
and ESRD kidney tissue with a similar 
grade of proteinuria is in favor of this 
theory. Additionally, the presented 
data indicate increase of intracellular 
vesicles containing ligands of megalin 
and cubilin, suggesting a blockade 
in the recycling mechanism in the 
cystinotic kidney. However, abundant 
expression of the receptors megalin 
and cubilin at the BBM do not support 
a recycling defect. Another possible 
explanation of these findings could 
be altered lysosomal enzyme activity 
in cystinotic proximal tubules. Recent 
data indicate that proteinuria itself can 
be the reason for this observation. A 
study by Nielsen et al. demonstrated 
that circulating lysosomal enzymes such 
as cathepsin B are filtered in glomeruli
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and reabsorbed by endocytosis 
[Nielsen 2007]. Intracellular, these 
hydrolases are transported to 
lysosomes and are functionally active 
for protein degradation. In case of 
proteinuria, competition of proteins for 
reabsorption in proximal tubules could 
result in insufficient uptake of hydrolytic 
enzymes. Our finding of basally located 
albumin vesicles in kidney tissue of 
MCNS patient supports this theory. The 
fact that we could not detect ligands of 
megalin and cubilin in straight proximal 
tubules of MCNS kidney tissue, suggests 
that enhanced glomerular filtration 
does not exceed the reabsorption 
capacity in convoluted proximal tubules 
at this range of proteinuria.
In conclusion, our findings indicate 
that LMW proteinuria in cystinosis is 
not caused by decreased megalin and 
cubilin expression and that glomerular 
damage might be present already at 
early stages of the disease.
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On a cellular level, lysosomes can be 
regarded as small recycling factories, 
where macromolecules are broken 
down and metabolites are transported 
to the cytosol to be reused in cellular 
metabolism. Specific transporters 
located at the lysosomal membrane 
are used to export the lysosomal 
metabolites to the cytosol. One of 
these transporters is CTNS, responsible 
for cystine efflux from the lysosomes. 
Malfunction of CTNS causes increased 
lysosomal cystine levels which is the 
biochemical basis for the inherited 
multi-systemic disorder nephropathic 
cystinosis. Lysosomal cystine 
accumulation leads to renal proximal 
tubular dysfunction in most patients 
during their first year of life, resulting in 
excessive excretion of vital metabolites 
via urine. Although many studies have 
focused on the mechanisms involved 
in the pathogenesis of nephropathic 
cystinosis, the relation between 
impaired lysosomal cystine efflux and 
renal dysfunction is still elusive.
To increase our knowledge of cellular 
pathways affected in nephropathic 
cystinosis, in vitro cell models have 
been introduced throughout the years, 
each with its own pro's and con's. 
In this thesis some of these models 
are re-evaluated and new models 
are presented. These cell models are 
applied to further investigate the 
contribution of ATP metabolism and 
GSH synthesis in the pathogenesis of 
cystinosis, together with the influence
of cystine depleting drug, cysteamine. 
Proteinuria in cystinosis as one of the 
features of renal Fanconi syndrome 
is characterized in detail. The results 
of these studies are discussed in this 
chapter and are placed in perspective 
of future research towards unraveling 
the pathogenesis of cystinosis.
9.1 In vitro models to study 
cystinosis: pro's and con's
Although the consequences of the 
cystine accumulation in cystinotic 
patients are first observed in the kidney, 
the pathology is not restricted to the 
kidney due to the widespread cystine 
accumulation in cells throughout 
the body. Elevated cystine levels are 
measured in a wide variety of tissues, 
including kidney, brain, muscle, lung, 
liver, pancreas, spleen, leukocytes and 
cultured fibroblasts [Gahl 2001]. The 
accumulation of cystine in leucocytes 
and cultured fibroblasts, gave 
researchers the opportunity to study 
the pathogenesis in vitro, since these 
cell types are relatively easy to obtain 
from cystinotic patients.
To study renal disease in cystinosis, 
cell models were required and were 
initially obtained by culturing renal 
cells derived from autopsy material 
[Pellett 1984]. Although these primary 
cells had an epithelial appearance and 
showed increased lysosomal cystine 
levels, the cells could only be cultured 
for a maximum of 7 passages. The lack
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of sufficient renal material that could 
be obtained from cystinotic patients 
initiated a quest for alternative renal cell 
models with the cystinotic phenotype. 
The use of CDME to artificially load 
lysosomes seemed to be an attractive 
approach. Loading lysosomes with 
CDME was a technique that resulted in 
a major step forward to the elucidation 
of the functional mechanism of CTNS 
[Steinherz 1982; Jonas 1982] and finally 
resulted in the recognition of defective 
lysosomal cystine transport [Gahl 
1982a].
Another application for CDME in 
cystinosis research was initiated by 
Foreman et al., who studied renal 
function in rats after treatment with 
CDME [Foreman 1987]. The effect of 
CDME on renal function was further 
explored in the early 90's using 
perfused tubules or cellular models 
[Moran 1990; Salmon 1990; Coor 1991; 
Bennun 1992]. These studies gave rise 
to the hypothesis of alterations in ATP 
metabolism as cause of diminished 
tubular reabsorption. Decreased Na,K- 
ATPase activity due to decreased 
ATP levels was suggested to result in 
decreased intracellular Na-gradient, 
consequently leading to decreased 
sodium-dependent transport in 
proximal tubules.
Although the contribution of CDME 
in our current understanding of the 
pathogenesis of cystinosis is greatly 
acknowledged, some critical remarks 
should be made. First, the effect of
CDME loading had an acute effect 
on cellular metabolism, including 
decreased transport activity: ATP levels 
were decreased within 10 min of cystine 
loading in renal tubule cells [Foreman
1995]. On the other hand, in cystinotic 
patients, cystine accumulation is 
present at birth, but symptoms of 
Fanconi syndrome gradually develop 
only after 3-6 months [Levtchenko 
2006a], which questions whether the 
effects evolving from CTNS mutations 
and CDME loading can be compared. 
Secondly, the administration of CDME 
in a control cell or a healthy animal, with 
normal cystine efflux from lysosomes 
via functional CTNS, is basically 
different from cystinotic cells, in which 
cystine accumulates in the lysosomes 
without (or much less) transportation 
to the cytosol.
The effect of CDME in cystinotic 
cells was re-evaluated in studies 
described in chapter 2. Fibroblasts 
loaded with CDME had decreased ATP 
levels, decreased mitochondrial ATP 
production and increased superoxide 
generation. Furthermore, cell viability 
was decreased in both CDME loaded 
fibroblasts and renal HK-2 cells. 
These effects were not observed in 
cystinotic fibroblasts with defective 
CTNS transporter and comparable 
cystine accumulation. This observation 
implicates that these metabolic 
alterations in artificially loaded cells 
are due to the toxicity of CDME and 
are not a direct consequence of
138
General discussion
lysosomal cystine accumulation. In 
this perspective, CDME loading as a 
method for studying the pathogenesis 
of cystinosis should be abolished.
The lack of sufficient renal cystinosis 
cell material, together with the disputed 
value of the CDME loading technique, 
stimulated the development of a 
suitable renal cell model of this genetic 
disorder by a non-invasive method. 
Urine of cystinotic patients can be 
used as a source of viable proximal 
tubular cells [Racusen 1995; Racusen 
1991; Laube 2006]. This approach was 
further explored in chapters 3-5. Using 
freshly collected urine of cystinotic 
patients and healthy controls, primary 
proximal tubular cells were cultured. 
To maintain proliferation of cells after 
several passages, cells were transfected 
using genes that stimulate cell division. 
In chapter 3, primary cells were 
transfected using HPV 16 E6/E7 genes, 
a method that has already been used 
to produce the commercially available 
human renal cell line HK-2 [Ryan 1994]. 
Next to epithelial characteristics, 
including cobblestone morphology, 
tight junctions and microvilli, the 
cells maintained proximal tubular 
characteristics such as AP activity and 
expression of aminopeptidase N. These 
characteristics made this cell model a 
useful tool to study cellular metabolism 
in cystinosis. Although cystine levels 
in cystinotic cells were approximately 
10-fold higher compared to control 
cells, levels in human cystinotic kidney
tissue are 60-350 fold increased [Gahl 
2001]. A possible explanation for the 
relative low cystine accumulation in the 
cystinotic cell model described above 
might be the high cell proliferation rate 
in culture as result of transfection with 
HPV 16 E6/E7 genes.
To limit proliferation rate, a novel 
PTEC model was developed, using a 
temperature sensitive vector SV40T 
that stimulates proliferation of 
transfected cells at 33°C (chapter 4). 
When cells were transferred to 37°C, 
expression of SV40T was eliminated 
and consequently proliferation 
was inhibited. This method was 
successfully used in combination with 
transfection with hTERT activity in the 
immortalization of human podocytes, 
glomerular endothelial cells and 
fibroblasts [Saleem 2002; Satchell 2002; 
O'Hare 2001]. The novel renal cell line, 
designated ciPTEC presents proximal 
tubular characteristics including 
expression of aminopeptidase N, ZO-1, 
AQP1, dppIV and MRP 4 together with 
AP activity. Furthermore, expression 
and activity of apical efflux transporter 
Pgp and basolateral influx transporter 
OCT2 were demonstrated together 
with endocytic uptake of albumin 
and sodium dependent phosphate 
uptake, making this a valuable in 
vitro human proximal tubular cell 
model to investigate cell metabolism 
and proximal tubular transepithelial 
transport. The maintained transport 
function in ciPTEC can also be used
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pro con
blood cells easy to  obtain; cystine accum ulation 
due to CTNS m utation
no renal phenotype
fibroblasts relatively easy to  obtain; cystine 
accum ulation due to  CTNS m utation; 
established m ethodology fo r studying 
cell m etabolism
no renal phenotype
renal epithelial cells
• autopsy m aterial renal phenotype; cystine accum ulation 
due to CTNS m utation
very lim ited availability
• CDM E loaded control cells renal phenotype; cystine transport can 
be studied; tub u lar function decreased
functional CTNS transport; high 
toxic ity w hen cystine levels are 
com parable to  cystinosis levels
• derived from  urine 
- primary renal phenotype; cystine accum ulation 
due to CTNS m utation; tub u lar function 
decreased
control cells should  be obtained 
in parallel; lim ited proliferation
- HPV E6/E7 renal phenotype; cystine accum ulation 
due to  CTNS m utation
relatively low cystine levels; 
d ifficu lties in obtain ing control 
cells using the sam e m ethod
- SV40T/ hTERT renal phenotype; cystine accum ulation 
due to  CTNS m utation; high cystine 
levels; functiona l transport
d ifficu lties in obtain ing control 
cells using the sam e m ethod
Table 9.1 Pro's and con's of in vitro models to study the pathogenesis of cystinosis
for pharmacological, toxicological 
and physiological research, since 
human cell models with maintained 
endogenous expression of transporters 
involved in excretion of xenobiotics are 
not yet available. Another attractive 
application for ciPTEC involves a renal 
replacement function as part of an (bio) 
artificial kidney. When a monolayer of 
ciPTEC is cultured on highly permeable 
filters, they can be used for specific 
reabsorption of electrolytes from 
ultrafiltrate and excretion of waste 
products. Although this technique 
is still far from being used in clinical 
practice, this application should be
further investigated, since currently 
available renal replacement therapies 
have technical shortcomings, such as 
limited clearance of protein bound 
uremic toxins, normally excreted by 
proximal tubular epithelium. More in 
the scope of this thesis, cells exfoliated 
in urine of patients with inheritable 
renal tubular disorders, such as 
nephropathic cystinosis, Dent's disease 
or Lowe syndrome, can be used to 
establish ciPTEC models with known 
genetic defects to investigate their 
pathogenesis.
Racusen et al. first demonstrated 
that cells exfoliated in urine of
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cystinotic patients could be used 
for the establishment of an in vitro 
cystinosis renal cell model [Racusen
1991]. Furthermore, they showed that 
cultured cystinotic cells accumulated 
cystine after immortalization with 
SV40T genes [Racusen 1995]. This 
conditionally immortalization technique 
using SV40T genes was investigated 
further in chapter 5, introducing four 
control and ten cystinotic ciPTEC with 
various mutations in CTNS. The ciPTEC 
model showed decreased proliferation 
rates correlating with decreased SV40T 
expression, when cells were transferred 
to 37°C. Consequently, cystine levels 
were indeed more increased in 
cystinotic ciPTEC compared to the 
HPV 16 E6/E7 model (approximately
6-fold higher compared to HPV 16 E6/ 
E7 model and 37-fold higher compared 
to healthy controls, approaching the in 
vivo situation). The presence of renal 
proximal tubular transporters together 
with the significant accumulation of 
cystine compared to control levels, 
supported our conclusion that human 
ciPTEC is an attractive in vitro model to 
study the pathogenesis of cystinosis.
Since lysosomal cystine
accumulation and its pathologic 
consequences are not restricted to 
proximal tubular cells in the kidney, 
the pathogenesis of cystinosis can be 
studied in other cell types. In chapters 
6 and 7, cultured fibroblasts were used 
to investigate the ATP metabolism in 
cystinotic cells compared to controls.
Although fibroblasts can not be used 
for studying kidney disease in cystinosis 
due to the absence of renal transport 
systems, their value has been proven in 
research of defects in ATP production 
in patients with deficiencies in the 
OXPHOS system [Loeffen 2000; Ugalde
2004].
In table 9.1, an overview of 
available cell models that can be used 
for investigating the pathogenesis of 
nephropathic cystinosis is provided.
9.2 Pathogenesis of 
nephropathic cystinosis
More than a decade ago, the 
mapping of the gene responsible for 
nephropathic cystinosis was a giant 
leap in our fundamental knowledge of 
the mechanisms underlying defective 
lysosomal cystine efflux. However, 
it remains elusive which affected 
(intra)cellular pathways lead to renal 
dysfunction and, moreover, whether 
these aberrations are directly initiated 
by increased lysosomal cystine. In this 
thesis, two of the main hypotheses 
of the pathogenesis of cystinosis 
are investigated: alterations in ATP 
metabolism and alterations in GSH 
metabolism.
9.2.1 Studies of ATP metabolism
The Na,K-ATPase pump, located 
at the basolateral membrane, is 
responsible for the establishment of
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an electrochemical gradient across 
the tubular epithelium and is the 
driving force for sodium-dependent 
reabsorption. Since decreased ATP 
levels imply less fuel for the Na,K- 
ATPase pump, reabsorption of solutes 
from the glomerular ultrafiltrate 
via sodium-dependent transporters 
located at the apical membrane of the 
proximal tubular epithelium can be 
affected. Taken together, decreased 
ATP levels in cystinotic proximal tubular 
epithelium can cause diminished 
sodium-dependent transport and, 
hence, increased excretion of vital 
solutes via urine. In line with this 
hypothesis, of the thirteen inherited 
diseases leading to renal Fanconi 
syndrome listed in table 1.1 (chapter 
1), five disorders are directly related to 
the ATP producing pathways: glycolysis 
or mitochondrial OXPHOS.
Following the investigations by Coor 
et al., who demonstrated decreased ATP 
levels in CDME loaded proximal tubules, 
it was postulated that alterations in 
ATP metabolism cause renal tubular 
dysfunction in nephropathic cystinosis 
[Coor 1991]. Involvement of ATP 
metabolism in the development 
of Fanconi syndrome is frequently 
reported in patients with mitochondrial 
disorders [Hall 2007; Van Biervliet 
1977; Niaudet 1998; Diomedi-Camassei
2007]. Additionally, histological 
studies in cystinotic renal tubular 
cells revealed swollen mitochondria 
[Jackson 1962]. Remarkably, swollen
mitochondria were also observed in 
a Pgp (mdr1a/1b) knock-out mouse, 
presenting with Fanconi syndrome 
[Huls 2007]. These studies supported 
the idea that alterations in ATP 
metabolism in cystinosis is responsible 
for in the development of renal Fanconi 
syndrome.
This hypothesis was confirmed in 
additional studies using CDME to mimic 
the cystinotic phenotype, showing 
decreased glucose and bicarbonate 
reabsorption together with decreased 
mitochondrial ATP production 
[Foreman 1995; Sakarcan 1994]. 
Additionally, decreased transepithelial 
sodium gradient was shown in perfused 
rabbit proximal tubules loaded with 
CDME [Salmon 1990]. Furthermore, 
Ben-Nun et al. demonstrated in LLC-PK1 
cells loaded with CDME a decreased 
activity of Na,K-ATPase [Bennun 1993]. 
These results were questioned by our 
finding that CDME loading had toxic 
effects on intracellular metabolism, as 
discussed in chapter 2 of this thesis. 
Consequently, the involvement of 
ATP metabolism in the development 
of Fanconi syndrome in cystinosis 
should be reevaluated preferably in 
cystinotic cells with lysosomal cystine 
accumulation caused by defects in 
CTNS mediated transport.
In this thesis, several cystinotic cell 
models were used to demonstrate 
decreases in intracellular ATP levels. 
In chapter 5, proximal tubular cell 
lines derived from urine of healthy
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controls and cystinotic patients were 
cultured and immortalized using a 
combination of SV40T and hTERT 
genes, in which decreased ATP levels 
were demonstrated. Since ATP 
production from both glycolysis as well 
as from mitochondrial OXPHOS was 
shown to be intact, it can be suggested 
that decreased ATP levels in cystinotic 
ciPTEC are caused by an increase in ATP 
consumption. It should be noted that 
the investigated in vitro models are 
mainly glycolytic, while the majority of 
ATP in vivo is derived from mitochondrial 
OXPHOS. Consequently, alterations 
in tubular transport could limit the 
availability of substrates required for 
the citric acid cycle and, hence, affect 
mitochondrial ATP production.
Decreased ATP levels were also 
demonstrated in cultured cystinotic 
fibroblasts and in PMN's, directly 
obtained from cystinotic patients, 
as described in chapter 6. Although 
cystine levels in the PMN's were 
only slightly increased by cysteamine 
treatment, no correlation was observed 
between cystine and ATP levels. In 
chapter 6, we demonstrate unaltered 
enzyme activities of respiratory chain 
complexes I-IV, which are responsible 
for the proton gradient at the inner 
mitochondrial membrane. This 
gradient is the driving force for the 
generation of ATP by complex V. The 
recent development of an assay to 
determine complex V activity in cellular 
homogenates[Morava 2006], allowed
comparison of the ATP producing 
capacity by complex V in control versus 
cystinotic fibroblasts. In line with the 
observation of intact mitochondrial ATP 
production, chapter 7 describes normal 
expression and activity of complex V in 
cystinotic fibroblasts.
The observation of intact 
mitochondrial ATP producing capacity 
in cystinotic fibroblasts and ciPTEC are 
in contrast with a recent publication 
demonstrating abnormal mitochondria 
in renal proximal tubular cells together 
with decreased mitochondrial ATP 
production due to defects in complex
I of the respiratory chain [Sansanwal 
2010]. A possible explanation of the 
discrepancy between the study of 
Sansanwal et al. and our own results, 
is their use of inappropriate controls, 
which were obtained by a different 
methodology comparing to the 
cystinotic cells, hence, not allowing an 
adequate comparison.
Although ATP levels were decreased 
in cystinotic fibroblasts, the Na,K- 
ATPase activity remained intact. Na,K- 
ATPase activity was also found intact in 
two ciPTEC cell lines (own unpublished 
data), suggesting that alterations in ATP 
metabolism are not directly responsible 
for the renal tubular dysfunction in 
cystinosis. Furthermore, an overlap 
between ATP levels in control versus 
cystinotic cells (in all tested cell types) 
suggests that decreased ATP is not 
a primary cause of cell dysfunction 
in cystinosis and other mechanisms
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underlying decreased sodium- 
dependent reabsorption in cystinosis 
should be explored further.
9.2.2 Studies of GSH metabolism
Next to the involvement of ATP 
metabolism in the pathogenesis 
of cystinosis, alterations in GSH 
metabolism were studied in this thesis. 
The detection of increased 5-oxoproline 
in cystinotic urine pointed towards 
involvement of the y-glutamyl cycle, the 
pathway responsible for GSH synthesis 
[Rizzo 1999]. Lysosomal accumulation 
of cystine can theoretically result 
in deficient cytosolic cysteine pool, 
consequently inhibiting synthesis 
of GSH. The reaction of free GSH to 
GSSG is catalyzed by GSH peroxidase 
and is important for maintaining the 
intracellular redox status. Maintenance 
of the intracellular GSH pool is therefore 
important to deal with oxidative stress 
for which GSSG/2GSH ratio can be used 
as a parameter for the cellular oxidation 
status [Kirlin 1999].
In cystinotic fibroblasts and proximal 
tubular cells derived from urine, 
decreased levels of GSH were reported 
previously [Chol 2004; Laube 2006]. 
Another study using human fibroblasts 
showed no differences in basal levels of 
GSH, but demonstrated decreased GSH 
levels in cystinotic cells upon inhibition 
of ATP synthesis and after application 
of oxidative stimuli [Mannucci 
2006]. These results implicated the
involvement of the ATP-dependent 
y-glutamyl cycle. In chapters 3 and 5, 
both in HPV 16 E6/E7 immortalized 
proximal tubular cells as well as in the 
newly presented ciPTEC model, normal 
levels of total GSH and increased 
levels of GSSG were demonstrated in 
cystinotic cells, suggesting increased 
oxidative stress. The GSH levels 
measured in cultured ciPTEC are 
comparable to the levels measured 
in tubular cells in vivo (~5 mM) [Lash
2005]. Although the GSSG/2GSH ratio 
was altered in all tested cell types, 
this was not reflected by enhanced 
ROS generation measured using ROS­
sensitive HEt and CM-H2DCFDA probes. 
Additionally in ciPTEC, alterations in 
the redox status had no effect on the 
oxidation of proteins or fatty acids, 
indicating that in vitro cellular reduction 
capacity was sufficient for protecting 
cells against oxidative damage. High 
metabolic activity and almost exclusive 
ATP generation via OXPHOS in vivo can 
result in enhanced ROS production. 
Hence, in vivo cystinotic cells might be 
more vulnerable to oxidative stimuli.
Importantly, cysteamine treatment 
increased total intracellular GSH 
pool in both control and cystinotic 
ciPTEC, increasing the capacity to deal 
with oxidative stress. Noteworthy, 
increased GSH levels upon cysteamine 
treatment might have beneficial effects 
in other chronic kidney diseases in 
which increased oxidation is involved 
in progressive renal failure and
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cardiovascular morbidity [Shah 2007; 
Santangelo 2004; Okamura 2009].
Next to the synthesis of GSH via 
the y-glutamyl cycle, proximal tubular 
cells derive GSH from basolateral 
uptake via sodium dependent SDCT-2 
and OAT1/3 transporters [Lash 2005]. 
In addition, GSH is filtered in the 
glomerulus and degraded to cysteinyl- 
glycine by the ectoenzyme y-glutamyl 
transferase, located at the BBM of the 
proximal tubular epithelium. In turn, 
cysteinyl-glycine can be reabsorbed 
via PEPT2 at the apical membrane and 
supplement the intracellular cysteine 
pool [Frey 2007]. In this perspective, it 
can be argued that decreased tubular 
reabsorption can be responsible for 
alterations in the intracellular GSH pool 
in cystinosis in vivo.
9.2.3 Studies of proteinuria in 
cystinosis
The reabsorption of LMW proteins 
in the proximal tubular epithelium is 
facilitated by the multi-ligand receptors 
megalin, cubilin and amnionless 
[Christensen 2002; Coudroy 2005]. 
Ligands present in the glomerular 
ultrafiltrate are bound to the receptors 
and internalized via clathrin-coated 
pits, transformed into endosomes 
and, eventually, convert to lysosomes. 
Acidic pH in the endosomes and 
lysosomes causes dissociation of the 
ligand-receptor complex, allowing 
recycling of the receptors to the BBM,
making the receptor available for the 
reabsorption of more ligands present 
in the tubular lumen. Lysosomal 
aberrations can lead to alterations 
in this renal recycling mechanism 
responsible for the reabsorption of 
the majority of the LMW proteins. It 
should be noted that five out of the 
thirteen Fanconi syndrome disorders 
listed in table 1.1 (cystinosis, Dent's 
disease, Lowe syndrome, I-cell disease 
and metachromatic leukodystrophy) 
are diseases with a main defect in 
lysosomal proteins or proteins linked to 
lysosomal trafficking.
Defects in endocytosis have been 
demonstrated in Dent's disease [Piwon 
2000; Christensen 2003], in which a 
defective chloride/proton exchanger 
located at the lysosomal membrane 
is the underlying cause of impaired 
proximal tubular endocytosis. Typically, 
mutations in the X-linked CLCN5 gene 
are responsible for the Dent's disease. 
However, mutations in OCRL1, usually 
associated with Lowe syndrome, have 
been reported in Dent's patients, 
designated as Dent 2 [Bockenhauer 
2006; Hoopes, Jr. 2005]. The OCRL1 
gene encodes inositol polyphosphate- 
5-phosphatase, which is involved in 
membrane trafficking and protein 
transportation to the lysosomes 
[Charnas 1991; Choudhury 2005]. 
Deficient urinary megalin excretion 
in patients with Lowe syndrome and 
Dent's disease suggest that impaired 
endocytosis is responsible for
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proteinuria [Norden 2002]. In Dent's 
disease, both megalin and cubilin 
expression at the BBM are decreased 
in clcn5'/' mouse [Christensen 2003]. 
However, in OCRL1 knockdown 
renal cells no impairment of megalin 
mediated endocytosis could be 
demonstrated [Cui 2010].
The similarities between renal 
phenotypes of Dent's disease, Lowe 
syndrome and nephropathic cystinosis 
substantiated the investigation of 
megalin and cubilin reabsorption, as 
addressed in chapter 8. Histological 
examination of renal cystinotic tissue 
revealed BBM localization of both 
megalin and cubilin together with 
the presence of endocytic vesicles 
containing their ligands, indicating the 
mechanism of proteinuria in cystinosis is 
likely to be different from that observed 
in Dent's disease. Additionally, high 
urinary levels of both LMW and HMW 
proteins in cystinotic patients (even in 
patients at the age of 1 year), suggested 
that proteinuria in cystinosis can be a 
result of glomerular defects.
On the other hand, the presence 
of LMW proteins and albumin 
in both urine and in intracellular 
vesicles extending to the straight 
proximal tubule points towards 
incomplete tubular reabsorption in 
the proximal convoluted tubules. 
Possibly, glomerular proteinuria in 
cystinosis results in an 'overload' of 
ligand binding sites on the endocytic 
receptors. This theory is supported
by the finding of HMW protein IgG in 
cystinotic urine and abundant luminal 
protein content. Interestingly, recent 
investigations using a mouse model of 
diabetic nephropathy demonstrated 
that extensive albumin reabsorption 
resulted in selective injury in sections 
with excessive proximal tubular albumin 
staining [Kralik 2009]. Moreover, using a 
megalin knockout mosaic mouse, it was 
shown that only tubular cells expressing 
megalin with functional endocytosis 
of albumin were expressing tubule 
injury markers [Motoyoshi 2008]. The 
latter observations, together with 
numerous other studies showing the 
role of proteinuria in renal damage [Liu 
2010], underscore that proteinuria in 
cystinosis contributes to renal disease 
progression and should be treated by 
ACE inhibitors or angiotensin II receptor 
antagonists [Levtchenko 2003].
9.3 Future perspectives
The content of this thesis provides 
mechanistic insights in nephropathic 
cystinosis and opens new directions for 
future research. In this paragraph, these 
future perspectives are discussed.
The presented ciPTEC model 
manifests cystine accumulation with 
levels approaching those observed 
in vivo, together with the functional 
expression of tubular transporters. 
The value of the control ciPTEC for 
pharmacological and physiological 
research should be investigated
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further by evaluating the expression 
and function of other transporters, 
such as SLC22 family members OAT 
and OCT, which are involved in 
tubular reabsorption and excretion of 
xenobiotics. The ciPTEC model should 
further be cultured on permeable 
supportive membranes, enabling cells 
to polarize for studying transcellular 
transport under exposure of various 
physiological and pharmacological 
stimuli. Regarding the pathogenesis 
of cystinosis, these growth conditions 
could be developed further to address 
questions on tubular transport function 
or intracellular protein trafficking.
The alterations observed in ATP and 
GSH metabolism as presented in this 
thesis suggest the involvement of these 
cellular pathways in the development 
of the cystinotic phenotype. Since 
substrates for ATP and GSH production 
are in vivo also dependent on tubular 
reabsorption and ATP production is 
mainly derived from mitochondrial 
OXPHOS, these observations should be 
further explored in vivo, for example by 
using the ctns'/' mouse [Nevo 2009].
Although cystine accumulation is the 
hallmark of cystinosis and is regarded 
as the primary effect due to mutations 
in the CTNS gene, increasing evidence 
indicates that cystine accumulation 
itself is not responsible (or insufficient) 
for metabolic alterations in cystinosis. 
First, upon CDME loading in animal 
models, researchers found an acute 
tubular dysfunction [Foreman 1987;
Salmon 1990], which is in contrast 
with the gradual development of 
Fanconi syndrome in patients during 
the first months of life [Levtchenko 
2006a]. Secondly, the observation that 
cysteamine therapy is not arresting the 
downward spiral leading to ESRD in 
cystinotic patients, despite decreased 
intracellular cystine levels, argues 
against the exclusive involvement 
of cystine accumulation in the 
pathogenesis of cystinosis. Finally, it has 
been shown that ctns'/' mice develop 
renal tubular dysfunction dependent 
on their genetic background, despite 
intracellular cystine accumulation 
[Nevo 2009]. This suggests involvement 
of other genes in the development of 
proteinuria in cystinosis.
In this perspective, the recently 
described function of CARKL, deleted 
in patients carrying the 57 kb deletion, 
together with the expression of CTNS- 
LKG, product of alternative splicing 
of the CTNS gene, might open new 
possibilities for future research 
[Wamelink 2008; Taranta 2008]. 
Phosphorylation of sedoheptulose is 
connected to the pentose phosphate 
pathway and therefore might contribute 
to alterations in cellular redox status. 
Since the pentose phosphate pathway 
is responsible for the production of 
NADPH, which has similar antioxidant 
functions as GSH, defects in CARKL might 
influence the NAPDH levels, hence 
intracellular redox status [Wamelink
2008]. Although the contribution of
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CARKL in the pathogenesis of cystinosis 
is still uncertain, patients with the 
homozygous 57 kb deletion (including 
CARKL and TRPV1) have a more severe 
phenotype [Gahl 2007]. Using ciPTEC 
derived from cystinotic patients with 
mutations comprising the 57 kb deletion 
or small deletions or point mutations 
in the CTNS gene, the contribution of 
CARKL on, for instance, cellular redox 
status, should be studied. Alternatively, 
the role of CARKL, TRPV1 or CTNS-LKG 
can be studied by introducing these 
genes in ciPTEC with homozygous 57 
kb deletion and measuring the cellular 
responses. More detailed comparison 
of the clinical phenotype of patients 
with and without homozygous 57 kb 
deletion should be further performed 
in a large cystinosis patients database.
It has been shown that the 
proximal tubular epithelium produces 
cytokines and chemokines, directly 
stimulated by excess albumin [Zoja 
1998; Wang 1 9 9 9 ; Y a r d  2001]. 
Consequently, inflammatory cells are 
attracted to the renal interstitium, 
initiating tubulo-interstitial fibrosis 
development. Whether lysosomal 
cystine accumulation can initiate 
proinflammatory responses in proximal 
tubular cells should be tested in ciPTEC. 
Patient material (such as urine, serum, 
and if available kidney tissue) can 
provide important information next to 
information gained via in vitro models. 
For example, the in vitro ciPTEC model 
with accumulation of cystine (and after
depletion with cysteamine) can be used 
to study the production of cytokines 
and chemokines upon overloading with 
albumin. Using high-throughput assays, 
such as metabolomics or proteomics, 
urine samples or cell fractions (e.g. 
lysosomes) could be analyzed to gain 
detailed insight in the protein excretion 
pattern and intracellular signaling 
pathways involved.
The observation of increased 
glomerular permeability in cystinosis, 
poses questions concerning the 
influence of CTNS mutations on the 
podocyte. To address these questions, 
a cellular podocyte model should be 
developed, either from cystinotic 
renal tissue or from cystinotic urine 
in which podocytes can be present 
[Vogelmann 2003]. This model 
could be used to investigate the cell 
monolayer permeability and cell-to-cell 
interactions.
Another important field to be 
explored in respect to the pathogenesis 
of cystinosis is the cascade of reactions 
leading to apoptosis or autophagy. In 
both cystinotic fibroblasts and in CDME 
loaded renal tubular cells an increase in 
apoptosis was reported after apoptotic 
triggers, such as exposure to TNF-a 
or UV light [Park 2002]. This process 
is possibly triggered by the binding of 
cystine to PKC-S , a proaptotic protein 
kinase, activated via cysteinylation 
[Park 2006]. Possibly, the typical 'swan- 
neck' formation in cystinosis, caused 
by tubular cell injury and resulting in
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atubular glomeruli could be a result 
of apoptosis [Chevalier 2008]. In 
perspective of this thesis, it should be 
noted that decreased levels of GSH can 
trigger apoptosis, possibly regulated 
via glutathionylation of proteins 
[Franco 2009]. Furthermore, the GSH 
transporters OAT1/3 and MRP2/4 seem 
to play a regulating role in this apoptotic 
cascade [Franco 2006]. Recently, 
autophagy, a process by which cellular 
organelles are digested in lysosomes, 
has been shown in cultured cystinotic 
fibroblast and tubular cells [Sansanwal 
2010]. Both apoptosis and autophagy 
of renal tubular cells can explain 
the formation of atubular glomeruli 
and decrease of renal function. This 
hypothesis should be studied further in 
ciPTEC and the influence of cysteamine 
on cell survival should be further 
evaluated.
In conclusion, this thesis provides 
us with new insights and a better 
understanding of the pathogenesis 
of cystinosis, although the exact 
mechanism is still not unraveled. The 
new presented human proximal tubular 
cell model is a useful tool for further 
mechanistic studies and for testing new 
therapies of cystinosis.
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The proximal tubular epithelium 
in the kidney is responsible for 
reabsorption of vital compounds in 
the glomerular filtrate and excretion 
of waste products. Defects in the 
reabsorption machinery results in 
loss of these vital compounds (i.e. 
LMW proteins, glucose, phosphate, 
amino acids) via urine. Dysfunction 
of the proximal tubules is called renal 
Fanconi syndrome, which can have 
both acquired and inherited causes. 
The most common cause of inherited 
Fanconi syndrome in children is 
the autosomal recessive disease 
nephropathic cystinosis. Mutations 
in the CTNS gene, encoding the 
lysosomal cystine transporter CTNS, 
result in accumulation of cystine in 
the lysosomes. In the majority of the 
patients this leads to Fanconi syndrome 
in the first year of life and progresses 
to ESRD within ten years. The effective 
treatment with the aminothiol 
cysteamine results in decreased 
lysosomal cystine levels and extends 
life-span of patients with cystinosis. 
However, renal Fanconi syndrome is 
not cured by cysteamine, which only 
post-pones the downward spiral to 
ESRD. The goal of this thesis was to:
• develop an in vitro model for 
investigating the pathogenesis of 
cystinosis
• understand the mechanism of 
impaired tubular transport
• understand the effect of cysteamine
treatment on proximal tubular
function
An important step forward in our 
current knowledge of cystinosis was 
made by the demonstration of impaired 
cystine exodus from lysosomes. This 
was facilitated by artificial loading 
of lysosomes with CDME, mimicking 
the cystine accumulation observed in 
cystinotic patients. The lack of sufficient 
renal cell material derived from 
cystinotic patients inspired investigators 
to use this technique to study the 
intracellular aberrations caused by 
increased cystine levels. In chapter 2 
the CDME model was compared with 
fibroblasts of cystinotic patients with 
known mutations in CTNS gene. By 
analyzing ATP and ROS production and 
cell viability, it became clear that CDME 
loading has a direct toxic effect on cells. 
Moreover, decreased ATP levels and 
ATP production together with increased 
ROS production and diminished 
viability in CDME loaded cells were not 
observed in cells with mutations in CTNS 
having comparable levels of cystine 
accumulation. Consequently, the CDME 
loading model should not be used for 
studying the pathogenesis of cystinosis 
and the hypothesis of alterations in ATP 
metabolism being responsible for the 
Fanconi syndrome in cystinosis should 
be reevaluated.
Since renal biopsies are not required 
for diagnosis of cystinosis, renal 
material is sparse. The lack of sufficient
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renal cell cystinotic cell material 
initiated a quest for the development 
of an in vitro model with the cystinotic 
phenotype. The observation that 
proximal tubular cells are exfoliated 
in urine enabled us to develop an in 
vitro model of both cystinosis patients 
and pediatric healthy controls as 
described in chapters 3 and 4. The 
major challenge in the development of 
cell lines was to overcome the limited 
cell proliferation in culture. In chapter 3 
we introduced the HPV 16 E6/E7 genes 
in cells derived from urine, allowing to 
maintain cell growth. The immortalized 
cells of cystinotic patients accumulated 
cystine (approximately 10-fold increase 
compared to controls) and both control 
and cystinotic lines manifested with 
proximal tubular characteristics, such 
as AP activity and aminopeptidase N 
expression.
Although the cystine levels were 
significantly increased in HPV 16 E6/ 
E7 cells, cystine accumulation in vivo 
is more pronounced, motivating the 
development of a second immortalized 
renal cell model with the cystinotic 
phenotype in chapters 4 and 5. 
Immortalization of primary cells with 
both SV40T and hTERT genes allowed 
us to maintain cell proliferation at 33°C. 
Transferring cells to 37°C decreased 
expression of SV40T antigen and 
consequently decreased proliferation. 
This resulted in a conditionally 
immortalized PTEC line with ~37- 
fold increase of cystine compared to
control levels. The ciPTEC maintained 
expression and function of transporters 
Pgp and OCT2, together with sodium- 
dependent phosphate transport and 
albumin reabsorption. The use of ciPTEC 
is not restricted to cystinosis research, 
but this human renal cell model can 
be of value in renal physiology and 
pharmacology.
Although the basic mechanism and 
the genetic background of cystinosis 
are well understood, the pathways 
that are involved in the development 
of renal Fanconi syndrome and 
ESRD are still elusive. Using the 
CDME model, it was postulated that 
alterations in ATP metabolism can 
lead to impaired sodium-dependent 
tubular reabsorption. In this thesis, 
this hypothesis was tested in two renal 
cell models (chapter 3: HPV 16 E6/E7 
and chapter 5: ciPTEC), in fibroblasts 
(chapters 6 and 7) and in PMN's 
derived from cystinotic patients. In 
all cell types, except the HPV 16 E6/ 
E7 immortalized cell lines, slightly 
decreased intracellular ATP levels were 
observed. However, the disturbances 
in ATP production (glycolysis and 
OXPHOS) could not be detected in 
any of the cells tested, suggesting 
decreased ATP levels are probably a 
result of enhanced consumption. In 
our opinion, an overlap in ATP levels 
between cystinotic and control cell 
indicates that ATP deficiency is not 
the cause of the development of renal 
Fanconi syndrome.
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To link cystine accumulation to 
renal dysfunction, alterations in 
GSH metabolism were proposed. If 
lysosomally trapped cystine is not 
transported to the cytosol, this might 
lead to insufficient cysteine levels and 
consequently decreased production of 
GSH via the y-glutamyl cycle. Since GSH 
is a major antioxidant, the cystinotic 
cell could be more susceptible to 
oxidative stress, which is linked to 
renal inflammation and progression of 
interstitial fibrosis. In both renal cell 
models (HPV 16 E6/E7 and ciPTEC) 
we found increased levels of GSSG, 
without alterations in the total GSH 
pool (chapter 3 and 5). This suggested 
increased oxidative stress caused by 
cystine accumulation, although normal 
ROS production, protein oxidation and 
lipid peroxidation were demonstrated. 
Redox status of GSSG/2GSH was 
altered in cystinotic cells, but the 
impact on progression of renal disease 
is doubtful. It should be noted that in 
vivo GSH levels, next to intracellular 
production, are also dependent on 
tubular reabsorption, which can be 
impaired in cystinosis. Consequently, 
the situation in vivo might be different 
and possible GSH depletion can occur 
resulting in less defense against ROS.
Importantly, elevated GSH levels 
upon cysteamine treatment was 
observed, increasing the capacity to 
deal with oxidative stress (chapter 5). 
This mechanism might be responsible 
for the protection of renal function
by cysteamine treatment in vivo. This 
effect was also observed in control 
ciPTEC, indicating that cysteamine can 
be used as an antioxidant in other renal 
disorders with enhanced oxidative 
stress.
To increase our knowledge on the 
mechanism of tubular dysfunction 
in cystinosis, we studied in chapter 
8 receptor mediated uptake of LMW 
proteins and albumin via the endocytic 
receptors megalin and cubilin. The 
availability of one cystinotic kidney 
allowed us to localize both megalin 
and cubilin at the BBM of proximal 
tubules as well as intracellular LMW 
proteins and albumin in a vesicular 
pattern. This suggested functional 
reabsorption via megalin and cubilin. 
However, intracellular vesicles 
were abundantly expressed and 
protruding into the straight proximal 
tubules contrasting the observation 
in the control kidneys, suggesting 
decreased endocytic uptake rate in 
the convoluted proximal tubules and/ 
or increased glomerular permeability 
resulting in receptor overload. The 
observation of HMW protein IgG in 
urine of all studied patients favors the 
'overload' hypothesis and implicates 
that glomerular proteinuria is already 
present at early stages of cystinosis.
Summarizing, the studies 
presented in this thesis give us new 
insights and a better understanding 
of the pathogenesis of cystinosis. 
However, the exact link between
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lysosomal cystine accumulation and 
the development of renal disease is 
still elusive. The presented ciPTEC can 
be used in future studies as a tool to 
increase our knowledge and for testing 
new therapies of cystinosis.
155
Summary
156

Samenvatting in het Nederlands
De proximale tubuluscellen in de nier 
zorgen ervoor dat belangrijke stoffen, 
die in de glomerulus uit het bloed zijn 
gefilterd, worden gereabsorbeerd via 
een ingewikkeld transportmechanisme. 
Daarnaast spelen ze een belangrijke 
rol bij de uitscheiding van afval- en 
lichaamsvreemde stoffen. Fouten in dit 
systeem kunnen leiden tot een verlies 
van diverse gefilterde stoffen (zoals 
kleine eiwitten, suikers, fosfaten en 
aminozuren) met de urine. Storingen 
in dit systeem worden algemeen 
aangeduid met de term renaal Fanconi 
syndroom. De oorzaken hiervan 
kunnen zowel aangeboren genetische 
afwijkingen als milieufactoren zijn. 
De meest voorkomende vorm van 
aangeboren Fanconi syndroom is de 
ziekte Nefropathische Cystinose. Door 
mutaties in het CTNS-gen, dat voor 
de lysosomale transporter cystinosin 
codeert, wordt bij deze ziekte het 
aminozuur cystine gestapeld in het 
lysosoom. De meeste patiënten krijgen 
symptomen van het Fanconi syndroom 
gedurende het eerste levensjaar en dit 
kan binnen tien jaar verder leiden tot 
terminaal nierfalen waarbij nierdialyse 
of -transplantatie noodzakelijk wordt. 
Als gevolg van de behandeling met 
cysteamine vermindert de lysosomale 
cystine stapeling en stijgt de 
levensverwachting van de patiënten. 
Helaas is het Fanconi syndroom 
hierdoor niet verdwenen en zorgt de 
cysteamine behandeling slechts voor 
een vertraging van het ziekteproces,
dat leidt tot het terminaal nierfalen. 
Het doel van dit proefschrift is:
• een in vitro model te ontwikkelen 
om het ziekteproces van cystinose te 
onderzoeken
• het mechanisme van verstoord 
tubulair transport te begrijpen
• het effect van cysteamine op de 
proximale tubuli beter te bestuderen
Toen bekend werd dat verstoord 
cystine transport vanuit de lysosomen 
de oorzaak was van cystinose, 
betekende dit een belangrijke stap 
voorwaarts in onze kennis om deze 
ziekte te begrijpen. Deze ontdekking 
werd mogelijk gemaakt door gezonde 
lysosomen op te laden met CDME, 
waardoor op een kunstmatige manier 
de cystine stapeling bij cystinose kon 
worden nagebootst. Het gebrek aan 
voldoende weefsel van cystinose 
patiënten zorgde ervoor dat deze 
methode gebruikt werd om de 
verstoorde intracellulaire processen 
als gevolg van cystine stapeling bij 
cystinose te onderzoeken. In hoofdstuk
2 werd dit CDME model vergeleken met 
fibroblasten van cystinose patiënten 
met een bekende mutatie in het CTNS- 
gen. Door de analyse van ATP- en ROS- 
productie en de cel viabiliteit werd 
duidelijk dat de lading met CDME een 
direct toxisch effect heeft op de cellen. 
Deze veranderingen werden niet 
waargenomen in cellen met mutaties in 
het CTNS-gen en met een vergelijkbare
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hoeveelheid gestapeld cystine. Daarom 
mag het CDME model niet verder 
gebruikt worden om het ziekteproces 
van cystinose te onderzoeken. Tevens 
zal de hypothese, dat veranderingen 
in het ATP metabolisme ten grondslag 
liggen aan het Fanconi syndroom bij 
cystinose, nog eens moet worden 
beoordeeld.
Doordat nierbiopten niet nodig 
zijn om de diagnose van cystinose 
vast te stellen, is nierweefsel van 
patiënten uiterst zeldzaam. Het gebrek 
aan voldoende onderzoeksmateriaal 
afkomstig van cystinose patiënten 
motiveerde de ontwikkeling van een 
nieuw in vitro model. Door gebruik 
te maken van niercellen die met de 
urine worden uitgescheiden konden 
we zowel van cystinose patiënten 
als van gezonde controle personen 
een celmodel ontwikkelen, zoals is 
beschreven in de hoofdstukken 3 en
4. De grootste uitdaging hierbij was om 
de beperkte celdeling te stimuleren. In 
hoofdstuk 3 werden de primaire cellen 
uit urine getransfecteerd met HPV 16 
E6/E7-genen, waardoor de celdeling 
werd bevorderd. De geïmmortaliseerde 
cellen van cystinose patiënten 
stapelde cystine (ongeveer 10 x zoveel 
vergeleken met controle cellen) 
en de cellen behielden kenmerken 
van proximale tubuluscellen, zoals 
alkalische fosfatase activiteit en 
aminopeptidase N expressie. Hoewel de 
cystinose cellen cystine stapelden, was 
dit nog lang niet zoveel als de stapeling
die in vivo gemeten werd. Daarom is 
er een tweede celmodel ontwikkeld 
zoals beschreven in de hoofdstukken 4 
en 5. Door de primaire cellen uit urine 
te immortaliseren met de SV40T- en 
hTERT-genen werd de celproliferatie 
in stand gehouden bij 33°C. Wanneer 
de cellen bij 37°C werden geïncubeerd, 
verdween de expressie van het SV40T- 
gen en vertraagde de celdeling. 
Hierdoor ontstond er een conditioneel 
geïmmortaliseerde cellijn met een 
cystine stapeling van 37x de controle 
waardes. Deze ciPTEC behielden de 
expressie én functie van de proximale 
tubulus transporters Pgp en OCT2 
samen met natrium-afhankelijk 
fosfaat transport en albumine 
reabsorptie. De toepassingen van dit 
ciPTEC model zijn niet beperkt tot het 
cystinose onderzoek, maar dit humaan 
niermodel kan ook worden toegepast 
voor fysiologisch en farmacologisch 
onderzoek.
Hoewel de genetische oorzaak 
en het fundamentele mechanisme 
bij cystinose bekend zijn, is het nog 
steeds onduidelijk welke processen 
betrokken zijn bij het ontstaan van 
Fanconi syndroom en nierfalen. Door 
gebruik te maken van het CDME model 
werd de hypothese gepostuleerd dat 
veranderingen in het ATP metabolisme 
kunnen leiden tot verstoord natrium 
afhankelijk tubulair transport. In dit 
proefschrift is deze hypothese getest 
in twee nier celmodellen (hoofdstuk 
3: HPV 16 E6/E7 en in hoofdstuk 5:
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ciPTEC), in fibroblasten (hoofdstukken
6 en 7) en in PMN's van cystinose 
patiënten. In alle celtypen, behalve de 
HPV 16 E6/E7 geïmmortaliseerde cellijn, 
kon een licht verlaagd ATP gehalte 
worden gemeten. De oorzaak hiervan 
werd niet gevonden in verstoorde ATP 
productie via de glycolyse of OXPHOS. 
Dit suggereert dat het ATP verbruik 
wellicht is verhoogd. De overlap in ATP 
gehaltes tussen cystinose en controle 
cellen duidt er volgens ons op dat een 
gebrek aan ATP niet de directe oorzaak 
is van de ontwikkeling van Fanconi 
syndroom bij cystinose.
Er is gesuggereerd dat het verband 
tussen cystine stapeling en nierfalen in 
veranderingen van GSH metabolisme 
moet worden gezocht. Wanneer 
cystine stapelt in het lysosoom en niet 
naar het cytosol wordt getransporteerd 
kan dit leiden tot verlaagde cytosolaire 
cysteïne gehaltes en verstoorde GSH 
productie via de y-glutamyl cyclus. 
Omdat GSH een belangrijke antioxidant 
is, kan de cel hierdoor meer vatbaar zijn 
voor oxidatieve stress, dat op zijn beurt 
weer in verband kan worden gebracht 
met verhoogde ontstekingen en 
interstitiële fibrosis in de nier. In beide 
ontwikkelde nier celmodellen (HPV 16 
E6/E7 en ciPTEC) werden verhoogde 
GSSG gehaltes gemeten, zonder 
veranderingen in de totale GSH pool 
(hoofdstukken 3 en 5). Dit suggereert 
een verhoogde oxidatieve stress door 
cystine stapeling, hoewel een normale 
ROS productie, eiwit- en vetzuur-
oxidatie werd gemeten. De redoxstatus 
van GSSG/2GSH was in cystinose cellen 
veranderd, maar de directe invloed 
daarvan op de ontwikkeling van 
nierfalen is discutabel. Hierbij moet 
worden opgemerkt dat het GSH gehalte 
in vivo niet alleen afhankelijk is van 
de intracellulaire aanmaak, maar dat 
het ook via tubulair transport in stand 
wordt gehouden, dat verstoord kan 
zijn bij cystinose patiënten. Daardoor 
kan de situatie in vivo anders zijn, met 
een eventuele GSH depletie en minder 
weerstand tegen oxidatieve stress. In 
dit perspectief is de bevinding, dat in 
ciPTEC de totale GSH gehaltes in de 
cel zijn toegenomen onder invloed van 
cysteamine behandeling van belang, 
omdat hierdoor de bescherming 
tegen oxidatieve stress is toegenomen 
(hoofdstuk 5). Dit mechanisme is 
wellicht verantwoordelijk voor de 
vertraging in de ontwikkeling van 
nierfalen bij behandelde cystinose 
patiënten. Omdat de verhoging in het 
gehalte van GSH ook in controle ciPTEC 
werd waargenomen, zou cysteamine 
behandeling ook overwogen kunnen 
worden in andere nierziektes, waarbij 
verhoogde oxidatieve stress een rol 
speelt.
Om ons inzicht te verhogen in het 
mechanisme van tubulaire defecten 
bij cystinosis, hebben we in hoofdstuk
8 de receptor-afhankelijke opname 
van kleine eiwitten en albumine 
via de endocytose receptoren 
megaline en cubiline onderzocht. De
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beschikbaarheid van één cystinose 
nier gaf ons de mogelijkheid om 
megaline en cubiline te lokaliseren 
op de brush border membraan van 
de proximale tubuluscellen. Tevens 
werden kleine eiwitten en albumine 
intracellulair gevonden, wat duidde 
op een functionerende opname via 
megaline en cubiline. De intracellulaire 
aanwezigheid van de kleine eiwitten 
en albumine werden echter veelvuldig 
gevonden tot in de laatste delen van 
de proximale tubulus bij de cystinose 
nier en niet in de controle nier. Dit 
suggereert, dat de endocytose in 
de eerste delen van de proximale 
tubulus niet optimaal functioneert en/ 
of dat een verhoogde glomerulaire 
permeabiliteit een verzadiging van de 
receptoren veroorzaakte. Aangezien 
hoogmoleculaire eiwitten, als IgG, in 
alle onderzochte cystinose patiënten 
(vanaf 1 jaar) werden gevonden is deze 
verhoogde glomerulaire permeabiliteit 
ook al aanwezig in een vroeg stadium 
van cystinose.
Samenvattend geeft dit proefschrift 
meer inzicht in de pathogenese 
van cystinosis, hoewel de exacte 
mechanismen nog niet volledig zijn 
opgehelderd. Het nieuwe ciPTEC model 
kan hulp bieden om het mechanisme 
verder op te helderen en om nieuwe 
behandelingsstrategieën te testen.
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Nog voordat de mens bedacht om 
zijn afval te recyclen om zo energie 
te besparen, gebeurde dit al veel 
langer in zijn eigen lichaam. In onze 
lichaamscellen zitten namelijk kleine 
afvalfabriekjes, de lysosomen. Hierin 
worden grote eiwitten afgebroken 
tot hun bouwstenen, aminozuren, die 
vervolgens beschikbaar worden gesteld 
aan de cel om weer gebruikt te worden. 
Uiteraard blijft er afval ontstaan dat via 
de urine het lichaam verlaat. Na filtratie 
van het bloed in de nieren ontstaat 
er voorurine, die nog nuttige stoffen 
bevat. Voordat deze voorurine het 
lichaam verlaat, worden de bruikbare 
stoffen eruit gehaald via een ingenieus 
transportsysteem, onder ander in de 
proximale tubulus, en hergebruikt in 
het lichaam. Bij de erfelijke nierziekte 
cystinose gaat er iets mis met deze 
twee recycling mechanismen van de 
lysosomen en de nieren.
Door een mutatie in ons erfelijk 
materiaal, het DNA, is er een 
transporteiwit op de lysosomen kapot. 
Dit eiwit, cystinosin, zorgt er normaal 
gesproken voor dat het aminozuur 
cystine na eiwitafbraak in de lysosomen 
weer beschikbaar komt voor de 
stofwisseling in lichaamscellen. Door 
het defecte cystinosin stapelt cystine 
zich op in de lysosomen. Dit kenmerk 
wordt ook gebruikt voor de diagnostiek 
van cystinose. Door de stapeling van 
cystine in de lysosomen treden er bij 
de meeste cystinose patiënten binnen 
een jaar na de geboorte nierproblemen
op, waardoor er nuttige stoffen, zoals 
suikers, zouten en kleine eiwitten, in 
de urine terechtkomen. Langzaam gaat 
de nierfunctie verder achteruit. Tijdens 
de vroege pubertijd zal de nierfunctie 
door nierdialyse of met behulp van 
een niertransplantatie moeten worden 
vervangen. Het ziekteverloop kan bij 
cystinose patiënten worden vertraagd 
met het medicijn cysteamine, dat de 
cystinestapeling sterk verlaagd, maar 
cystinose niet geneest. Dit proefschrift 
probeert meer inzicht te geven hoe de 
stapeling van cystine in de lysosomen 
kan leiden tot nierproblemen bij 
cystinose patiënten.
Om onderzoek te kunnen doen 
naar de verstoorde mechanismen in 
de cellen van cystinose patiënten, 
is het essentieel om cellen met 
gestapelde cystine in de lysosomen in 
het laboratorium te kunnen kweken. 
Omdat niercellen van cystinose 
patiënten vrijwel niet beschikbaar zijn, 
hebben onderzoekers in het verleden 
geprobeerd om gezonde niercellen 'op 
te laden' met een stof die lijkt op cystine. 
In dit proefschrift laten we zien dat dit 
model inderdaad cystine stapelt, maar 
dat er ook toxische processen optreden 
die niet in cystinose cellen voorkomen. 
De conclusies die met dit model in het 
verleden gemaakt zijn, moeten dus nog 
eens goed bekeken worden, liefst in een 
celmodel dat afbomstig is van cystinose 
patiënten met een DNA mutatie in het 
gen voor cystinosin.
Af en toe laten niercellen los,
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waardoor ze in de urine terecht komen. 
Door urine te verzamelen van cystinose 
patiënten én gezonde vrijwilligers, is 
het ons gelukt om niercellen in het 
laboratorium te kweken. Met behulp 
van een speciale techniek is er in deze 
cellen een virus ingebracht, zodat 
de cellen blijven delen. Daardoor 
kunnen we voldoende cystinose 
niercellen verkrijgen om uitgebreid 
onderzoek mee te doen. De gekweekte 
niercellen blijven hun specifieke 
kenmerken, waaronder een aantal 
transport systemen behouden. Het 
hier ontwikkelde celmodel uit gezonde 
personen is dus ook erg geschikt om de 
normale nierfunctie beter te kunnen 
onderzoeken.
Met behulp van het cystinose 
celmodel zijn twee mechanismen nader 
onderzocht, die mogelijk betrokken zijn 
bij de ontwikkeling van nierproblemen 
bij cystinose. Ten eerste hebben we 
onderzocht of de energiestofwisseling 
van cystinose cellen intact is. Aangezien 
het terugpompen van bruikbare stoffen 
uit de voor-urine veel energie kost, zou 
het verstoorde transport bij cystinose 
een gevolg kunnen zijn van een tekort 
aan energie. Opvallend was dat we 
inderdaad een verlaagd niveau vonden 
van de energierijke stof ATP, maar de 
productie van deze stof was geheel 
normaal. Wellicht dat deze verlaging 
een gevolg is van een hoger ATP 
verbruik.
Een ander mechanisme dat 
we hebben onderzocht in het nier
celmodel, is de status van antioxidanten 
in cystinose cellen. Antioxidanten 
zijn betrokken bij de bescherming 
van lichaamscellen tegen schadelijke 
stoffen, zoals zuurstofradicalen, die 
bij de stofwisseling vrijkomen. De 
belangrijkste antioxidant in de cellen 
is de stof glutathione. Om dit te 
kunnen bouwen, maakt de cel onder 
andere gebruik van cystine dat uit de 
lysosomen vrijkomt. Wanneer dit niet 
beschikbaar is, zoals bij cystinose, kan 
de aanmaak van glutathione verstoord 
raken en zo de natuurlijke afweer van 
cellen negatief beïnvloeden. In ons 
nier celmodel hebben we inderdaad 
een verandering gevonden van de 
glutathionestatus, die duidde op een 
verhoogde beschadiging. De oorsprong 
van deze beschadiging werd niet 
gevonden. Wel vonden we dat door 
het medicijn cysteamine toe te voegen, 
de cel meer beschermd was door een 
verhoogd glutathion gehalte.
Samenvattend laat dit proefschrift 
een aantal celmodellen zien, die meer 
inzicht kunnen geven in de verstoorde 
mechanismen bij cystinose in de cel 
als gevolg van de cystinestapeling. 
We hebben aangetoond dat zowel de 
energiestofwisseling als de status van 
anti-oxidanten in cystinose cellen zijn 
aangetast. Er zal meer onderzoek nodig 
zijn om vast te kunnen stellen of deze 
verstoringen direct van invloed zijn op 
het ziekteproces.
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Dankwoord
Op de kaft van dit proefschrift 
staat geheel onterecht de naam van 
slechts één auteur, terwijl de inhoud is 
geproduceerd door alles behalve één 
persoon. Ik zal proberen om op deze 
laatste pagina's iets goed te maken en 
de bijdrage van alle collega's, vrienden 
en familie vast te leggen. Waarschijnlijk 
is dat een grotere opgave dan het 
opschrijven van sommige voorgaande 
hoofdstukken.
Prof. Dr. E. Levtchenko. Lieve 
Elena, als analist van jouw promotie 
onderzoek, ben ik volgens jou 
"gegroeid van een 'schooljongen' 
tot een volwassen wetenschapper" 
(Proefschrift Elena Levtchenko, 2006). 
Toen jij aan mij voorstelde om het 
vervolg van jouw onderzoek voort te 
zetten als junior onderzoeker (en nóg 
volwassener te worden?) was ik je 
daar erg dankbaar voor. Jouw enorme 
inzet en betrokkenheid zijn voor mij de 
reden geweest om daar voor te gaan. 
In ruim vier jaar tijd ben jij ondertussen 
doorgegroeid van promovenda tot 
promotor. Dat heb je meer dan 
verdiend en daar mag je trots op zijn. 
Je eigen onderzoeksgroep in Leuven 
is groeiende, net als onze cellen, die 
je tot mijn verbazing (en schrik) ook 
zelf zou willen laten groeien... En wat 
je richtingsgevoel betreft: je kunt nog 
zoveel moeite hebben om de juiste 
route te vinden in een ziekenhuis, ik 
denk dat jij de juiste weg voor jou al 
lang hebt gevonden. Maar mocht je
de weg toch nog eens kwijt raken, zorg 
dan dat je de juiste mensen om je heen 
hebt verzameld die je weer op het juiste 
spoor kunnen zetten!
Prof. Dr. L. Van den Heuvel. Beste 
Bert, ondanks je enorme werklast was 
je in staat om op de juiste momenten 
de juiste eindjes aan elkaar te 
knopen. Uiteindelijk zijn de meeste 
knooppunten overwonnen en ligt hier 
een proefschrift voor je waarvan jij de 
promotor bent. Door jouw netwerk kon 
ik in Bristol aan mijn cellen werken. Je 
hebt me geleerd om niet altijd alles te 
zeggen wat ik denk, al denk ik dat je 
soms wel alles moet zeggen om elkaar 
beter te kunnen begrijpen. Ik hoop van 
harte dat je met al het getouwtrek om 
je heen het onderzoek met vertouwen 
tegemoet zult blijven gaan.
Prof. Dr. L Monnens. Beste prof, 
uw dromen zijn verdronken. Laat dit 
dan alstublieft in een zee van tijd zijn, 
want uw dromen zijn het waard nog 
lang voort te bestaan. Uw dromen 
voor deze wereld heeft u gemaakt 
vanuit een steeds kleiner wordend 
'verdonkhoekje'. Gelukkig mocht ik u 
daar af en toe uithalen voor uitstapjes 
naar het Begijnenhof in Diest of voor 
een bedevaart naar Scherpenheuvel, 
waar ik oprecht van genoten heb. Ik 
heb veel geleerd van de discussies die 
ik met u (of u met mij?) heb gevoerd, 
of het nu ging om de kwaliteiten van 
Kim Clijsters, de kwaliteit van zorg in
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een reorganiserend Radboud of de 
kwaliteit van de nierfunctie. Altijd liep 
ik, iets later dan gepland, iets wijzer bij 
u de deur uit. Ik hoop dat er nog een 
aantal dromen voor u en door u boven 
mogen komen drijven.
Dr. R. Masereeuw. Beste Roos, 
ik ben er hartstikke trots op dat jij 
mijn co-promotor bent. Jouw inzet 
en kennis hebben er voor gezorgd 
dat ons onderzoek, zeker wat betreft 
ons celmodel, een flinke impuls 
heeft gekregen. Je kritische, maar 
altijd vriendelijke blik heb ik enorm 
gewaardeerd. Dankzij jouw contacten 
klinkt er nog meer toekomstmuziek, 
waarvan de eindnoot hopelijk nog lang 
op zich zal laten wachten.
Een belangrijke groep mag ik hier 
zeker niet vergeten te bedanken: de 
cystinose patiënten. Zonder jullie 
vrijwillige medewerking was niets uit 
dit proefschrift mogelijk geweest. Elke 
keer als we voor ons onderzoek weer 
urine of bloed nodig hadden, was dit 
geen enkel probleem. Enkelen van 
jullie (en jullie ouders) heb ik mogen 
ontmoeten tijdens de poli's of op 
congressen. Hierdoor werd ik steeds 
weer gemotiveerd en besefte ik weer 
dat mijn 'cellen in een potje' veel 
meer zijn dan een onderdeel van mijn 
onderzoek.
Nooit zal ik vergeten hoeveel plezier 
ik heb gehad met mijn collega's van het
lab kindergeneeskunde en neurologie, 
laboratoriumgeneeskunde, LGEM, 
sectie P (what's in a name?). Naast de 
praktische hulp (of materiële hulp in 
de vorm van een gevulde urinepot) die 
velen van jullie hebben bijgedragen, 
hebben de vele koffiepauzes, uitjes 
en etentjes ervoor gezorgd dat ik 's 
morgens weer fluitend naar het lab 
wilde gaan. Nou ja, er waren ook 
genoeg uitjes waardoor er 's morgens 
van het fluiten niet veel terecht kwam. 
Door de vele labverhuizingen en 
afscheidsetentjes is het voor mij nu 
onmogelijk jullie allemaal bij naam te 
noemen. Toch noem ik er een paar.
Lieve Thea, je lachte al toen ik je voor 
het eerst zag bij mijn sollicitatiegesprek, 
terwijl je je hardop afvroeg wat jij met 
mij moest. Jaren later wist je wel beter 
toen de HUS even stil stond en er 
ineens urinecellen gekweekt moesten 
worden! Ik hoop dat je nog lang in het 
lab zult blijven lachen én 'zingen'.
Lieve Joyce, als mijn nierbuddy was 
jouw ontemmende enthousiasme voor 
mij elke dag weer een stimulans om ook 
zo'n proefschrift af te maken. Ondanks 
je (logische) keuze om het 'hard-core' 
labwerk te verlaten voor de kliniek ben 
ik erg blij dat we nog steeds contact 
hebben en hopelijk nog lang houden.
Thea en Joyce, met jullie als 
paranimfen heb ik zoveel vrolijkheid 
aan mijn zijde, waardoor de promotie
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minstens net zo leuk zal worden als 
onze tijd op het lab. Bedankt voor jullie 
steun!
De 'nieuwe lichting' niergroep wens 
ik ontzettend veel succes toe, binnen 
of buiten ons lab. Ik hoop dat het 
speerpunt Kindernefrologie nog een 
paar keer in de roos kan schieten.
Hoe chaotisch onderzoek doen ook 
is, met de DNA'tjes als directe buren, 
de mito-researchers van iets verder 
weg en die van achterin dat aquarium 
met hun high throughput full facility 
centrum werd het een chaos om met 
plezier op terug te kijken. Lieve Cindy 
en Saskia, bij sommige wedstrijden gaat 
het er niet om wie als eerste de finish 
haalt, maar om de manier waarop je 
dat doet. Jullie hebben veel kwaliteiten 
die jullie van jezelf nog moeten leren 
(er)kennen! Roel en Edwin, sinds het 
begin van mijn labcarriére kom ik al bij 
jullie voor alle genetische vragen, maar, 
eerlijk is eerlijk, meer plezier had ik in 
de dagelijkse popquiz-vragen om kwart 
voor vier! Rutger, Antoon, Leo Nijtmans 
en Richard Rodenburg, bedankt voor 
jullie hulp bij de mitochondriële kanten 
van mijn onderzoek.
Ook de spiergroep en weefselkweek 
als onderdeel van ons lab mag ik hier 
niet vergeten. Lang geleden zat ik nog 
samen met de spieren op één lab, 
daarna bruut gescheiden. Zonder jullie 
inzet en technologie was dit boekje een
flink aantal pagina's dunner geweest! 
De kweekgroep heeft ervoor gezorgd 
dat mijn cellen constant een fijne thuis 
hadden!
En dan 'Q'. De afstand tussen 'ons' 
lab en dat van 'jullie' is steeds weer 
overbrugbaar gebleken. En dat is maar 
goed ook, want jullie zijn hard nodig 
geweest voor dit proefschrift!
Addy van onze eigen cystinose 
groep wil ik hier als eerste bedanken. Je 
hebt enkele jaren geleden het cystinose 
onderzoek verlaten. Maar jou bijdrage 
hierin heeft enorm veel betekend voor 
de patiënten. Persoonlijk waardeer ik je 
directheid, al verschoot ik daardoor af 
en toe van kleur!
Prof. Dr. H. Blom. Beste Henk, jou wil 
ik bedanken voor je inzet in het begin 
van mijn onderzoek. Ik was erg blij met 
jou als 'rustpunt' in onze hectische 
besprekingen. Addy, Henk, jullie taken 
zijn in goede handen terecht gekomen.
Leo Kluijtmans, Jenneke, Dinny 
en Gwendolyne, jullie hebben het 
stokje van de cystine en glutathione 
bepalingen goed opgepakt en ik ben blij 
dat jullie tijd konden maken om steeds 
weer mijn monsters tussendoor te 
meten. Fokje, de polyolen-data liggen 
nog op de plank, klaar om eraf gehaald 
te worden!
Mijn enige echte eigen stagiaire 
ben ik natuurlijk niet vergeten. Lieve 
Dorien, je hebt met veel enthousiasme 
en doorzettingsvermogen aan het
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Pgp-project gewerkt. Je passie voor je 
stage beperkte zich niet tot op het lab, 
maar kreeg daarbuiten nog een veel 
mooier vervolg. Het Pgp-project kreeg 
uiteindelijk een langer vervolg en daar 
mag jij trots op zijn. Voor welke keuzes 
jij nog komt te staan en hoeveel stress 
je dat ook gaat opleveren, als je net 
zoveel enthousiasme toont als tijdens 
en na je stage wordt jouw toekomst 
fantastig toch!
Prof. Dr. Frans Russel. Beste Frans, 
jouw betrokkenheid bij het onderzoek 
heeft uiteindelijk geleid tot een octrooi 
aanvraag op ons celmodel. Door je 
kennis en netwerk wist je de juiste 
wegen hiervoor in te slaan. Je zakelijke 
aanpak tussen al het onderzoek door 
heb ik bewonderd en hier ben ik je zeer 
dankbaar voor.
De samenwerking met Farmacologie 
en Toxicologie heb ik tijdens mijn 
promotie altijd als zeer prettig ervaren. 
Miriam, Susan, tijdens jullie promotie 
traject konden we elkaar af en toe 
uit de brand helpen. Jeroen, mijn 
stempelkaart kom ik binnenkort nog 
wel inleveren. Janny, jij hebt flink werk 
gestoken in ons Pgp project, dat nog 
een vervolg heeft gekregen. Alwin, 
dankzij je 96-wells assay om ROS te 
meten heb ik me veel tijd bespaard! 
Rick, ik wens je heel veel succes toe met 
jouw promotie. Het uitgangsmateriaal 
is goed; en je weet wat ze zeggen over 
een goed begin!
Ook de Biochemie groep is me veel 
dank verschuldigd.
Dr. P. Willems. Beste Peter, jou oog 
voor het biochemische detail heeft me 
vaak aan het denken gezet. Dankzij jou 
steun en hulp van je groep zijn we onze 
cellen beter gaan begrijpen.
Sjoerd, als AIO bij Peter heb ik je 
leren kennen als die vrolijke Brabantse 
collega. Buiten het lab ben je een goede 
vriend geworden waar ik nog steeds 
graag een biertje mee drink.
Dear Fede, although I forgot you 
after we first met, I am absolutely 
positive that won't happen ever again. 
Wherever the future brings you, we'll 
keep in touch. As long as you make 
the pasta!
Herman, Jeanette, John, Henk- 
Jan, Werner, door jullie hulp liepen 
de meeste experimenten voor mij bij 
Biochemie vlekkeloos!
Dr. M. Cornelissen. Beste Marlies, 
na het vertrek van Elena verliep mijn 
contact met de cystinose patiënten 
via jou. Dankzij je 'wonderbonnen' 
kreeg ik elke keer toch nog op het 
laatste moment de benodigde plasjes 
in handen. Ondanks de bezuinigingen 
hoop ik dat de kindernefrologie in de 
toekomst de hoge kwaliteit kan blijven 
bieden voor onze patiënten en het 
patiëntgebonden onderzoek mogelijk 
blijft.
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Dr. J. Koenderink. Beste Jan, ik heb 
altijd veel plezier beleefd tijdens onze 
samenwerking bij het opwerken van 
de cellen van de hypomagnesemie 
patiënten. Ik ben blij dat dit toch nog 
tot een publicatie heeft geleid.
Dr. P. Scheffer. Beste Peter, dankzij 
jou techniek om isoprostanen te 
kunnen meten, hebben we meer inzicht 
gekregen in het effect de veranderde 
oxidatie status bij cystinosis. Bedankt 
voor je inzet!
Dr. H. Dijkman. Beste Henry, bedankt 
voor je expertise op het gebied van de 
electronen microscopie.
Onderzoek breekt landsgrenzen. 
Door de keuze van Bert en Elena ben ik 
bij onze Zuiderburen terecht gekomen. 
Voor een Limburger niet zo'n grote 
stap, maar toch. De tijd die ik op het 
lab in Leuven heb gewerkt, heb ik als 
plezant ervaren.
Joost, dat ene experiment met die 
andere cellen moet je denk ik toch 
ook nog eens proberen. Martine, laat 
je niet gek maken op het lab, straks 
in de kliniek wordt het alleen maar 
nog leuker! Sandra en Inge, met jullie 
enthousiasme en handigheid was het 
voor mij niet zo moeilijk om alles over 
te dragen. Ik wil jullie allevier heel erg 
bedanken voor mijn tijd in Leuven en 
hoop van harte dat jullie het onderzoek 
samen met Elena en Bert nog lang 
zullen voortzetten.
Prof. Dr. E.I. Christensen. Dear Erik, 
I am very thankful for the opportunity 
to perform my research in your lab. I 
have learned a lot from your expertise, 
which was a very nice experience 
thanks to your patience and hospitality. 
Working with you and your technicians, 
Anne, Pia, Henne and Inger have made 
my stay in Ârhus as great as the amount 
of protein reabsorbed by the proximal 
tubules every day. Mange Tak!
Prof. Dr. M. Saleem. Dear Moin, 
thanks to your experience on 
immortalizing podocytes, we were able 
to apply this technique on our tubular 
cells. I'd like to thank both you and Lan 
for our fruitful collaboration and Prof. 
Dr. Peter Mathieson for giving me the 
opportunity to stay at your lab in Bristol.
Prof. Dr. F. Emma. Dear Francesco, 
thank you for your giving your thoughts 
on our research, which really improved 
our manuscripts. I admire your creativity 
and open mind in science. Further, I 
really liked our meetings together with 
Anna , Francesco Bellomo and Coraline 
at the cystinosis conferences around 
the world.
Een accu gaat soms leeg en zal 
moeten worden opgeladen. Don, 
Edwin, Guido, Maikel, Luc, Tim, Josien 
en Chiel, Pieter en Inge, Ralph en José, 
René en Rianne, Roel en Noortje: 
bedank veur ut oplaaje van miene accu 
in de wiekende. En as we wér beej un
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plaskruuts sjtaon op un festivalwei, heej 
kin ge laeze wat d'r van kin kómme! 
Maikel, bedankt voor de grafische steun 
bij dit boekje!
Pap en Mam; Stan en Liselore; wao 
ich auch bin of nag naor toe zal gaon 
in de toekóms, veur mich is d'r mér 
eine thoës, wao ich gaer bliéf kómme! 
Bedank dèt geejmich heb groët gebrach 
en altiëd achter mich sjtong met wat ich 
auch deej of woej, woa ich auch waar.
En ge weit ut:
Geneet van 't leave, de leafs toch 
mèr ens!
Martijn
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van Dr. L. van den Heuvel en Prof. Dr. 
L. Monnens als research analist bij 
het Laboratorium Kindergeneeskunde 
en Neurologie, waar hij de praktische 
begeleiding verzorgde voor het 
promotietraject van kindernefrologe 
mw. Dr. E. Levtchenko. In deze periode 
verrichtte hij onderzoek naar de 
pathogenese van cystinose en heeft 
hij een aantal werkbezoeken afgelegd 
aan de University of Bristol, Groot 
Brittannië, onder leiding van Dr. M. 
Saleem. Door het verkrijgen van
een persoonlijke subsidie voor een 
werkbezoek van het Ter Meulen Fonds, 
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van Wetenschappen en het Sengers 
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kon hij in 2006 als junior onderzoeker 
starten bij het Laboratorium 
Kindergeneeskunde en Neurologie. Als 
onderdeel hiervan heeft hij zes maanden 
gewerkt aan de Universiteit van Aarhus, 
Denemarken, onder leiding van Prof. 
Dr. E. Christensen. Het laatste deel van 
zijn onderzoek naar de pathogenese 
van cystinose werd gefinancierd door 
een persoonlijke subsidie van de 
Cystinosis Research Foundation. De 
resultaten van dit promotieonderzoek 
staan beschreven in dit proefschrift. 
Van januari tot juni 2010 was hij onder 
leiding van Prof. Dr. E. Levtchenko 
en Prof. Dr. L.P. Van den Heuvel als 
wetenschappelijk onderzoeker aan 
de Katholieke Universiteit Leuven, 
België, betrokken bij het opstarten 
van het onderzoek aldaar naar de 
pathogenese van cystinose. Sinds 1 juli 
2010 is hij werkzaam binnen de afdeling 
Farmacologie-Toxicologie van het UMC 
St. Radboud onder supervisie van Dr. 
R. Masereeuw. Hier zal hij met behulp 
van het in dit proefschrift beschreven 
humane niercelmodel meer inzicht 
proberen te krijgen in de toxiciteit en 
klaring van potentiële geneesmiddelen 
via niertransporteiwitten.
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..so  what to do with all these questions
who and what and why
just sit back relax,
accept the comfort of the sky
Kevn Kinney, 'Whatever' 1999
206
Colofon
Development, evaluation and utilization 
of in vitro models in the investigation of 
Nephropathic Cystinosis
Een wetenschappelijke proeve op het gebied 
van de Medische Wetenschappen
Printed by:
Ipskamp drukkers, Nijmegen
Cover design and lay-out:
Martijn Wilmer and Studiomik.nl
Publication of this thesis was financially 
supported by:
Fonds Bevordering Wetenschappen, afdeling 
Kindergeneeskunde, Radboud University 
Nijmegen Medical Centre; Nierstichting 
Nederland; J.E. Jurriaanse Stichting; Abcam 
plc.; Perkin Elmer Netherlands B.V.
ISBN 978-90-9025551-4
© 2010 M.J.G. Wilmer, The Netherlands
207
